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ABSTRACT 
CHAPERONE-MEDIATED PROTEIN FOLDING IN THE ENDOPLASMIC 
RETICULUM 
FEBRUARY 2021 
BENJAMIN M. ADAMS, B.A., ASBURY UNIVERSITY 
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST 
Directed by: Professor Daniel N. Hebert 
Protein folding and maturation is a complex and error-prone process. Errors in 
this process may lead to deleterious effects ranging from non-functional single proteins to 
large-scale protein aggregation leading to cell death. It is essential for cellular function 
that protein misfolding does not occur unchecked, and therefore numerous chaperone 
systems exist within the cell. For the thousands of proteins which traffic through the 
secretory pathway, the primary site of folding and maturation is the endoplasmic 
reticulum (ER). Multiple chaperone pathways within the ER, generally termed ER 
protein quality control, must support the proper maturation process of these thousands of 
substrates. While some simple secretory pathway proteins may be able to fold with 
minimal chaperone engagement, more complex proteins may commonly misfold even 
under native conditions, which is especially important for multi-cellular organisms which 
have larger and more complex secretory pathway proteomes. 
viii  
The chaperone pathways within the ER engage substrates based generally on 
features those substrates possess. These include hydrophobic regions, free cysteines, and 
N-glycans. However, which substrates are selected by each of these pathways is not well
understood on a systematic level. The work presented here examines the chaperone 
selection process for a substrate which possess all features and demonstrates that 
substrate features do not dictate chaperone pathway engagement. As such, an 
understanding of which substrates are engaged by which pathway under endogenous 
conditions requires experimental determination. The N-glycan based chaperone pathway 
was next examined, and the substrates which heavily engage this process under 
endogenous conditions were described. This information allows for a previously lacking 
understanding of the folding and maturation process of many proteins and therefore 
presents possible interventions for the diseases and cellular functions associated with 
these proteins. 
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The site of protein folding and maturation for the majority of proteins that are 
secreted, localized to the plasma membrane or targeted to endomembrane compartments 
is the endoplasmic reticulum (ER). It is essential that proteins targeted to the ER are 
properly folded in order to carry out their function, as well as maintain protein 
homeostasis, as accumulation of misfolded proteins could lead to the formation of 
cytotoxic aggregates. Because protein folding is an error-prone process, the ER contains 
protein quality control networks that act to optimize proper folding and trafficking of 
client proteins. If a protein is unable to reach its native state, it is targeted for ER 
retention and subsequent degradation. The protein quality control networks of the ER that 
oversee this evaluation or interrogation process that decides the fate of maturing nascent 
chains is comprised of three general types of families: the classical chaperones, the 
carbohydrate-dependent system, and the thiol-dependent system. The cooperative action 
of these families promotes protein quality control and protein homeostasis in the ER. This 
review will describe the families of the ER protein quality control network and discuss 






Gunter Blobel’s seminal studies on protein targeting that led to his proposal of the 
signal hypothesis theory in the 1970s (Blobel & Sabatini, 1971; Blobel & Dobberstein, 
1975b, 1975a), laid the conceptual framework for later studies on the eukaryotic 
secretory pathway and provided a valuable experimental system to dissect processes 
involving the endoplasmic reticulum (ER) (Bulleid & Freedman, 1988; Nicchitta & 
Blobel, 1993; Hebert et al., 1995). A third of the proteome was later found to be targeted 
to the ER for entry into the secretory pathway for maturation and eventually secretion or 
delivery to various locations within the secretory/endocytic pathways (Huh et al., 2003). 
With the discovery of molecular chaperones a decade later by Ellis, Hartl, Horwich, 
Laskey, Lorimer, Pelham and others  (Laskey et al., 1978; Pelham, 1986; Cheng et al., 
1989; Goloubinoff et al., 1989; Ellis, 1996), protein folding and assembly was found to 
be an assisted process within the cell. Several molecular chaperone families reside in the 
ER to help these early maturation events including the folding reaction for proteins that 
traverse the secretory pathway. As protein folding is an error-prone process, prolonged 
binding to molecular chaperones is also utilized in an interrogation or evaluation process 
to determine if the structural integrity of the protein product is sound so that native 
proteins can be passed along the secretory pathway and non-native products can be 
retained and repaired, or eventually sorted for degradation. This cellular interrogation 
step was termed protein quality control by Ari Helenius shortly after the discovery of 
molecular chaperones (Hurtley & Helenius, 1989). In this article, we will review the 
quality control processes that take place in the early eukaryotic secretory pathway or ER 
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that seek to ensure that only native substrates are passed along the secretory pathway 
while terminally misfolded proteins are targeted for degradation. 
 The ER is the site of protein maturation for secretory pathway cargo. These 
processes are assisted by chaperone and oxidoreductase family members that help 
increase the efficiency of reaching the native and active state of a protein. Many of these 
maturation assistance factors are also central players in the protein quality control 
evaluation and sorting processes. There are three general categories of protein quality 
control factors in the ER that will be discussed below: (1) the classical molecular 
chaperone systems; (2) glycan-dependent molecular chaperone systems; and (3) thiol-
dependent oxidoreductases. These factors play diverse but well integrated roles in 
maintaining protein homeostasis in the ER that involves the passage of properly folded 
cargo, while defective cargo is retained and subsequently degraded.  
 
The Classical Chaperones of the ER 
Chaperones from the classical heat shock (heat shock proteins, Hsp) families 
generally bind to hydrophobic domains on substrates in order to promote productive 
folding and prevent aggregation (Horwich et al., 1990). The binding cycle of the classical 
chaperones is regulated by adenine nucleotides. The ER contains members from the 
Hsp40s, Hsp70 (BiP/GRP78) and Hsp90 (GRP94) families. Of these, BiP is the most 
abundant and appears to play the widest role in the ER, including assisting protein 
folding, protein translocation, ER retention and promotion of ER-associated degradation 
(ERAD) of misfolded substrates, and inducing the unfolded protein response (UPR) 
4 
 
signaling cascade (Hendershot, 2004; Behnke et al., 2015). Here, we will focus largely on 
the protein quality control functions of BiP and its associated regulators.  
BiP binds promiscuously to clients frequently at a number of sites on a maturing 
protein (Behnke et al., 2016; Blond-Elguindi et al., 1993). These sites are generally 
hydrophobic and contain alternating aliphatic residues (Flynn et al., 1991; Blond-
Elguindi et al., 1993). There are algorithms that predict BiP sites on client proteins by 
analyzing the primary amino acid sequence (Schneider et al., 2016). However, the 
utilization of these predicted sites by BiP requires experimental demonstration for 
validation. BiP interacts with substrates via its substrate binding domain (SBD) that is 
regulated by its nucleotide binding domain (NBD; Figure 1.1A and B) (Behnke et al., 
2015). When the NBD is bound by ATP, BiP exhibits a low substrate affinity due to the 
lid of the SBD being in an open conformation, leading to a high on-and-off rate of the 
substrate. Hydrolysis of ATP, leaving BiP in an ADP-bound state, increases substrate 
affinity by allowing the lid of the SBD to close over the substrate. In the case of some 
substrates, direct interaction between the lid and the substrate can occur without the lid 
domain closing over the substrate, therefore allowing for significant substrate tertiary 
structure and suggesting that BiP has a relatively flexible substrate preference (Schlecht 
et al., 2011).  
BiP co-factors regulate the binding and release of substrates. Proteins that contain 
J-domains or HPD motifs (the tripeptide His-Pro-Asp) are known to interact with Hsp70 
family members to induce their ATPase activity at locations throughout the cell 
(Kampinga et al., 2018). The ATPase activity of BiP is stimulated by the ERdj proteins 
that also assist the recruitment of substrates to BiP (Otero et al., 2010). Release of 
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substrate occurs when ADP is exchanged for ATP, placing BiP back in a low substrate 
affinity conformation. Nucleotide exchange is regulated by nucleotide exchange factors 
(NEFs). There are two known NEFs for BiP: Sil1 and Lhs1 in Saccharomyces cerevisiae 
(Boisramé et al., 1998; Kabani et al., 2002; Tyson & Stirling, 2000), and Bap and 
GRP170 are mammalian homologues (Tyson & Stirling, 2000; Chung et al., 2002; Steel 
et al., 2004; Behnke et al., 2015). GRP170, in addition to being a NEF for BiP, also 
possesses a region that is homologous to Hsp70 itself (X. Chen et al., 1996). However, 
the role for this region is uncertain.  
In yeast, BiP (Kar2p), is localized to the ER translocon by its association with 
the J-domain protein Sec63 (Matlack et al., 1999). This positions BiP in its substrate 
bound state to help with the translocation and early stages of nascent chains folding to 
its native state (Nicchitta & Blobel, 1993; Helenius & Hammond, 1994; Hebert et al., 
1998). BiP also plays a central role in targeting misfolded proteins for degradation 
(Plemper et al., 1997; Skowronek et al., 1998; Brodsky et al., 1999). These alternate fates 
for a BiP substrate may be directed by multiple factors. Prolonged substrate binding, as 
opposed to transient interactions with early folding intermediates, may target a 
substrate for ERAD (Farinha & Amaral, 2005; Sörgjerd et al., 2006). Further specificity 
may be conferred by the BiP cofactor J-proteins. While the role of each J-protein is 
currently unclear, certain J-proteins have been shown to promote distinct fates for BiP 
substrates. ERdj4 promotes the degradation of a natural variant of surfactant protein C 
(SP-C) and represses UPR by promoting BiP interaction with IRE1 and repressing 
IRE1 dimerization (Dong et al., 2008; Amin-Wetzel et al., 2017). ERdj5 possesses 
reductase activity and has been shown to promote the degradation of multiple substrates 
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including SP-C and the a1-antitrypsin variant null Hong Kong (NHK), possibly by 
reduction of disulfide bonds, allowing the substrate to be threaded through the ERAD 
retrotranslocon (Cunnea et al., 2003; Dong et al., 2008; Ushioda et al., 2008). A cellular 
peptide library demonstrated that ERdj4 and ERdj5 recognize peptides rich in aromatic 
residues, suggesting that these J-proteins recognize misfolded residues exposing 
aggregation prone domains and therefore support degradation of these proteins (Behnke 
et al., 2016). ERdj3 has a diverse set of roles, but generally promotes protein folding 
(Behnke et al., 2015; Khodayari et al., 2017). However, ERdj3 can also promote 
degradation of specific substrates such as b-glucocerebrosidase (Tan et al., 2014). 
ERdj6 (p58IPK) appears to promote protein folding and the protection against ER stress 
(Rutkowski et al., 2007). The J-domain co-factors of BiP control the localization of 
BiP, its substrate selection, and activity, thereby contributing to the diversification of its 
roles in ER protein quality control.  
The activity of BiP can also be regulated by chemical modification. In the absence 
of ER stress, BiP is chemically modified by AMPylation (Ham et al., 2014; Anwesha et 
al., 2015; Preissler et al., 2015). AMPylation of BiP by FICD (or HYPE) has been 
shown to be inhibitory to BiP substrate binding as it confers a substrate affinity similar 
to the ATP-bound state (Preissler, Rohland, et al., 2017). AMPylation does not inhibit 
ERdj protein binding but allosterically inhibits ERdj mediated ATP-hydrolysis, causing 
BiP to remain in a low substrate affinity state. Under stress, the level of BiP increases 
and it is de-AMPylated by FICD, which can act to both AMPylate and de-AMPylate BiP, 
depending on its functional state (Figure 1.1B) (Preissler et al., 2015; Preissler, Rato, et 
7 
 
al., 2017). In this manner, a large pool of BiP can be quickly converted into an active 
state upon ER stress, thereby decreasing the time required to respond to stress. 
While the ER hsp90 family member GRP94, is absent from the yeast ER, it is found in 
higher eukaryotes. ERAD substrates including α-1 antitrypsin NHK and γ-aminobutyric 
acid type A (GABAA) receptors were stabilized by the knockdown of GRP94 in cells 
(Christianson et al., 2009; Zhong et al., 2015; Di et al., 2016). These studies also found 
GRP94 associated with the lectin ERAD receptor, Os-9, and the ERAD E3 ligase HRD1. 
However, other data demonstrates that Os-9 preferentially interacts with 
hyperglycosylated GRP94, and knockdown of GRP94 does not stabilize α-1 antitrypsin 
NHK (Dersh et al., 2014). Together these results support a possible role for GRP94 in 
ERAD substrate selection and targeting, but these conclusions remain unclear. 
 
Carbohydrate-dependent protein quality control 
The majority of proteins that are targeted to the ER are N-linked glycosylated 
(Apweiler et al., 1999). N-linked glycosylation plays numerous roles during protein 
folding. These large, hydrophilic protein appendages promote protein solubility and alter 
folding energetics (Figure 1.2), as well as protein function (Haraguchi et al., 1995; Cai et 
al., 2005; Skropeta, 2009; Culyba et al., 2011; Hebert et al., 2014). N-linked glycans also 
act as reporters of the folded state and age of the glycoprotein. As a glycoprotein folds 
and matures, the glycan is modified, through both trimming and addition, and these 
modifications affect the glycoprotein’s interaction with carbohydrate-binding proteins 
resident to the ER, thereby altering folding and trafficking (Hebert et al., 2005; Caramelo 
& Parodi, 2015; Lamriben et al., 2016). At the hub of the glycan-dependent quality 
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control system are the lectin chaperones calnexin and calreticulin. Calnexin and 
calreticulin substrate binding plays a central role in the folding and quality control of 
glycosylated cargo in the ER. 
The N-linked glycan (Figure 1.2) is preassembled on a dolichol phosphate in the 
ER membrane and is appended en bloc by the oligosaccharyltransferase (OST) as 
GlcNAc2Man9Gluc3 to the Asn in the consensus site of Asn-X-Ser/Thr (where X is not 
Pro) on the substrate (Breitling & Aebi, 2013; Lamriben et al., 2016). While most 
glycosylation occurs co-translationally via OST complexes containing the catalytic 
subunit STT3A, skipped acceptor sites can be glycosylated post-translationally via 
STT3B-containing OST complexes (Shrimal et al., 2015).  
After glycosylation, the glycan is then trimmed by a-glucosidase I, generating a 
glycan with two glucoses. In this state, the glycoprotein can interact with the lectin 
malectin. Malectin is a membrane-associated ER-resident protein that specifically 
recognizes di-glucosylated glycans (Schallus et al., 2008). Malectin associates with the 
OST component ribophorin I and acts to retain misfolded glycoproteins in the ER (Qin et 
al., 2012; K. Takeda et al., 2014). The ER retention role of malectin is somewhat 
surprising as it resides in a region of the ER where early folding steps occur. A potential 
answer to this conundrum may be that malectin is ER-stress induced, and therefore may 
only play a relevant role under stress when proteins translocating into the ER are less 
likely to undergo productive folding (Galli et al., 2011). Alternatively, the association of 
malectin with an OST subunit may aid in glycosylation of downstream sites as most 
glycoproteins contain more than one site of modification. 
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Trimming of the second glucose by a-glucosidase II creates monoglucosylated 
glycans. In this state, the glycan can be bound by the membrane-bound lectin chaperone 
calnexin or its soluble paralogue calreticulin that bind to monoglucosylated glycans with 
micromolar affinity (Figure 1.4) (Hammond et al., 1994; Schrag et al., 2001; 
Gopalakrishnapai et al., 2006). Trimming of the final glucose by a-glucosidase II yields a 
non-glucosylated glycan that supports release of the glycoprotein from calnexin and 
calreticulin. In this state, natively folded glycoproteins can be further trafficked through 
the ER. Non-natively folded glycoproteins are recognized by the folding sensor UDP-
glucose: glycoprotein glucosyltransferase 1 (UGGT1). UGGT1 reglucosylates substrates 
regenerating monoglucosylated glycans that then become substrates for 
calnexin/calreticulin rebinding, supporting retention of misfolded substrates while 
allowing for continued folding (Hebert et al., 1995; Sousa & Parodi, 1995a). Cycles of 
substrate binding to calnexin and calreticulin, trimming by a-glucosidase II, and 
reglucosylation by UGGT1 support the retention of misfolded glycoproteins in the ER 
while promoting folding through interactions with chaperones and their associated co-
factors. As such, UGGT1 acts as a gatekeeper of the calnexin/calreticulin cycle, 
determining if glycoproteins may exit the ER or must be retained.  
While calnexin and calreticulin share 39% sequence identity, each has unique 
properties (Hebert et al., 1997; Vassilakos et al., 1998). Both calnexin and calreticulin are 
composed of a lectin domain, a flexible proline-rich domain (P-domain) and a C-terminal 
domain (Figure 1.3A and B) (Schrag et al., 2001). Calnexin possesses a transmembrane 
domain near its C-terminus, while the soluble calreticulin’s C-terminal domain has low 
affinity and high capacity calcium binding sites comprised of a series of acidic residues 
10 
 
that support its role as a calcium buffer (Z. Li et al., 2001). The lectin binding domain of 
both calnexin and calreticulin folds to a globular conformation containing a single 
carbohydrate binding site (Figure 1.3B). Isothermal calorimetry data has demonstrated 
that the lectin domain alone is capable of binding substrate (Kozlov, Pocanschi, et al., 
2010). The P-domain adopts an extended, arm-like conformation with a hairpin turn. The 
P-domain of calnexin contains four copies of a Pro rich motif (Ellgaard et al., 2002), 
while the P-domain of calreticulin contains three such motifs, though both are structurally 
similar. The P-domain of both calnexin and calreticulin are interaction sites for the 
cofactors ERp57 and ERp29, protein disulfide isomerases; and cyclophilin B, a peptidyl 
proline isomerase (Oliver et al., 1997; Kozlov, Bastos-Aristizabal, et al., 2010; Kozlov et 
al., 2017a). By interacting with a diverse set of folding factors, the P-domains of calnexin 
and calreticulin function to bring substrates and folding factors in close proximity, 
supporting productive protein folding and quality control. 
 UGGT1 is a soluble ER-resident protein consisting of an N-terminal folding 
sensor domain and a C-terminal glucosyltransferase domain. Recent x-ray crystal 
structures from both Thermomyces dupontii and Chaetomium thermophilum have found 
that the N-terminal domain consists of four catalytically inactive thioredoxin like 
domains (Roversi et al., 2017; Satoh et al., 2017). Three of these domains are sequential 
while the fourth is non-sequential, comprised of long range interactions. The N-terminal 
folding sensor domain adopts a flexible, curved conformation with a prominent central 
cavity that contains hydrophobic patches. These findings suggest that UGGT1 interacts 
with high-mannose substrates primarily via hydrophobic interactions. UGGT1 has a 
homologue UGGT2 that is 55% identical to UGGT1. UGGT2 has been shown to possess 
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an active glucosyltransferase domain when domain swapped with UGGT1, but biological 
substrates have not been identified for UGGT2 (Y. Takeda et al., 2014).  
Selenoprotein 15 (Sep15/Selenof) is a UGGT binding protein with redox activity 
(Ferguson et al., 2006). Sep15 interacts tightly with UGGT1 and 2, such that the entire 
pool of Sep15 is bound to UGGT1/2, though not all UGGT1/2 are bound by Sep15 
(Korotkov et al., 2001). In vitro, Sep15 has been shown to increase the enzymatic activity 
of UGGT1/2 (Y. Takeda et al., 2014). Sep15 may modulate the selection of substrates by 
UGGT or act upon substrates modified by UGGT to help with their repair and folding 
(Yim et al., 2018). Selenocysteines, considered the 21st amino acid, are found in the 
active site of Sep15. Since selenocysteines generally possess reducing or disulfide bond 
breaking activity, it is possible that Sep15 acts to reduce disulfides to try to repair non-
native cargo. Additional work is needed to elucidate the biological role of Sep15. 
 The roles of the calnexin/calreticulin cycle are diverse and important for proper 
ER function. These roles range from promoting productive folding, limiting deleterious 
folding pathways and aggregation, and retention of non-native or incompletely assembled 
proteins (Rajagopalan & Brenner, 1994; Cannon et al., 1996; Vassilakos, Myrna, et al., 
1996; Hebert et al., 1996). Indicative of these vital roles is the embryonic lethality of 
knocking out multiple factors in the calnexin/calreticulin pathway including calreticulin 
(18 days), UGGT1 (13 days) and ERp57 (13.5 days) (Mesaeli et al., 1999; Molinari et al., 
2005; Coe et al., 2010). Calnexin knockout mice display decreased rates of survival 
within 48 hr post-birth while survivors displayed multiple motor disorders (Denzel et al., 
2002). Such lethality and disorders are indicative of the diverse roles of calnexin and 
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calreticulin, and the extensive set of substrates that are dependent on this carbohydrate-
dependent chaperone pathway for proper folding and trafficking.  
 A central role of the calnexin/calreticulin pathway is to promote proper folding of 
glycoprotein intermediates. Numerous substrates exhibit reduced folding efficiency and 
decreased rates of trafficking when interactions with calnexin and calreticulin are 
abrogated, including hemagglutinin, neuraminidase, vesicular stomatitis virus G protein, 
MHC class I, antithrombin III and corin (Cannon et al., 1996; Hebert et al., 1996; 
Vassilakos, Myrna, et al., 1996; N. Wang et al., 2008; Chandrasekhar et al., 2016; H. 
Wang et al., 2018). Calnexin and calreticulin act as molecular chaperones by decreasing 
the rate of folding of substrates in a region-specific manner (Hebert et al., 1997; Daniels 
et al., 2003; Chandrasekhar et al., 2016; N. Wang et al., 2008). This is done by sterically 
blocking regions proximal to the glycan interacting with the lectin domain while leaving 
regions distal to the glycan free to fold or interact with other factors. In this manner, the 
folding pathway of a protein can be determined both by the amino acid sequence and the 
location of glycans. 
When proper folding or multimer assembly of calnexin and calreticulin substrates 
does not occur, the calnexin/calreticulin pathway generally acts to retain such substrates 
through persistent reglucosylation by UGGT1 and rebinding to calnexin or calreticulin 
(Gao et al., 2002; Pearse et al., 2008, 2010; Tannous et al., 2015). However, data from 
UGGT1-/- mouse embryonic fibroblasts showed that the effect of reglucosylation and 
interaction with the calnexin/calreticulin pathway is substrate specific (Soldà et al., 
2007). There appears to exist three classes of UGGT1 substrates. The first class are 
proteins that require only one round of binding to calnexin or calreticulin, and therefore 
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do not require reglucosylation by UGGT1 to fold properly. When UGGT1 is knocked 
out, the trafficking of these proteins is unaltered. The second class involves proteins that 
are secreted faster when reglucosylation does not occur, and this might be due to the 
decreased interaction time with calnexin/calreticulin. Alternatively, some proteins 
displayed decreased rates of secretion, suggesting that reglucosylation and multiple 
rounds of calnexin/calreticulin binding acts to increase the rate of secretion. This may be 
due to the calnexin/calreticulin pathway promoting folding efficiency and sequestration 
of structural elements that act to retain such substrates in the ER. Overall, the 
calnexin/calreticulin pathway alters the folding and trafficking of a diverse set of 
substrates, but it does not function in a common manner for all substrates. Eventually 
non-productively folding substrates must be extracted from the calnexin/calreticulin cycle 
for targeting for degradation to maintain proper ER homeostasis (Tannous et al., 2015). 
Mannose trimming plays a central role both in the extraction of terminally misfolded or 
slow folding glycoproteins from the calnexin/calreticulin cycle and the sorting for 
degradation to the ERAD process. Trimming of A-branch mannose residues precludes the 
ability of UGGT1 to modify the glycan for calnexin and calreticulin rebinding. Whereas 
removal of B- and C-branch mannoses creates a degradation signal that is recognized by 
downstream sorting lectins that target the demannosylated substrates for ERAD. The 
secretory pathway possesses a number of mannosidases that trim the various mannose 
residues including ER mannosidase I (ER Man I also called Man1B1), the EDEM family 
members (EDEM1-3), Golgi a1,2-mannosidases (Golgi Man IA, IB, and IC) and 
endomannosidase that help to support these functions (Figure 1.5) (Olivari & Molinari, 
2007; Sunryd et al., 2014; Caramelo & Parodi, 2015). 
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 The extraction of substrates from the calnexin and calreticulin binding cycle 
appears to be cell type dependent. Some cells possess an endomannosidase activity 
capable of cleaving the A-branch mannose residues and abolishing UGGT1 modification. 
However, this activity is missing from Chinese Hamster Ovary (CHO) cells and possibly 
other cells (Karaivanova et al., 1998). While EDEM1 has been shown to be able to 
extract substrates from the lectin chaperone binding cycle (Molinari et al., 2003; Oda et 
al., 2003), it is not clear if this is through direct binding to the substrate, mannose 
trimming of the A-branch glycans, or possibly the utilization of both properties. Further 
investigation is required to understand the full mechanism of extraction of misfolded 
substrates from the calnexin and calreticulin binding cycle. 
 Treatment with mannosidase inhibitors stabilizes ERAD substrates (Su et al., 
1993). Mannose trimming on B- and C-branches is linked to creating a degradation signal 
on ERAD glycoprotein substrates. Initially, it was thought that the transition of the N-
linked glycans to Man8GlcNAc2 sorted the protein for ERAD (Jakob et al., 1998). ER 
Man I/Man1B1 has been implicated in removing the B-branch terminal mannose and 
recognizing tertiary and quaternary structure (Aikawa et al., 2012; Shenkman et al., 
2018). The activity of ERManI/Man1B1 is enhanced in the presence of the 
oxidoreductants PDI or TXNDC11 (Shenkman et al., 2018). In S. cerevisiae, the ER Man 
I equivalent, Mns1p, removes the outermost mannose from branch B, creating an eight 
mannose residue glycan (termed M8B) (Jakob et al., 1998; Słomińska-Wojewódzka & 
Sandvig, 2015). More recent studies discovered that degradation signaling required an 
additional ER mannosidase in yeast, Htm1p, that removes the C-branch terminal 
mannose, to expose an a1,6-linked mannose residue, and it is this residue that is the 
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signal for ERAD (Jakob et al., 1998; Quan et al., 2010). The ER lectin yos9p recognizes 
and binds ERAD substrates containing exposed or terminal a1,6-linked mannoses and 
targets them to the Hrd1p-containing dislocon complex in the ER membrane for 
dislocation, ubiquitination and degradation by the proteasome (Bhamidipati et al., 2005; 
W. Kim et al., 2005; Szathmary et al., 2005; Denic et al., 2006). 
 The process in metazoans appears to be more complex as the mannosidases 
involved have diversified. The EDEM family of three (EDEM1-3) serves as homologues 
to Htm1p. While all three EDEM family members have now been shown to possess 
mannosidase activity in cells, as well as using purified proteins more recently (Olivari et 
al., 2005; Hosokawa et al., 2010; Ninagawa et al., 2014; Lamriben et al., 2018; 
Shenkman et al., 2018), the precise glycans they act upon and generate remains uncertain. 
Following the yeast paradigm, ER ManI/Man1B1 and the EDEMs work together to 
create Man7-5 glycans with exposed a1,6-linked mannose residues on the C-branch 
(Ninagawa et al., 2014). These demannosylated ERAD substrates are recognized by two 
downstream mannose-receptor homology (MRH) domains containing lectins that reside 
in the ER; OS9 and XTP3B (Hosokawa et al., 2008; Christianson et al., 2009; van der 
Goot et al., 2018). It is these carbohydrate-binding proteins that then target the substrate 
to the HRD1 dislocation/ubiquitination complex in the ER membrane. Multiple 
mechanisms likely protect substrates from improper trimming by mannosidases including 
mannosidase sub-compartmentalization and regulated concentration of mannosidases in 
the ER (Calì et al., 2008; Benyair et al., 2015). 
 The mannosidases involved in ERAD do not act as traditional glycosidases that 
trim glycans by transiently interacting with the carbohydrate. Some of them appear to 
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contain folding sensing properties directly or through their associated co-factors. Htm1p 
mannosidase activity is aided by an associated oxidoreductase, Pdi1p (Gauss et al., 2011; 
C.-Y. Liu et al., 2016). While EDEM1 appears to stably bind ERAD substrates 
independently of its associated factors BiP and ERdj5, its binding appears to be bi-partite 
in that it has a stable interaction that survives harsh treatments that is thiol dependent and 
likely covalent, as well as a weaker interaction with substrates that is thiol independent 
(Cormier et al., 2010; Lamriben et al., 2018). The associated ERdj5 appears to assist in 
the reduction of substrates to make them competent for dislocation but is not required for 
thiol dependent binding (Ushioda et al., 2008; Cormier et al., 2010; Ushioda et al., 2013; 
Lamriben et al., 2018). BiP is recruited to the EDEM1 complex by the J-domain of 
ERdj5. BiP may also contribute to ERAD substrate selection, translocation preparation 
and dislocon complex delivery in some way. 
 The role for EDEMs in protein quality control is further complicated by the fact 
that they also appear to bind and select substrates in a glycan-independent manner 
(Cormier et al., 2010; Tang et al., 2014; Lamriben et al., 2018). In the case of EDEM1, 
the mannosidase-like domain can also act as a lectin and aid in the delivery of ERAD 
substrates to downstream dislocation complex by binding to the N-linked glycans on the 
HRD1 complex adapter, SEL1L (Hrd3p homologue in yeast) (Cormier et al., 2010; Saeed 
et al., 2011). While mannose trimming clearly marks terminally misfolded substrates for 
turnover through the ERAD process, the versatility and possible redundancy of lectin 





Thiol-dependent protein quality control 
The ER is an oxidizing environment and the site of disulfide bond formation 
between proximal Cys pairs on maturing proteins. Disulfide bonds are crucial for the 
structure and activity of many proteins that traverse the secretory pathway. Numerous 
oxidoreductase proteins in the ER aid in the formation, reduction, and isomerization of 
disulfide bonds in order to ensure the correct native disulfides are formed, which is 
dependent upon the redox potential of an active site disulfide (Figure 1.6). As most Cys 
are paired in disulfides before trafficking from the ER, free thiols can act as an indicator 
that a protein is non-native. The ER has quality control machinery that recognizes 
proteins with free thiols. While extensive studies have been performed to elucidate the 
mechanism of disulfide bond formation and the factors involved, here we will focus on 
thiol-dependent protein quality control. 
 Protein disulfide isomerase (PDIf) is a large family of ER proteins with more than 
twenty members that play essential roles in disulfide bond formation and maintenance 
(Hatahet & Ruddock, 2007; Appenzeller-Herzog et al., 2008; Määttänen et al., 2010; 
Saeed et al., 2011; Sato et al., 2013). We will focus on a subset of PDIf which are well 
characterized, though other proteins of the PDI family exist which may interact with a 
smaller subset of clients (TXNDC5, TXNDC15, TMX1, etc.). A protein by the same 
name as the family is also used to identify the most abundant member of the family and 
PDI can help form, reduce, and isomerize disulfide bonds. The oxidative partner of PDI 
is ERO1a/b, allowing PDI to remain in a redox competent state (Sevier & Kaiser, 2008). 
PDI is comprised of four thioredoxin like domains; a, b, b’ and a’. Of these domains, a 
and a’ are active thioredoxins, containing catalytically active Cys-Xxx-Xxx-Cys motifs 
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(Oka & Bulleid, 2013). PDI appears to be able to bind substrates in both a redox 
dependent and independent manner as the b’ domain of PDI binds to hydrophobic 
substrates (McLaughlin & Bulleid, 1998; Pirneskoski et al., 2004; Denisov et al., 2009). 
PDI may be capable of scanning proteins for misfolded regions and potentially oxidize, 
reduce, or isomerize disulfide bonds of clients in order to promote proper folding 
(Okumura et al., 2015). PDI is a versatile protein as it has also been shown to promote the 
degradation of misfolded substrates (Forster et al., 2006). 
Two members of the PDI family associate with the P-domain of calnexin and 
calreticulin, ERp57 and ERp29, for recruitment to glycosylated substrates. Similar to 
PDI, ERp57 is comprised of four thioredoxin-like domains of which two are catalytically 
active (Frickel et al., 2004). ERp57 acts as an oxidoreductase and is brought in close 
contact with glycoprotein folding intermediates or retained substrates through its 
interaction with the carbohydrate-binding chaperones, allowing for scanning of substrates 
to ensure proper disulfide bonding (Zapun et al., 1998). ERp29 is unusual in that it is a 
dimer and lacks a catalytic active site as it only possesses a single Cys residue. It is 
possible that this Cys is used for isomerization. Its role in polyomavirus infection and 
virus disassembly and penetration across the ER membrane is analogous to the 
preparation and translocation of aberrant proteins for ERAD but this connection will 
require further investigation (Walczak & Tsai, 2011).  
ERp72 consists of five thioredoxin domain; a°, a, a’, b, and b’, of which a°, a, and 
a’ possess catalytically active Cys-Xxx-Xxx-Cys motifs (Mazzarella et al., 1990). 
Despite the high level of structural similarity to ERp57, ERp72 does not interact with 
calnexin or calreticulin, likely due to differences in exposed surface charges (Kozlov et 
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al., 2009). However, ERp72 interacts with cyclophilin B via a polyacidic stretch of amino 
acids on ERp72 (Jansen et al., 2012). This interaction increases the rate of in vitro folding 
of immunoglobulin G. ERp72 retains misfolded cholera toxin and thyroglobulin as shown 
by RNAi and overexpression studies (Forster et al., 2006). ERp72 has been shown to 
stably interact with and retain thyroglobulin through a disulfide bond (Menon et al., 
2007). While more work is needed to fully understand the role of ERp72, these data 
suggest that ERp72, for a subset of clients, promotes folding and ER retention.  
ERdj5 is the largest PDI family member. It has six thioredoxin domains and a J-
domain that recruits BiP. Its redox state favors a role as a reductase for preparation of 
non-native proteins for dislocation to the cytoplasm for proteasomal degradation 
(Ushioda et al., 2008). ERdj5 can reduce glycosylated substrates through its association 
with EDEM1. BiP can also capture nonglycosylated ERAD substrates independent from 
EDEM1 for passage to ERdj5 and delivery to the SEL1L/HRD1 dislocation complex 
(Ushioda et al., 2013). Work from the Hendershot group using a peptide library, mapped 
ERdj5 binding sites to aggregation-prone sequences on a protein underscoring its role in 
quality control (Behnke et al., 2016). The structure of ERdj5 is dynamic as measured by 
high-speed atomic force microscopy and this flexibility in some way assists its ability to 
enhance ERAD (Maegawa et al., 2017). ERdj5 plays a central reductive role in the 
preparation of both glycosylated and non-glycosylated substrates for degradation. 
 While numerous proteins facilitate proper disulfide bond formation, errors can 
occur that could, if progressed unchecked, lead to secretion of non-native proteins with 
free Cys. This is potentially problematic as reactive thiols can enhance aggregation 
mediated by non-native intermolecular disulfide bonds. As such, ER quality control 
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recognizes proteins with non-native, reactive free thiols and retains them in the ER. 
ERp44 is a soluble chaperone of the protein disulfide isomerase family that cycles 
between the ER and early Golgi (Anelli et al., 2007). It contains three thioredoxin 
domains; a, b, and b’, of which a is catalytically active (Määttänen et al., 2010). ERp44 
uses Cys29 to retain non-native or unassembled substrates containing free thiols and this 
has been shown for substrates including unassembled IgM, adiponectin and SUMF1 
(Tiziana et al., 2003; Qiang et al., 2007; Fraldi et al., 2008; Mariappan et al., 2008). The 
manner in which ERp44 binds and retains proteins in the ER is proposed to be pH 
dependent (Anelli et al., 2015; Watanabe et al., 2017). In this model, ERp44 traffics from 
the ER to the Golgi, where the pH is progressively lower. The C-terminal tail of ERp44 
undergoes a pH-dependent conformational change in the Golgi, exposing the Cys29 
necessary for client binding while also exposing the RDEL retention/retrieval sequence at 
its C-terminus (L. Wang et al., 2008; Vavassori et al., 2013). ERp44 then traffics back to 
the ER by interacting with KDEL receptors with its substrate covalently attached. It is 
currently unclear how ERp44 releases substrates upon re-entry into the ER, though the 
intermolecular disulfide bond is likely reduced by another member of the PDI family. In 
this manner, clients with free thiols can be retained in the ER via cycling between the ER 
and early Golgi.  
Open questions remain regarding the extent to which free thiols act as hallmarks 
of misfolded proteins. Native proteins with free thiols exit the ER for secretion or 
residence in the lysosome, as in the case of lysosomal cysteine proteases with active site 
cysteines. How these proteins escape quality control recognition is unclear. One 
possibility is any unpaired Cys are buried and therefore not accessible to factors involved 
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in recognizing proteins with free thiols. Also, the nearby environment or context of the 
Cys may contribute to its pKa and reactiveness, and thereby determine its effectiveness in 
supporting retention and subsequent degradation. Additionally, non-native proteins with 
free thiols may evade thiol dependent quality control by forming non-native, 
intermolecular disulfide bonds, thereby generating disulfide linked protein aggregates 
which are resistant to degradation. 
 
Summary 
Sequence specific chaperone and oxidoreductase binding appears to be the basis 
for quality control recognition. Hallmarks of misfolded proteins include exposed 
hydrophobic domains and free thiols. These features can also impact the N-linked glycan 
composition to further signal aberrancy to the quality control system. As the quality 
control process is responsible for monitoring thousands of proteins that traverse the 
secretory pathway, the sequences that signal non-nativeness must be degenerate. While 
some factors appear to recognize substrates that are folding intermediates and should be 
given additional time to fold and can be repaired, others must recognize terminally 
misfolded proteins to target them for degradation. Chaperones play promiscuous roles in 
all these functions with their precise role in some cases being determined by their 
associated co-factors, while others possess more specialized activities. The interplay 
between these diverse quality control systems that relies on exposed hydrophobic 
residues, free thiols or carbohydrate compositions helps to evaluate the large variety of 
cargo that travel through the ER. The interplay is underscored by the many complexes 
found between traditional chaperones, oxidoreductases and lectin chaperones or 
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glycosidases. A deeper understanding of these quality control processes and their 
manipulation provides an avenue for disease intervention for the large number of diseases 




















Figure 1.1 BiP domain architecture and binding cycle 
 
(A) BiP is targeted to the ER via a signal sequence (SS) that is cleaved in the mature form 
of the protein. From N- to C-terminus, BiP is comprised of a nucleotide binding domain 
(NBD) (green), interdomain linker (blue), and substrate binding domain (SBD) (purple). 
It is retained in the ER via a KDEL motif. (B) The substrate binding cycle of BiP is 
regulated by ATP. When the NBD is bound by ATP, BiP is in a low substrate affinity 
state. Interaction with a substrate bound J-protein promotes ATP hydrolysis, leading to an 
extended conformation of the interdomain linker, SBD lid closing, and a high substrate 
affinity. A BiP nucleotide exchange factor (NEF) can then exchange ADP for ATP, 
placing BiP back in a low substrate affinity state. This process can be inhibited by 









Figure 1.2 Structure of an N-linked glycan 
 
N-linked glycans are transferred en bloc to an Asn residue in acceptor sites Asn-X-
Ser/Thr/Cys, where X is not a proline. The precursor glycan is depicted, which can be 














Figure 1.3 The domain architecture of calnexin and calreticulin 
 
(A) Both calnexin and calreticulin possess an N-terminal signal sequence (black) that is 
cleaved in the mature protein. Calnexin possesses a lectin domain (red) that is composed 
of two regions separated by the P-domain (orange), a transmembrane region (TM) (grey) 
and a cytosolic C-terminal domain (green). Calreticulin possesses a contiguous lectin 
domain, a P-domain, a C-terminal domain, and a KDEL retention motif. (B) Surface 
representation of the crystal structure of the luminal domain of calnexin (PDB: 1JHN). 
The lectin domain is shown in red and the P-domain in orange. The carbohydrate binding 
pocket in the lectin domain and the binding site of CypB/ERp57/ERp29 on the tip of the 












Figure 1.4 The calnexin/calreticulin substrate binding cycle 
 
Proteins targeted to the ER receive N-linked glycans that are transferred by the OST 
complex to acceptor sites. The first two glucoses are trimmed by glucosidases I and II, 
leaving a monoglucosylated glycan. In this state, the glycan is a substrate for calnexin 
and calreticulin. Release from calnexin/calreticulin and trimming of the final glucose by 
glucosidase II leaves the glycan in a non-glucosylated state. Productive folding and 
adoption of a native state allows for trafficking of the glycoprotein from the ER. 
Glycoproteins that do not adopt a native fold can be recognized by the folding sensor 
UDP-glucose: glycoprotein glucosyltransferase 1 (UGGT1). UGGT1 reglucosylates 
substrates, allowing for rebinding to calnexin/calreticulin or trimming by glucosidase II. 
Glycoproteins that continue to non-productively fold can be removed from the 
calnexin/calreticulin cycle through trimming by mannosidases and targeting to ER 























Figure 1.5 The architecture of mannosidases involved in quality control 
 
Domain architecture of mannosidases: ER Man1, EDEM1, EDEM2, EDEM3, and 
endomannosidase. The signal sequences (black), predicted transmembrane domains 
(grey), the mannosidase domains (orange), and putative catalytic residues (stars) are 
designated. Endomannosidase possesses a predicted non-cleavable signal sequence, as 












Figure 1.6 Redox reactions catalyzed by PDI family members 
 
PDI, or members of the protein disulfide isomerase family (PDIf), can oxidize, reduce 
and isomerize disulfide bonds of substrates. In all cases, a transient intermolecular 
disulfide bond is formed between PDIf and the substrate (not pictured). While the various 
PDIf members have varying numbers of catalytic domains, a single catalytic site of PDIf 
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 The protein quality control machinery of the endoplasmic reticulum (ERQC) works to 
ensure that clients are properly folded. ERQC substrates may be recognized as non-native 
by the presence of exposed hydrophobic surfaces, free thiols, and/or processed N-
glycans. How these features dictate which ERQC pathways engage a given substrate is 
poorly understood. We used the human serpin antithrombin III (ATIII) to explore the 
interaction of ERQC systems in cells. Although ATIII has N-glycans and a hydrophobic 
core, we found that its quality control depended solely on free thiol content. Mutagenesis 
of all six Cys residues to Ala resulted in efficient secretion even though the product was 
not natively folded. ATIII variants with free thiols were retained in the ER but not 
degraded. These results provide insight into the hierarchy of ERQC systems and reveal a 






Protein maturation is an error-prone process which, if allowed to proceed 
unchecked, would cause major cellular dysfunction. To prevent such calamities, quality 
control processes monitor the integrity of maturing polypeptide chains. For proteins that 
traverse the endoplasmic reticulum (ER), including secretory and plasma membrane 
proteins and proteins that reside in endomembrane compartments, proteins evaluated as 
native are allowed to exit to the Golgi. Proteins deemed non-native are initially targeted 
for ER retention and potential repair. If the non-native properties persist and the proteins 
accumulate in the ER, two processes can be initiated (Lamriben et al., 2016; 
Lederkremer, 2009). The unfolded protein response (UPR) is activated, causing a 
transcription-based remodeling of the ER contents in an attempt to maintain protein 
homeostasis (Kozutsumi et al., 1988; Hwang & Qi, 2018). If the interrogated proteins are 
determined to be irreparably or terminally misfolded, they are eventually targeted for 
destruction in order to recycle components and ensure that a potentially toxic misfolded 
substrate is not released from the ER or cell (McCracken & Brodsky, 1996; Olzmann et 
al., 2013). 
A small number of quality control factors is responsible for evaluating the 
thousands of different client proteins that traverse the ER (Huh et al., 2003; Määttänen et 
al., 2010; Tamura et al., 2010). Therefore, general protein hallmarks of foldedness must 
be queried to provide an efficient and plastic quality control process that supports the 
evaluation of a large number of substrates. Regardless of cellular location, exposed 
hydrophobic regions appear to be a defining signature of folding intermediates, misfolded 
proteins or unassembled oligomers – all forms of protein that are frequently recognized 
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by molecular chaperones and should be retained in the ER (Ellgaard & Helenius, 2003; 
Y. E. Kim et al., 2013). The ER is also an oxidizing environment that supports the 
formation of disulfide bonds assisted by a family of ER-resident oxidoreductases (Bulleid 
& Ellgaard, 2011). These oxidoreductases are involved in a thiol-dependent quality 
control process (Isidoro et al., 1996; Z. V. Wang et al., 2007; Anelli et al., 2015). The 
vast majority of proteins that travel through the mammalian secretory pathway are also 
modified in the ER with multiple 14-residue N-linked oligosaccharides with the 
composition Glc3Man9GlcNAc2 (Helenius & Aebi, 2004). The maturation of the glycan 
provides a quality control code that reports on the fitness of the attached protein (Hebert 
& Molinari, 2012). Glycosidases and transferases orchestrate the glycan composition 
based on protein structural features, supporting binding and sorting of glycoproteins by 
quality control carbohydrate-binding factors. Among these are the lectins calnexin and 
calreticulin, which bind monoglucosylated glycans (Hammond et al., 1994; Hebert et al., 
1995; Peterson et al., 1995). While the use of multiple quality control interrogation 
mechanisms that are based on the features of the specific protein is thought to maximize 
coverage and minimize mistakes, the interplay between these various quality control 
mechanisms is poorly understood. For instance, if there is overlap or redundancy in 
coverage, how is it determined which quality control process dominates? Or can multiple 
pathways query the same protein? 
Serpins have been used extensively as model substrates to study protein quality 
control, as mutations in several inhibitory serpins are associated with degradation and 
accumulation of these proteins in the ER (Y. Liu et al., 1997; Gooptu & Lomas, 2009). 
Functional inhibitory serpins are metastable; they fold to a kinetically trapped state that 
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allows them to store potential energy, which is deployed to inhibit their cognate protease 
(Huntington et al., 2000; Dementiev et al., 2006; Gooptu & Lomas, 2009; Corral et al., 
2018). This metastability and the need to avoid alternative conformations that might be 
more stable when folding likely make serpin maturation particularly problematic and may 
provide an explanation for why serpin misfolding is associated with a large number of 
pathologies or serpinopathies (Davies & Lomas, 2008). Functional, properly folded, 
inhibitory serpins form inactive covalent complexes with their cognate proteases 
providing a simple activity assay to determine whether a secreted serpin has successfully 
folded.  
The human serpin antithrombin III (ATIII) is an inhibitory serpin that is modified 
by multiple N-linked glycan. The three native ATIII disulfide bonds have been used to 
map its cellular folding pathway (Chandrasekhar et al., 2016). ATIII inhibits thrombin 
thus playing an essential role in the blood coagulation cascade. Mutations in ATIII are 
commonly associated with thrombosis, and some of these mutations also lead to 
accumulation of ATIII in the ER (Perry & Carrell, 1996; Corral et al., 2018). Therefore, 
ATIII provides an apt model substrate to explore various ER quality control processes. 
Here, we made use of ATIII variants with disrupted folding by mutating native Cys 
residues to Ala. We hypothesized that these variants would be targets for the thiol-based 
quality control pathway. We also predicted that these variants would be compromised in 
their folding in such a way that they would present non-native hydrophobic surface and 
potentially glycan signals. Thus, these variants should reveal the interplay and hierarchy 
of ER quality control systems.  
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We found that quality control of ATIII relied solely on thiol-dependent quality 
control and diversion from the thiol-dependent quality control pathway led to improper 
secretion of misfolded and inactive protein. These results demonstrate that ER quality 
control pathways do not necessarily act redundantly and the general features of a 
substrate do not automatically dictate which quality control pathways will be engaged.  
 
Results 
Misfolded and inactive Cys-less ATIII is efficiently secreted  
As shown previously, the three intramolecular disulfide bonds of ATIII (C8/C128, 
C21/C95, and C247/C430) are required for folding to the functional, metastable 
conformation (Chandrasekhar et al., 2016). We began to explore how the ERQC handles 
misfolded ATIII by determining the fate of ATIII with all its Cys mutated to Ala (Cys-
less ATIII). Chinese hamster ovary (CHO) cells transfected with wild type (WT) or Cys-
less ATIII were pulsed for 30 min with [35S]-Met/Cys and chased for the designated 
times (Figure 2.1A). ATIII from the lysates and media was then immuno-isolated using 
antibodies directed towards the C-terminal Myc-tag present on the ATIII constructs. 
Samples were analyzed by reducing SDS-PAGE and phosphorimaging. As expected, 
secreted ATIII shows two bands due to incomplete glycosylation at Asn135 (Picard et al., 
1995). Surprisingly, the level of secretion of WT and Cys-less ATIII was similar, 
reaching levels in the media after 3 hr of chase of 48.0% and 43.6%, respectively (Figure 
2.1A and B). Strikingly, the remaining in-cell ATIII fraction for both constructs remained 
stable as degradation did not appear to occur even for Cys-less ATIII (Figure 2.1A, lanes 
1-4, 9-12).  
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Normally, the ERQC machinery interrogates proteins as they traverse the 
secretory pathway sensing whether their native structures have been reached (Hurtley & 
Helenius, 1989; Määttänen et al., 2010; Adams, Oster, et al., 2019), and only properly 
folded proteins are packaged into COPII vesicles for eventual secretion, while misfolded 
or non-native structures are directed for ER retention (C. K. Barlowe & Miller, 2013). To 
assess the completeness folding of Cys-less ATIII, the activity of the product secreted 
into the media was analyzed by gel shifts due to its ability to form a covalent inhibitory 
complex with its target protease, thrombin. When the protease thrombin cleaves the 
reactive center loop of the serpin ATIII, an acyl bond is formed between the Ser in the 
loop of ATIII and thrombin. The formation of the covalent complex can be visualized by 
a gel shift on SDS-PAGE. Inactive ATIII does not demonstrate this gel shift, while 
partially active ATIII, though not functional as a thrombin inhibitor, can act as a substrate 
for thrombin while not forming a covalent bond. This leads to ATIII being cleaved and 
running at a lower molecular weight (Figure 2.2A). Cells were pulsed for 30 min, chased 
for 3 hr, and ATIII from lysates and media samples were immune-isolated. Protease 
inhibition by serpins requires large conformational changes (Huntington et al., 2000; 
Dementiev et al., 2006). Therefore, prior to performing the activity assay, ATIII was 
eluted from the beads and antibody using excess Myc-peptide to remove steric 
constraints. The eluted fraction was equally divided between thrombin-treated and non-
treated samples and analyzed by reducing SDS-PAGE. While WT ATIII in the media 
was active as shown by the formation of a thrombin and ATIII complex (Figure 2.2A, 
lane 4), Cys-less ATIII was completely inactive (Figure 2.2A, lane 8).  
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To further characterize the state of folding of the secreted Cys-less ATIII, we used 
protease sensitivity. A natively folded protein should be relatively resistant to protease 
digestion as compared to an unfolded protein as, generally, natively folded proteins adopt 
more compact conformations that expose fewer sites for cleavage. Cells were pulsed for 
30 min, chased for 3 hr, and ATIII was immunoprecipitated from media samples. 
Samples were then divided equally between untreated samples and trypsin treated for 
either 0, 15, 30, or 60 minutes. Samples were then analyzed by SDS-PAGE. Secreted 
Cys-less ATIII showed significantly higher protease sensitivity compared to WT (Figure 
2.2B and 2.2C). This result indicates that Cys-less ATIII is secreted like a natively folded 
protein, despite the fact that it is an inactive and significantly misfolded protein. Both the 
secretion of Cys-less ATIII and its stability in the cell suggests that it is evaluated as 
properly folded by the ERQC network even though it has not achieved its native, 
functional fold. 
There is a formal possibility that Cys-less ATIII is being improperly secreted and 
misevaluated by the ER quality control network because it is secreted via an 
unconventional secretory pathway, thereby escaping ERQC. In traversing the full 
secretory pathway, glycoproteins trafficked from the ER pass through the Golgi where 
their glycans are extensively remodeled to receive complex glycans. However, proteins 
that pass through recently identified pathways for unconventional secretion, both 
including and excluding the ER, can bypass portions of the canonical secretory pathway 
such as the Golgi and thus lack remodeled complex glycans (Fatal et al., 2002; Rabouille, 
2017). The differential susceptibility of secretory proteins to glycosidases PNGaseF, 
which can cleave both complex and high-mannose glycans acquired in the Golgi, and 
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EndoH, which can only cleave high-mannose glycans, can be used to ask whether a given 
protein has traversed the canonical secretory pathway. Proteins carrying glycans found in 
the ER or on secreted proteins that have bypassed the Golgi are sensitive to both 
PNGaseF and EndoH, while proteins carrying glycans that have passed through the Golgi 
are sensitive to PNGaseF and resistant to EndoH. Glycosidase sensitivity, analyzed by 
size shifts using SDS-PAGE, can therefore be used as an assay for unconventional 
secretion. As expected, both WT and Cys-less ATIII in the cell lysate were sensitive to 
PNGaseF and EndoH, indicating that cellular ATIII mainly resides in the ER. In contrast, 
both WT and Cys-less ATIII from the cell media were sensitive to PNGaseF and resistant 
to EndoH (Figure 2.2D, lanes 5, 6, 11 and 12), showing that both had received complex 
glycans due to passage through the Golgi. Therefore, the Cys-less variant of ATIII 
utilizes the conventional secretory pathway.  
Taken together, these results indicate that Cys-less ATIII, an inactive and 
misfolded protein, evades ER protein quality control and instead is secreted similarly to 
WT ATIII. These results support the hypothesis that free thiols are essential for ERQC 
recognition of misfolded ATIII and its consequent retention in the ER. Concomitantly, 
evasion of thiol-dependent quality control in this case allowed improper secretion rather 
than attempts by a complementary quality control branch to correct the misfolding or 
action of the ER-associated degradation pathway to eliminate the misfolded product.  
 
Cellular retention and characterization of ATIII disulfide mutants 
According to the recently discovered cellular pathway of disulfide bond formation 
for ATIII, the C-terminal disulfide, C247/C430, must form first in order for the two N-
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terminal disulfides, C8/C128 and C21/C95, to form properly (Chandrasekhar et al., 
2016). If the C-terminal disulfide is mutated, this model predicts that the remaining two 
disulfides would not form, leading to the generation of free thiols that may support ER 
retention. In contrast, this model predicts that mutating either pair of Cys residues that 
comprise the two N-terminal disulfides, C8A/C128A or C21A/C95A, allows the two 
remaining disulfides to form, reconciling all thiols into disulfides. This previous work, 
which elucidated the disulfide formation pathway of homogeneously glycosylated ATIII 
missing the partially recognized N-linked glycan at position Asn135, led to the 
predictions that ATIII quality control is mediated, at least in part, by free thiols directing 
ER retention (Chandrasekhar et al., 2016).  
To characterize the disulfide requirements for proper ATIII quality control and 
secretion, and to test the predictions for ATIII disulfide mutants, the secretion rates of the 
three disulfide mutants (C8A/C128A, C21A/C95A, C247A/C430A) and WT ATIII (all 
constructs possessing all four native glycosylation sites) were analyzed via pulse-chase in 
cells. Transfected cells were pulsed for 30 min with [35S]-Met/Cys and chased for the 
designated times. Samples were analyzed by non-reducing and reducing SDS-PAGE and 
phosphorimaging (Figure 2.3A).  
Secretion of C247A/C430A ATIII was significantly reduced compared to WT, 
C8A/C128A and C21A/C95A ATIII, (Figure 2.3A, 13-15 and Figure 2.1B). After a 2 hr 
chase, WT secretion levels reached 50% compared to 8% for C247A/C430A ATIII. The 
secretion of the N-terminal disulfide mutants, ATIII C8A/C128A and C21A/C95A, was 
similar to WT secretion levels. Non-reducing SDS-PAGE displayed an increase in 
disulfide linked adducts for all mutants compared to WT ATIII. Similar levels of 
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aggregated ATIII were found in the triton insoluble fractions for all constructs (Figure 
2.3A, lanes 16-18). 
While secreted WT ATIII was active, as observed by the formation of the 
thrombin-ATIII complex (Figure 2.4A, lane 4), the disulfide mutants displayed little 
activity and did not form an inhibitory complex (Figure 2.4A, lanes 8, 12 and 16). This 
demonstrates that all of the ATIII disulfide mutants analyzed are inactive proteins, 
including C8A/C128A and C21A/C95A ATIII, which were efficiently secreted into the 
cell media. Thus, like Cys-less ATIII, the ATIII N-terminal disulfide mutants were 
mistakenly evaluated as natively folded by the ER quality control process. By contrast, 
the inactive C247A/C430A ATIII construct, which lacked the key early forming disulfide 
previously shown to be critical for initiation of proper folding, was properly retained. 
A question that emerges from these data is whether secretion correlates with 
protection or inaccessibility of thiols. To address this question a polyethylene glycol-
maleimide (PEG-Mal) modification gel-shift assay was performed on the ATIII mutants. 
PEG-Mal modifies exposed free thiols, and the bulky PEG group causes an increase in 
mass that can be visualized by a gel shift. Transfected cells were pulsed for 30 min then 
chased for 30 min. Lysate and media samples were split equally, and one half was treated 
with PEG-Mal, and analyzed by reducing SDS-PAGE.  
For all ATIII constructs analyzed, secreted ATIII found in the media had 
insignificant levels of PEG-Mal modification, which in turn indicates near absence of 
accessible free thiols (Figure 2.4B, lanes 4, 8, 12 and 16; and Figure 2.4C for 
quantification). This result suggests that in ATIII constructs that are successfully secreted 
to the media, any thiols had either formed disulfide bonds or were otherwise inaccessible, 
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most likely through partial folding. The level of accessible thiols modifiable by PEG-
MAL for WT, C8A/C128A, and C21A/C95A ATIII constructs in cell lysates was similar, 
ranging from 55 to 72% (Figure 2.4E). In contrast, the level of C247A/C430A ATIII 
modified by PEG-Mal was 89%, arguing that in this construct there is little sequestration 
of the Cys thiols. This result supports the model that the disulfide between C247 and 
C430 is critical for folding, and its absence leads to poor formation of the two N-terminal 
disulfides (Chandrasekhar et al., 2016). Free thiols are present in all forms of ATIII in the 
cell lysates, including WT, because the intracellular pool of protein is sampled during 
formation and isomerization of intermediate disulfide bonds. These results suggest that 
C247A/C430A ATIII is retained in the ER because its folding is impaired so that its free 
thiols cannot form disulfide bonds, while C8A/C128A and C21A/C95A ATIII are 
secreted because they can initiate folding and hence partially form disulfides, which 
together with partial folding, protect their free thiols. These findings support both the 
hypotheses that the C-terminal disulfide of ATIII must form before the N-terminal 
disulfides in order for ATIII to fold correctly and that free thiols lead to retention in the 
ER. 
 
A single Cys is sufficient to retain ATIII in the ER 
As the results in Figures 2.1, 2.2, 2.3, and 2.4 suggest that free thiols play a 
significant role in the ER retention of ATIII, we next investigated whether the presence 
of a single Cys would be sufficient to retain ATIII in the ER. To this end, six single Cys 
mutants were created by adding the individual Cys back at their natural sites in the Cys-
less ATIII background (A8C, A21C, A95C, A128C, A247C, A430C) and their secretion 
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was analyzed by pulse-chase. Cells were pulsed for 30 min and chased for 10, 60, and 
120 min. When secretion was analyzed by reducing SDS-PAGE, three single Cys 
mutants, A8C, A21C, and A247C, were poorly secreted as compared to Cys-less ATIII. 
A128C and A95C were secreted at a similar level to Cys-less ATIII. While there was no 
significant difference between secretion of A430C and Cys-less, A430C secreted to a 
lower level than Cys-less (Figure 2.5A, B). When secretion was analyzed by non-
reducing SDS-PAGE, a high molecular weight band of secreted single Cys ATIII was 
present, suggesting that a portion of secreted single Cys ATIII mutants was in the form of 
a redox-dependent complex in which the Cys was no longer a free thiol but rather was in 
an intermolecular disulfide (Figure 2.5A, top NR image).  Altogether, these results 
demonstrate that thiol-dependent quality control is a robust retention mechanism as a 
single free thiol led to the cellular retention of ATIII. These results also suggest that the 
location of the free thiol has relatively little influence as the majority of the thiols lead to 
retention of ATIII. 
 
C247A/C430A ATIII is stably retained in the ER in a redox-dependent complex 
We sought to obtain a better understanding of the cellular fate of the 
C247A/C430A ATIII, which was inefficiently secreted. CHO cells expressing WT, Cys-
less, or C247A/C430A ATIII were imaged by immunofluorescence confocal microscopy, 
and co-localization with ER (KDEL) and Golgi (giantin) markers was monitored. All 
three variants were found throughout the ER as observed by extensive co-localization 
with the KDEL ER marker (Figure 2.6A). Some co-localization of all three constructs 
with the Golgi marker was also observed. These results indicated that regardless of their 
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different fates and properties, after 16 h of expression, these three ATIII variants localize 
throughout the ER. 
Despite their similar cellular localization, we hypothesized that misfolded ATIII 
variants may not be monomeric within the ER. We therefore investigated whether ATIII 
variants were present in complexes within the ER. Cell lysate was layered on top of a 10-
40% sucrose gradient and subjected to ultracentrifugation. Fractions were then analyzed 
by SDS-PAGE and immunoblotting. Both Cys-less and C247A/C430A ATIII are found 
in complexes that are larger than WT (Figure 2.7). Addition of the reducing agent 
dithiothreitol (DTT) post cell lysis causes C247A/C430A ATIII to shift to lower 
molecular weight fractions while addition of DTT had no effect on WT and Cys-less 
ATIII, suggesting that C247A/C430A is in a complex formed via accessible thiols and 
that retention of C247A/C430A is redox-dependent. Cys-less ATIII is also in a complex 
in the media, which may be due to secretion as an aggregate or secretion while bound to a 
partner. These data suggest that C247A/C430A ATIII is retained in a multimeric, 
disulfide-dependent complex in the ER while ATIII Cys-less is secreted in a non-
monomeric state.  
 
WT ATIII is more efficiently reglucosylated than Cys-less and C247A/C430A ATIII  
The carbohydrate-binding chaperone calnexin and its soluble paralogue 
calreticulin play an important role in glycoprotein folding, quality control, and ER 
retention (Hebert et al., 1996; Vassilakos, Cohen-Doyle, et al., 1996; Lamriben et al., 
2016; Kozlov et al., 2017b). Within the calnexin/calreticulin cycle, the folding sensor 
UDP-glucose:glycoprotein glucosyltransferase 1 (UGGT1) acts as a gatekeeper of 
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secretion by reglucosylating misfolded or incompletely folded proteins, which then 
allows calnexin/calreticulin to rebind the glycoprotein, leading to ER retention (Sousa & 
Parodi, 1995b; Pearse et al., 2008; Lamriben et al., 2016). Furthermore, recent x-ray 
crystal structures have shown that UGGT1 proteins from both Thermomyces dupontii and 
Chaetomium thermophilum have four thioredoxin-like domains (Satoh et al., 2017; 
Roversi et al., 2017). Oxidoreductases are frequently comprised of multiple thioredoxin 
domains, contributing to their oxidizing, reducing or isomerizing activities (Holmgren et 
al., 1975; Marin, 1995). Although the active oxidoreductase motif, CysXxxXxxCys, is 
not present in any of these domains, the multiple Cys residues present in UGGT1 and the 
thioredoxin-like folds likely aid UGGT1 in substrate recognition. We therefore 
investigated whether UGGT1 reglucosylation, and by extension the N-glycan quality 
control pathway, contributed to the ER retention of C247A/C430A ATIII.  
We have previously developed a cell-based reglucosylation assay (Pearse et al., 
2008, 2010; Tannous et al., 2015). Briefly, an Alg6 defective CHO cell line, MI8-5 CHO, 
generates glycans lacking glucoses on their A-branches (Quellhorst et al., 1999). 
Therefore, in this cell line a monoglucosylated glycan can only be generated by UGGT1. 
In contrast, in WT cells, the presence of a monoglucosylated glycan could indicate either 
trimming of two glucoses from the original Glc3Man9GlcNAc2 glycan or reglucosylation 
of an unglucosylated side chain by UGGT1. MI8-5 CHO cells were treated with N-butyl 
deoxynojirimycin (DNJ) for 30-min prior to the 30-min pulse and then throughout the 
indicated chase times. DNJ is a glucosidase inhibitor and therefore traps 
monoglucosylated proteins in their monoglucosylated state. Monoglucosylated proteins 
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were first pulled down using recombinant glutathione S-transferase (GST)-calreticulin, 
and from this pull-down ATIII was immunoprecipitated using anti-Myc antibodies.  
While all three variants of ATIII, WT, Cys-less and C247A/C430A, were 
reglucosylated by UGGT1, WT ATIII was found to be modified most efficiently 
followed by C247A/C430A ATIII and then Cys-less ATIII (Figure 2.8A and B). As WT 
ATIII was recognized at a higher level than the other two ATIII variants, UGGT1 
modification does not explain the greatly increased ER retention of C247A/C430A.  
To explore the timing of reglucosylation, DNJ was added for only 15 min prior to 
each time point, which allows for detecting reglucosylation at that specific window of 
time. Using this experimental scheme, C247A/C430A ATIII was found to be 
reglucosylated more than either WT or Cys-less ATIII after 2 hr (Figure 2.8C and D). 
These results suggest that UGGT1 best recognizes WT ATIII, but once WT has folded 
and trafficked out of the ER, ATIII C247A/C430A becomes a better substrate for 
modification as it is still present in the ER where UGGT1 has access to it.  
In order to confirm that UGGT1 is not retaining the free thiol-carrying mutant, 
C247A/C430A ATIII, the secretion of WT and C247A/C430A ATIII was examined in 
WT and Uggt1-/- mouse embryonic fibroblast (MEF) cell lines using a pulse-chase 
approach. Cells were pulsed for 30 min and chased for 0 or 2 hr before the media and 
lysate were collected. ATIII was immunoprecipitated from the media and lysate, and the 
percent fraction of ATIII in each pool was analyzed as previously described. WT ATIII 
was secreted similarly in both WT and Uggt1-/- MEF cells, suggesting that repetitive 
rounds of calnexin/calreticulin binding were not needed for efficient ATIII secretion 
(Figure 2.9A and B). In contrast, ATIII C247A/C430A was poorly secreted in either WT 
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or Uggt1-/- MEF cells, indicating that in the absence of UGGT1, the misfolded ATIII 
mutant C247A/C430A was still efficiently retained within the cell. Therefore, all together 
UGGT1 does not appear to play the determinative role in C247A/C430A ATIII quality 
control. 
 
C247A/C430A ATIII is a poor ER-associated degradation (ERAD) substrate 
When a misfolded protein is persistently retained in the ER, the ERAD process 
generally degrades the protein to maintain proper secretory pathway flow and protein 
homeostasis (Brodsky, 2012; Olzmann et al., 2013). Because C247A/C430A ATIII is 
retained in the ER, we would be expected it to be degraded. The stability of 
C247A/C430A ATIII was therefore compared to WT ATIII and the classical ERAD 
substrate alpha-1-antitrypsin null Hong Kong (A1AT NHK), which is also an inhibitory 
serpin and serves as a positive control for ERAD.  
After an 8-hr chase, both WT and C247A/C430A ATIII were stable with 74% and 
115% of the total protein remaining relative to zero time, respectively (Figure 2.10A and 
B). WT ATIII accumulated in the media, while C247A/C430A ATIII largely 
accumulated in the Triton-insoluble fraction. In contrast, A1AT NHK was turned over 
rapidly with 48% total protein remaining after 8-hr of chase and only a small fraction 
being secreted. Interestingly, though ATIII C247A/C430A was retained in the ER, it is a 
poor ERAD substrate as it was not efficiently degraded. 
 
Overexpression of ATIII constructs activates the IRE1a arm of the UPR pathway 
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One possible explanation for the lack of degradation of C247A/C430A ATIII 
retained in the ER is that expression of this impaired protein does not activate the 
unfolded protein response (UPR).  In turn, the basal level UPR pathways would be unable 
to process the high load of retained ATIII mutant. Thus, we sought to examine whether 
UPR pathways were induced by overexpression of ATIII variants in CHO cells. The UPR 
consists of three branches controlled by the ER sensors IRE1a, ATF6, and PERK, and 
each sensor initiates a signaling cascade, which can increase the folding capacity of the 
ER, decrease the protein load in the ER, or increase the capacity of ERAD (Walter & 
Ron, 2011). Thus, we carried out experiments to test whether any of the three UPR 
branches were upregulated upon expression of WT, C247A/C430A, or Cys-less ATIII or 
NHK A1AT. 
Upon activation, IRE1a splices an unconventional intron from X-box protein 1 
mRNA (Xbp1), creating a spliced form of Xbp1 (Xbp1s). A frameshift caused by the 
splicing supports the translation of an active transcription factor, XBP1s, which leads to 
the up-regulation of multiple genes involved in protein folding and ERAD (Calfon et al., 
2002; Plate et al., 2016). Therefore, the production of Xbp1s is indicative of IRE1a 
activation. Tunicamycin (Tm), which inhibits N-linked glycosylation and leads to a 
strong activation of the UPR, was used as a positive control. CHO cells were transfected 
either with the serpin variants or treated with Tm for 24 hr. RNA was then collected and 
cDNA was generated. In all cases, Xbp1s was generated, suggesting that IRE1a is 
activated by ATIII/A1AT overexpression regardless of the construct (Figure 2.11A). The 
level of activation during NHK ATIII and A1AT overexpression appears to be less than 
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that of Tm, suggesting that overexpression of the proteins was not maximally activating 
IRE1a. 
 Next, the second branch of the UPR, activation of the kinase PERK, was tested. 
During activation by ER stress, PERK undergoes trans-autophosphorylation, which 
activates PERK and leads to multiple downstream effects including up-regulating 
chaperone expression, translational attenuation, and cell cycle arrest (Shi et al., 1998; 
Hetz & Papa, 2018). In order to test for the activation of PERK, CHO cells were either 
transfected or treated with Tm for 24 hr. Cells were then lysed and trichloroacetic acid 
(TCA) precipitated before immunoblotting. Phosphorylated PERK (pPERK) can be 
distinguished from non-phosphorylated PERK by an increase in mass on a gel. 
Overexpression of ATIII variants and A1AT NHK did not generate pPERK (Figure 
2.11B). This suggested that PERK was not activated by the overexpression of these 
proteins. 
The third branch of the UPR, activation of the transcription factor ATF6, was also 
examined. Activation of ATF6 leads to the up-regulation of multiple ER chaperones and 
ERAD factors (Haze et al., 1999; Yoshida et al., 2001). One of the prime targets of ATF6 
is the Hsp70 family member BiP (Plate et al., 2016). As such, the level of BiP expression 
was examined as an indicator of ATF6 activation. CHO cells were either transfected or 
treated with Tm for 24 hr. Cells were then lysed and TCA precipitated before 
immunoblotting. BiP expression was not found to be upregulated by the overexpression 
of any of the constructs when compared to the positive control Tm (Figure 2.11C and D). 
Therefore, ATF6 was not activated by the overexpression of ATIII or A1AT variants. In 
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total, these results indicate that the only branch of UPR activated by overexpression of 
ATIII variants and A1AT NHK was the IRE1a pathway. 
 
C247A/C430A ATIII interacts poorly with ERAD factors 
IRE1a activation leads to up-regulation of numerous ER-resident proteins 
including the ERAD factors ER degradation enhancing a-mannosidase-like (EDEM) 
proteins EDEM1, EDEM2, and EDEM3 (Yoshida et al., 2003; Bernasconi et al., 2008; 
Plate et al., 2016). Up-regulation of ERAD factors is expected to lead to robust 
degradation of misfolded and ER retained proteins as they are thought to be responsible 
for directing glycosylated misfolded proteins like C247A/C430A ATIII to the ERAD 
pathway (Molinari et al., 2003; Olivari et al., 2005; Hirao et al., 2006; Cormier et al., 
2010; Araki & Nagata, 2011; Lamriben et al., 2018).. However, C247A/C430A ATIII 
was degraded significantly less than the ERAD substrate A1AT NHK (Figure 2.10A and 
B). A possible explanation is that C247A/C430A ATIII does not bind well to EDEM1, 
EDEM2 and EDEM3. To test this, we co-transfected CHO cells with either WT or 
C247A/C430A ATIII, or A1AT NHK, and EDEM1, EDEM2 and EDEM3. Cells were 
pulsed for 30 min and chased for the indicated times. Cells were lysed with buffer 
containing Triton X-100 (MNT). Interactions were queried by performing co-
immunoprecipitations . EDEM1, EDEM2 and EDEM3 all associated efficiently with 
NHK A1AT as demonstrated by their co-immunoprecipitation with the A1AT pulldowns 
(Fig 2.12A-F, lanes 21 and 22). In contrast, neither WT nor C247A/C430A ATIII showed 
significant association with any of the EDEMs. We conclude that the misfolded and ER 
retained C247A/C430A ATIII is a poor substrate for recognition by these ERAD sorting 
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factors, thus providing a possible explanation for the stability of C247A/C430A ATIII 
retained in the ER. 
Discussion 
A central question regarding protein quality control in the ER is how thousands of 
proteins that pass through the secretory pathway are evaluated by a small number of 
quality control factors. The ERQC must efficiently and accurately enable natively folded 
proteins to exit to their final destination, and identify incompletely or misfolded proteins 
so that they are retained in the ER to allow fresh starts on proper folding or degradation. 
ERQC must rely on features of secretory pathway clients that indicate those with  non-
native characteristics, such as exposed hydrophobic residues, mispaired or free Cys 
residues, or processed N-glycans (Hammond et al., 1994; Anelli et al., 2015; Parodi & 
Caramelo, 2015; Behnke et al., 2016) (Figure 2.13). Exposed hydrophobic residues are 
most notably monitored by the BiP/ERdj network in the ER (Hendershot, 2004; Pobre et 
al., 2018; Preissler & Ron, 2018), while disulfides are formed and monitored for their 
integrity by a group of some 20 oxidoreductases or PDI family members (Hatahet & 
Ruddock, 2007; Määttänen et al., 2010; Tsunoda et al., 2014). Glycosidases, transferases, 
lectin chaperones and sorting factors comprise an N-linked carbohydrate-dependent 
glycoprotein quality control system (Parodi & Caramelo, 2015; Lamriben et al., 2016). 
How these different quality control pathways work together to ensure that only native 
proteins are passed along the secretory pathway is poorly understood.   
In this work, we have focused on a member of the serpin family of secreted 
proteins to gain insight into ERQC. The serpin native fold is complex and challenged by 
the need to adopt a metastable state that is required for inhibitory activity. Many 
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examples of mutant serpins have been characterized to have secretion defects; often 
theses are associated with diseases arising from loss of function and/or toxicity caused by 
retention and aggregation in the ER(Chandrasekhar et al., 2016; Gooptu & Lomas, 2009; 
Ronzoni et al., 2016; Stein & Carrell, 1995). While the fold is conserved in the serpin 
family, the number and locations of Cys and disulfides bonds, as well as N-linked 
glycans, vary among serpins. Therefore, we anticipated that different serpins would 
engage different quality control systems. We selected ATIII for this study as it is a 
glycoprotein with six Cys that are paired into three intramolecular disulfides bonds in its 
properly folded native, functional state (Zhou & Smith, 1990; Chandrasekhar et al., 
2016). Therefore, it is expected to engage the three quality control pathways: 
hydrophobic-, thiol- and glycan-dependent.  
Our previous work provided insight into the cellular folding pathway of ATIII: 
the C-terminal disulfide between Cys 247 and Cys 430 must form first for the protein to 
achieve its native fold with the next two disulfides in place (Chandrasekhar et al., 2016). 
Cys residues in proteins that traverse the ER are generally either buried or reside in 
disulfide bonds once a protein is natively folded and assembled (Oka & Bulleid, 2013; 
Anelli et al., 2015). Exposed, unpaired Cys present in unpaired oligomers can be 
recognized by the thiol quality control pathway and retrieved from the ER-Golgi 
intermediate compartment and retained in the ER via a pH-dependent interaction with 
ERp44, as in the case of IgM (Sitia et al., 1990; Anelli et al., 2015), acetylcholinesterase 
(Kerem et al., 1993), SUMF1 (Fraldi et al., 2008), and adiponectin (Z. V. Wang et al., 
2007), while IgG CH1 domain mutants are free thiol quality control substrates retained by 
an unclear mechanism (Elkabetz et al., 2005). However, little is known about the role of 
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the thiol dependent quality control process for monomeric, secreted proteins. Previous 
work has also been limited by a lack of a clear method to detect the folded status of 
secreted protein, thereby leaving the possibility that Cys mutants are properly folded and 
secreted rather than evading quality control as inactive and misfolded mutants. Therefore, 
we sought to delineate the role of oligomerization from thiol-dependent quality control 
while monitoring folded status by examining the quality control of a monomeric protein, 
ATIII.  
Strikingly, mutation of all six Cys of ATIII to Ala resulted in the efficient 
secretion of a significantly misfolded and inactive protein, adding back a single native 
Cys to the Cys-less construct resulted in efficient ER retention in all but one case, and all 
disulfide mutants with free thiols were retained while disulfide mutants without free 
thiols were not. These compelling results indicate that ATIII relies almost completely on 
thiol-dependent quality control for its interrogation within the ER. Our data therefore 
expands the clientele of thiol dependent quality control by demonstrating that ATIII, a 
monomeric and secreted protein, is a substrate of thiol dependent quality control. 
Furthermore, it is notable that no other features of ATIII that signal incomplete folding or 
misfolding were exploited by ER quality control in order to retain the non-native species, 
demonstrating a lack of redundancy between ER quality control pathways. 
 Interestingly, there are other proteins that possess unpaired Cys residues in their 
native sequences and nonetheless are efficiently secreted, including the serpin A1AT 
which possesses a single Cys (Ronzoni et al., 2016). Additionally, when Cys 128 was 
added back to Cys-less ATIII, the resulting protein was secreted at a level near to that of 
the Cys-less variant. The observation of a higher molecular weight species in the non-
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reducing gel for this variant suggests that a population formed a disulfide bond either in 
an ATIII dimer or with another luminal species, cloaking the free thiol and allowing 
secretion of this ATIII variant (Fig 2.5). Thus, not all free thiols designate ER retention, 
and there must be additional determinants that contribute to a retention outcome. The 
most obvious factor is the solvent accessibility of a Cys, but even for ATIII an active 
mutant with an extra solvent accessible Cys (R57C) is properly secreted, while other 
mutants with a seventh Cys (Y63C, F402C, Y2166C), are retained (Perry et al., 1995; 
Chandrasekhar et al., 2016), and some data suggest that Cys solvent accessibility does not 
impede secretion of functional WT A1AT (Griffiths et al., 2002; Patschull et al., 2011). 
How accessible single Cys residues are to thiol-reactive proteins in the cell is not well 
understood. Additional factors involved in recognition may include the pKa of a given 
Cys, as Cys displays a wide variety of reactivity which is dictated by interactions with 
residues in the local environment (Weerapana et al., 2010), the presence of local 
hydrophobic domains, or oxidative modifications of a Cys. Future work should address 
these questions in order to determine the specific requirements of a thiol dependent 
quality control substrate. 
Why did the other quality control pathways that monitor structural features 
associated with protein misfolding or incomplete folding not recognize the Cys-less 
ATIII variant? It is clear from our results that this construct is not natively folded, as it is 
inactive and protease labile. A major cellular strategy to recognize “unfoldedness” in a 
substrate is the exposure of hydrophobic surfaces or sequences. In the ER lumen, the 
most well studied quality control mediators that utilize hydrophobic surface belong to the 
BiP-ERdj network. Serpins have an ellipsoidal, watermelon shaped fold which increases 
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their surface to volume ratio relative to other globular proteins that are more spherical 
(Dima & Thirumalai, 2004; L. Liu et al., 2014), suggesting the serpins are likely to be 
more hydrophilic than more common, more spherical protein folds. This higher 
hydrophilicity and lower hydrophobicity could interfere with BiP binding. Future work 
may explore the possibility of a poor interaction of Cys-less ATIII with BiP directly. 
The carbohydrate chaperone system of the ER is responsible for directing the 
folding and retention of aberrant glycoproteins (Parodi & Caramelo, 2015; Adams, Oster, 
et al., 2019). While retention is mediated by binding to the ER-resident lectin chaperones, 
calnexin and calreticulin, the decision for chaperone rebinding or ER retention is made by 
UGGT1. Though UGGT1 is understood to reglucosylate proteins that it determines to be 
non-native, the parameters by which UGGT1 select substrates remains incompletely 
understood. One general possibility is that UGGT1 recognizes generally misfolded 
proteins, as in the case of misfolded mutants of A1AT (Tannous et al., 2015). A second 
hypothesis suggests that UGGT1 specifically recognizes on-pathway folding 
intermediates, so as to promote productive folding rather than futile rounds of 
reglucosylation of irreparable substrates (Caramelo et al., 2004). While it is hard to 
envision distinguishing features of on-pathway proteins from off-pathway targets, our 
cellular results are consistent with this model as WT ATIII was reglucosylated at a higher 
level than the misfolded off-pathway mutants of ATIII (Figure 2.9A and B). Studies 
using purified components have found that UGGT1 favors modifying glycopeptides that 
have hydrophobic patches C-terminal to the glycan (Taylor et al., 2003). Analyzing ATIII 
with this pattern in mind did not reveal such hydrophobic sequences C-terminal to the N-
linked glycans; by comparison, A1AT, which is a better substrate of UGGT1 (Tannous et 
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al., 2015), displayed two strong hydrophobic patches following glycans at Asn 70 and 
271 (Figure 2.14). This observation would account for the apparent poor recognition of 
ATIII by the glycan-dependent pathway of ERQC and underline its reliance on the thiol-
dependent quality control pathway. The presence of the robust thiol dependent pathway 
for monitoring ATIII may have alleviated any evolutionary pressure to maintain motifs 
suitable for reglucosylation and the reliance on the UGGT1 directed carbohydrate-
dependent quality control pathway. Further work examining the substrate preferences of 
UGGT1 in a cellular context are required to elucidate the selection process for this 
intriguing folding sensor. 
The remaining puzzle in our findings is why persistent retention of misfolded 
ATIII variants does not correlate with degradation. We postulate that stability of retained 
ATIII mutants is promoted by weak interactions with the ERAD promoting proteins 
EDEM1/2/3 (Figure 2.12). Why C247A/C430A ATIII is not recognized by the EDEMs is 
unclear. However, the presence of higher molecular weights of C247A/C430A ATIII, as 
demonstrated by sucrose gradients (Fig 2.7), may indicate that C247A/C430A ATIII is 
present in small, disulfide linked aggregates with which the EDEMs are unable to 
interact. Despite weak degradation, cells expressing C247A/C430A ATIII did not show 
higher UPR activation as compared to cells expressing other ATIII variants (Fig 2.11). 
As such, it is unclear how cells are capable of maintaining proteostasis during retention 
of this substrate, though it is possible long term retention may more strongly activate 
UPR or potentially other mechanisms such as autophagy. 
It is notable that even other members of the serpin family, which fold to very 
similar structures, do not use the same quality control pathway as ATIII. Neuroserpin, 
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though trafficked through the secretory pathway, lacks Cys residues and as such does not 
engage thiol-dependent quality control. Multiple serpins, such as serpinB3 (squamous 
cell carcinoma antigen 1 (SCCA1)), the human serpin with the highest sequence identity 
(39%) to ATIII, are cytoplasmic and therefore also must use unique quality control 
pathways as compared to secretory serpins. This suggests that universal protein quality 
control mechanisms are not generally applicable as even highly related proteins do not 
use the same quality control pathways. Rather, slight differences in specific substrate 
features dictate which quality control pathways are engaged. 
Together these results point to hierarchies in ERQC that are tailored to particular 
proteins through the process of evolution. We found that the serpin ATIII, a protein 
containing multiple glycans and a hydrophobic core, and characterized in its native state 
by three disulfide bonds, is solely reliant on the thiol-dependent quality control pathway. 
In the case of ATIII, this heavy reliance on the thiol-dependent quality control pathway 
introduced a vulnerability, which was revealed by removing all six Cys residues from 
ATIII. The resulting protein was completely incapable of folding to a native, functional 
state, but nonetheless bypassed ERQC and was secreted efficiently. These results 
highlight the potential lack of redundancy between ER quality control pathways and 
demonstrate that general substrate features do not necessarily predict the quality control 
pathways of a substrate. Future studies should explore the reasons that ATIII variants 
were poorly recognized by key players in the other quality control systems as well as 
conduct a more detailed analysis of other serpins in order to elucidate the nuances of 
protein quality control and accurately predict the quality control pathways a substrate will 
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engage. This predictive understanding will open the door to therapeutic approaches to 




MI8-5 Chinese hamster ovary (CHO) cells were a gift from S. Krag (Johns 
Hopkins University, Baltimore, MD). CHO-K1 (Lot# 62960170) cells were purchased 
from ATCC. Cells were authenticated by universal mycoplasma detection kit (Cat. No. 
30-012K, ATCC). WT MEF and Uggt1-/- MEF cells were a gift from R.J. Kaufman and 
were generated as previously described (Molinari et al., 2005; Soldà et al., 2007). CHO 
and MI8-5 CHO cells were grown in alpha-MEM media supplemented with 10% fetal 
bovine serum (FBS) and 1% penicillin/streptomycin at 37 °C and 34 °C, respectively, and 
5% CO2. MEF cells were grown in DMEM supplemented with 10% FBS and 1% 
penicillin/streptomycin at 37 °C and 5% CO2. All cell culture reagents were purchased 
from ThermoFisher Scientific.  
 
Reagents 
The plasmid for pGEX-3X GST-calreticulin was from M. Michalak (University 
of Alberta, Edmonton, Canada). Antibodies used were: Monoclonal mouse Myc-tag 
9B11 antibody, rabbit monoclonal C33E10 PERK (Cell Signaling), monoclonal mouse 
HA-probe 12CA5 (Santa Cruz Biotechnology), monoclonal mouse KDEL 10C3 DyLight 
488 (Enzo Life Sciences), Goat anti-mouse secondary antibody Alexa Fluor 594 
(ThermoFisher), monoclonal mouse anti-FLAG M2 F1804 (Millipore-Sigma), rabbit 
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polyclonal anti-A1AT (Dako), and mouse monoclonal GAPDH 374 (Millipore-Sigma). 
Rabbit polyclonal affinity-purified anti-BiP was from L. Hendershot (St. Jude Children’s 
Research Hospital). S-tag agaraose was purchased from Millipore-Sigma. All ATIII 
constructs, EDEM1, and EDEM2 were cloned into a pcDNA3.1(+) vector. 
pcDNA3.1(+)EDEM3-HA was from N. Hosokawa (Kyoto University). All chemicals 
were purchased from Millipore-Sigma, except where indicated. 
  
Metabolic Labeling 
Cells were pulse labeled for 30 min with 60 µCi of EasyTag Express35S Protein 
Labeling Mix [35S]-Cys/Met (PerkinElmer; Waltham, MA) in 3 cm plates and 120 µCi of 
[35S]-Cys/Met in 6 cm plates. Immediately after pulse, cells were washed with PBS and 
either lysed in lysis buffer with protease inhibitors (MNT; 20 mM MES, 100 mM NaCl, 
30 mM, 0.5% Triton X-100, 50 µM calpain inhibitor I, 1µM pepstatin, 10 µg/ml 
aprotinin, 10 µg/ml leupeptin, 400 µM phenylmethylsulfonyl fluoride, and 20 mM NEM) 
or chased for indicated time using regular growth media. Media and Triton X-100 
insoluble fractions were collected where indicated.  
 
Immunoprecipitations and SDS-PAGE  
After lysis, samples were vortexed at high speed at 4 °C for 5 min then 
centrifuged at high speed at 4 °C for 5 min. The supernatant was then pre-cleared using 
protein-A sepharose beads (GE Healthcare) by end-over-end rotation for 1 hr at 4 °C. 
Samples were then centrifuged at 3,000 rpm for 5 min at 4°C and the beads were 
discarded. Samples were then incubated with protein-A sepharose beads and the indicated 
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antibody overnight at 4 °C under end-over-end rotation. Samples were then washed with 
Connie’s Wash (100 mM Tris-HCl pH 8.6, 300 mM NaCl, 0.1% SDS, 0.05% Triton X-
100) or lysis buffer without protease inhibitors, where indicated. The Triton-X 100 
insoluble pellet was either discarded or solubilized in 1% SDS in 100mM Tris-HCl, pH 8 
by trituration followed by high speed vortexing at room temperature, heating for 10 min 
at 95 °C, dilution in lysis buffer and sonication. Samples were eluted from beads using 
Werner’s sample buffer (30 mM Tris-HCl pH 6.8, 9% SDS, 15% glycerol, 0.05% 
Bromophenol Blue), and SDS-PAGE was performed. Radiolabeled samples were imaged 
by phosphorimaging using a GE Typhoon FLA 9500 phosphorimager (GE Healthcare) 
and quantified using ImageQuant (Fujifilm). 
 
Secretion assay 
Cells were seeded onto 3 cm plates, transfected, and metabolically labeled using 
[35S]-Cys/Met, as previously described. After 30 min of pulse and the indicated time of 
chase, media and lysate portions were collected and immunoprecipitations were 
performed as previously described. After washing with Connie’s Wash, sample buffer 
was added and samples were analyzed by SDS-PAGE and imaged by phosphorimaging.  
  
Activity assay 
Cells were seeded into 6 cm plates, transfected, and metabolically labeled using 
[35S]-Cys/Met, as previously described. After 30 min of pulse and 3 hr of chase, the 
media and lysate portions were collected and immunoprecipitations were performed as 
previously described. After washing with 0.5% Chaps HBS (0.5% Chaps, 50mM HEPES 
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pH 7.5, 200mM NaCl), samples were eluted from beads with 10 ul of 0.5 mg/ml c-Myc 
peptide (Millipore-Sigma) for 1 hr at 37 °C. The beads were then discarded and the 
sample was split equally between treated and non-treated, 2 units of thrombin was added 
to treated samples and an equal volume of water to non-treated samples. Samples were 
then incubated for 1 hr at 37 °C before the addition of sample buffer. All samples were 
then analyzed by SDS-PAGE and imaged by phosphorimaging. 
 
Protease sensitivity assay 
Cells were seeded into 6 cm plates, transfected, and metabolically labeled using 
[35S]-Cys/Met, as previously described. After 30 min of pulse and 3 hr of chase, the 
media and lysate portions were collected and split equally into treated and non-treated 
samples. Samples were immunoprecipitated as previously described. After washing with 
0.5% Chaps HBS, 0.05 ug of trypsin was added to treated samples and an equal volume 
of water was added to non-treated samples. Samples were then incubated for 15, 30, or 60 
mins at 37 °C before the addition of sample buffer. All samples were then analyzed by 
SDS-PAGE and imaged by phosphorimaging. 
 
Glycosylation assay 
Cells were seeded onto 3 cm plates, transfected, and metabolically labeled using 
[35S]-Cys/Met, as previously described. After 30 min of pulse and 2 hr of chase, the 
media and lysate portions were collected and immunoprecipitations were performed as 
previously described. After washing, samples were treated with either EndoH or 
59 
 
PNGaseF (New England Biolabs), according to the manufacturer’s instructions. Samples 
were then analyzed by SDS-PAGE and imaged by phosphorimaging.  
 
Assay for the presence of free thiols 
Cells were seeded onto 3 cm plates, transfected, and metabolically labeled using 
[35S]-Cys/Met, as previously described. After 30 min of pulse and 30 min of chase, the 
media and lysate portions were collected and split equally into treated and non-treated 
samples. To treated samples, 100 µl of Polyethylene glycol maleimide (Millipore-Sigma) 
was added to a final concentration of 1.4 mM and to the non-treated samples 100 µl of N-
ethyl maleimide was added to a final concentration of 5 mM. Samples were then 
incubated at room temperature for 30 min. Treated samples were then quenched by 
adding Dithiothrietol (DTT) (ThermoFisher) to a final concentration of 100 mM. 
Immunoprecipitations were then performed as previously described. All samples were 




CHO cells were seeded onto glass coverslips in alpha-MEM supplemented with 
10% FBS. 24 hr later cells were transfected with the indicated plasmid using 
polyetheyleneimine (PEI) (Polysciences Incorporated; Warrington, PA) according to the 
manufacturer’s instructions. After 16 hr, cells were washed with phosphate buffered 
saline (PBS) (2.7 mM KCl, 1.5 mM KH2PHO4, 136.9 mM NaCl, 8 mM Na2PHO4, pH 
7.4) and fixed using 3.7% formaldehyde for 15 min, permeabilized using 0.1% Triton X-
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100 in PBS for 15 min, then washed with PBS and blocked with 10% FBS in PBS for 30 
min. Cells were incubated in Myc-tag antibody in 10% FBS in PBS (1:500) for 1 hr, 
washed with PBS, blocked with 10% FBS, and incubated with highly cross-adsorbed 
Goat-anti Mouse IgG secondary antibody conjugated to Alexa Fluor 594 (1:500) for 1 hr. 
Cells were then incubated with KDEL antibody conjugated to DyLight 488 (Enzo Life 
Sciences) (1:200) for 1 hr. Cells were then washed with PBS and mounted to glass slides 
using vectashield with DAPI (VectorLabs; Burlingame, CA) and sealed with nail polish. 
All images were acquired using an Olympus Fluoview FV1000 confocal microscope. 




Cells were seeded onto 10 cm plates and transfected. Media and lysate fractions 
were collected. Lysate fractions were then split equally between DTT treated and non-
treated samples. Treated samples contained 100 mM DTT. Sucrose gradients were made 
by solubilizing sucrose into MNT to a concentration of 10% or 40%. 6 ml of 10% sucrose 
was then laid on top of an equal volume of 40% sucrose and the gradient was established 
using a BioComp Model 153 gradient station (BioComp Instruments; Fredericton, NB). 
Samples were then laid on top of the 10-40% sucrose gradient. Gradients were then 
centrifuged at 38K rpm for 18 hrs in a Beckman Optima L-90K Ultracentrifuge. Samples 
were taken from the gradient by pipetting 1 ml from the top of the gradient using a wide-
bore pipette tip. Samples were treated with trichloroacetic acid to a final concentration of 
10% and incubated for 30 mins. Samples were then centrifuged at 14K rpm in a bench-
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top centrifuge for 10 minutes at 4°C, washed with acetone, and centrifuged at 14K rpm 
for 10 minutes at 4°C. Reducing sample buffer was added to all samples followed by 
analysis by SDS-PAGE and western blot. 
 
Western Blot 
After SDS-PAGE, gels were washed with ultra-pure water and transfer membrane 
(Immobilon-FL; Millipore) was pre-treated according to the manufacturer’s instructions. 
Transfer was then conducted using a wet-transfer apparatus (Invitrogen Novex mini-cell). 
Blots were blocked in 5% milk, 2% BSA in PBS solution for 1 hr under gentle shaking at 
room temperature. Primary antibodies at the indicated concentration in a 5% milk, 2% 
BSA, PBST (2.7 mM KCl, 1.5 mM KH2PO4, 136.9 mM NaCl, 8 mM Na2PHO4, 0.5% 
Tween 20, pH 7.4) solution were added to blots and incubated overnight at 4 °C under 
gentle rotation. Blots were then washed with PBST and incubated with IRDye 800CW 
conjugated goat secondary antibody against the appropriate species (LI-COR; Lincoln, 
NE) in a 5% milk, 2% BSA, 0.02% SDS, PBST solution for 1 hr at room temp under 
gentle shaking. Blots were then washed with PBST and imaged using a LI-COR Odyssey 
CLx imaging system. 
 
 
GST-calreticulin pull down 
Recombinant GST-calreticulin was expressed in Escherichia Coli and purified as 
previously described (Baksh & Michalak, 1991; Pearse et al., 2008). MI8-5 cells were 
seeded into 3 cm plates, transfected, and metabolically labeled using [35S]-Cys/Met, as 
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previously described. Cells were either treated with N-butyl deoxynojirimycin (Toronto 
Research Chemicals) for 30 mins prior to the experiment and then continuously 
throughout or for 15 mins prior to each time point, as indicated. 80% of the cell lysate 
was incubated with 8 µg of GST-Calreticulin pre-bound to glutathione beads (GE Life 
Sciences) overnight at 4°C while 20% of the lysate was immunoprecipitated with Myc 
antibody, as previously described. All samples were washed with Connie’s wash and 
reducing sample buffer was added to the immunoprecipitations. GST-calreticulin samples 
were treated with 20 µl of elution buffer (1% SDS in 10 mM Tris, pH 7.5, 150 mM NaCl) 
at 95°C for 10 min, centrifuged for 2 min at 2000 rpm, the supernatant was collected and 
quenched with MNT buffer, followed by immunoprecipitation with protein-A sepharose 
beads with Myc antibody, as previously described. Beads were then washed with 
Connie’s wash and the sample was treated with reducing sample buffer. Sample was then 




Cho cells were seeded onto 10 cm plates and transfected for 24 hr. Untransfected 
cells were either treated with tunicamycin in DMSO at a concentration of 5 µg/ml or 
DMSO alone for 24 hr. Total RNA was then collected using an RNeasy kit (Qiagen). 
cDNA was then generated using AMV Reverse Transcriptase (NEB) and mouse Xbp1 
primers (Lee et al., 2002), according to the manufacturer’s instructions. The resulting 
cDNA product was then separated using a 2.5% agarose gel and visualized using a 





Cells were seeded onto 10 cm plates and transfected for 24 hr. Untransfected cells 
were either treated with tunicamycin (5 µg/ml) in DMSO or DMSO alone for 24 hr. Cells 
were then lysed using MNT and trichloroacetic acid (TCA) precipitated. TCA 
precipitation was conducted by adding TCA to cell lysate to a final concentration of 10%. 
Cell lysate was then briefly rotated and allowed to incubate on ice for 15 min before 
spinning at 14,000 rpm for 10 min at 4 ºC. Supernatant was then aspirated and washed 
with acetone and centrifuged for 10 min at 4 ºC. Supernatant was then aspirated and the 
remaining precipitant was allowed to dry for 5 minutes at room temperature and briefly at 
65 ºC. Reducing sample buffer was then added and 5% of total lysates were resolved on a 
9% reducing SDS-PAGE. Gels were then imaged by western blotting, as previously 
described, using the following antibodies; anti-BiP (1:1000), Myc (1:2,500), A1AT 
(1:500), and GapDH (1:1000). 
 
PERK phosphorylation  
Cells were seeded onto 10 cm plates and transfected for 24 hr. Untransfected cells 
were either treated with tunicamycin (5 µg/ml) in DMSO or DMSO alone for 24 hr. Cells 
were then lysed using MNT and TCA precipitated as previously described. 5% of total 
lysates were resolved on a 9% reducing SDS-PAGE. Gels were then imaged by western 
blotting, as previously described, using the following antibodies: PERK (1:500), Myc 





Cells were seeded onto 3 cm plates, transfected, and metabolically labeled using 
[35S]-Cys/Met, as previously described. After 30 mins of pulse and the indicated chase 
times, cells were lysed and the lysate was collected. For EDEM co-IPs, half of the plates 
were lysed in MNT. For OS9.2 and XTP3B, half of the plates were lysed in buffer 
containing 150 mM NaCl, 5 mM EDTA pH 7.4, 50 mM Tris pH 7.4, 1% Triton X-100, 
50 µM Calpain inhibitor I, 1µM pepstatin, 10 µg/ml aprotinin, 10 µg/ml leupeptin, 400 
µM phenylmethylsulfonyl fluoride, and 20 mM NEM. In all cases, the other half of plates 
were lysed with 2% CHAPS HBS buffer. Cell lysates were then split equally and 
immunoprecipitated for either substrate or ERAD factor. ATIII was immunoprecipitated 
as previously described. AlAT NHK was immunoprecipitated using A1AT antibody and 
protein-A agarose beads EDEM1/2 were immunoprecipitated using Flag-tag and protein-
A agarose beads while EDEM3 was immunoprecipitated using HA-tag and protein-A 
agarose beads. OS9.2/XTP3B were affinity purified using S-tag agarose beads 
(Millipore-Sigma). IPs were then washed with Connie’s buffer if lysed using 1% Triton 
X-100, or 0.5% CHAPS HBS buffer if lysed using 2% CHAPS HBS. After washes, 
sample buffer was added and samples were analyzed by 9% reducing SDS-PAGE and 
imaged by phosphorimaging. 
 
Statistics  
Percentages of reglucosylation were calculated by dividing the number obtained 
from quantification of bands in the GST-calreticulin lanes by the number obtained from 
quantification of bands in the single immunoprecipitation lanes multiplied by four to 
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correct for the amount of cell lysate used in each pull-down. The comparative percentage 
of reglucosylation was then obtained by dividing the amount of reglucosylation of mutant 
protein over that of wild type. For all quantifications, error bars were calculated by 
determining the standard deviation of three independent samples. Statistical significance 





Figure 2.1 ATIII Cys-less is efficiently secreted 
 
(A) ATIII and ATIII Cys-less were expressed in CHO cells. Cells were  
radiolabeled with [35S]-Cys/Met for 30 min and chased for the indicated times. At each 
time point, cell lysate and media were collected. Cells were lysed in MNT  
buffer. ATIII was immunoprecipitated using anti-Myc antibodies. Samples were resolved 
by reducing 9% SDS-PAGE. (B) Quantification of ATIII secretion from  
panel A. The lysate and media was quantified and ATIII secretion is presented as a 






Figure 2.2 Secreted ATIII Cys-less is inactive and misfolded 
 
(A) ATIII WT and ATIII Cys-less were expressed in CHO cells and radiolabeled with 
[35S]-Cys/Met for 30 min and chased for 3 hr. Cells were lysed in MNT buffer. Cell 
lysate and media were collected and ATIII was immunoprecipitated using anti-Myc 
antibodies and washed with buffer containing 0.5% CHAPS. ATIII was then eluted from 
the immunoprecipitation beads by incubation with 0.5 mg/ml c-Myc peptide for 1 hr at 
37 °C. Sample was then evenly split between treated and non-treated samples. 0.648 mg 
(2 units) of thrombin were added to treated samples while non-treated samples received 
an equal volume of water. Samples were then incubated at 37 °C for 1 hr and resolved by 
reducing 9% SDS-PAGE. (B) ATIII WT and Cys-less were expressed in CHO cells. 
Cells were radiolabeled with [35S]-Cys/Met for 30 min, chased for 3 hr, and cell lysate 
and media were collected. Cells were lysed in MNT buffer. ATIII was 
immunoprecipitated using anti-Myc antibodies. 0.05 µg of trypsin was added to treated 
samples and an equal volume of water was added to non-treated samples. Samples were 
then incubated for the indicated times at 37 °C and resolved by reducing 9% SDS-PAGE. 
(C) Quantification of ATIII remaining post-trypsin degradation from panel B. (D) ATIII 
WT and Cys-less were expressed in CHO cells. Cells were radiolabeled for 30 mins with 
[35S]-Cys/Met, chased for 2 hr, and cell lysate and media were collected. Cells were 
lysed in MNT buffer. ATIII was immunoprecipitated using anti-Myc antibodies. Lysate 
and media samples were treated with EndoH, PNGaseF, or left untreated. Samples were 
then resolved on a reducing 9% SDS-PAGE. All experiments are representative 





Figure 2.3 ATIII C247A/C430A is retained in the cell while remaining disulfide mutants 
are secreted 
(A) ATIII and ATIII disulfide mutants were expressed in  
CHO cells. Cells were radiolabeled with [35S]-Cys/Met for 30 min and chased for the 
indicated times. At each time point, cell lysate and media were collected.  
Cells were lysed in MNT buffer. ATIII was immunoprecipitated using anti-Myc 
antibodies. Samples were resolved by both reducing and non-reducing 9%  
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SDS-PAGE. (B) Quantification of ATIII secretion from panel A. The lysate and media 
were quantified and ATIII secretion is presented as a percentage of ATIII  













































Figure 2.4 Cellularly retained ATIII C247/430A is inactive and contains a higher level of 
free thiols than secreted disulfide mutants 
 
(A) ATIII and ATIII disulfide mutants were expressed in CHO cells, radiolabeled with 
[35S]-Cys/Met for 30 min and chased for 3 hr. Cells were lysed in MNT buffer. Cell 
lysate and media were collected and ATIII was immunoprecipitated using anti-Myc 
antibody and washed with 0.5% CHAPS buffer. ATIII was then eluted from the 
immunoprecipitation beads by incubation with 0.5 mg/ml c-Myc peptide for 1 hr at 37 
°C. Samples were then evenly split between treated and non-treated samples. 0.648 mg (2 
units) of thrombin were added to treated samples while non-treated samples  
received an equal volume of water. Samples were then incubated at 37 °C for 1 hr and 
resolved by reducing 9% SDS-PAGE. (B) ATIII and ATIII disulfide mutants were 
expressed in CHO cells, radiolabeled with [35S]-Cys/Met for 30 min and chased for 30 
min. Cells were lysed in MNT buffer. To treated samples, PEG-maleimide was added to 
a final concentration of 1.4 mM and to the non-treated samples N-ethyl maleimide was 
added to a final concentration of 5 mM. Samples were incubated at room temperature for 
30 min. Treated samples were then quenched by adding dithiothreitol to a final 
concentration of 100 mM. ATIII was immunoprecipitated using anti-Myc antibodies and 
samples were resolved by reducing 9% SDS-PAGE. (C) Quantification of PEG-
Maleimide unmodified ATIII from panel B. Percent PEG-Maleimide unmodified was 
determined by quantifying the amount of unmodified ATIII in PEG-Maleimide treated 
and non-treated samples and dividing the treated sample by the untreated sample. All 






Figure 2.5 ATIII with a single free thiol is retained in the ER 
 
(A) ATIII Cys-less and ATIII single Cys mutants were expressed in CHO cells. Cells 
were radiolabeled with [35S]-Cys/Met for 30 mins and chased for the indicated times. At 
each time point, cell lysate and media were collected and processed as previously 
described in Figure 2.1A. Samples were resolved by both reducing (R) and non-reducing 
(NR) 9% SDS-PAGE. (B) Quantification from panel A. Asterisks denote statistical 















Figure 2.6 ATIII C247A/C430A is retained and diffuse throughout the ER 
 
ATIII WT, ATIII Cys-less and ATIII C247A/C430A were expressed in CHO cells. Cells 
were fixed in buffer containing 3.7% formaldehyde, permeabilized in buffer containing 
0.1% Triton X-100 and stained using anti-Myc antibodies, KDEL, and giantin primary 
antibodies, as indicated, goat anti-mouse IgG secondary antibody, and DAPI. Cells were 
























Figure 2.7 ATIII C247A/C430A is retained in a disulfide-dependent multimer 
 
ATIII WT, ATIII Cys-less, and ATIII C247A/C430A were expressed in CHO cells. Cells 
were lysed in MNT. Media and lysate fractions were collected and split equally between 
DTT-treated and non-treated fractions. Sucrose gradients were generated by solubilizing 
sucrose into MNT and a 10-40% gradient was established. Samples were then laid on top 
of the sucrose gradient. Gradients were then centrifuged at 38K rpm for 18 hr. Samples 
were taken from the gradient by pipetting 1 ml from the top of the gradient. Samples 
were TCA precipitated and then resolved on a 9% reducing SDS-PAGE and imaged by 






















Fig 2.8 ATIII C247A/C430A is not a strong UGGT1 substrate 
 
(A) ATIII variants were expressed in MI8-5 CHO cells. 30 minutes prior to the pulse  
and throughout the chase, cells were treated with 0.5 mM N-butyl deoxynojirimycin 
(DNJ). Cells were radiolabeled with [35S]-Cys/Met for 30 mins and chased  
for the indicated times. At each time point, cells were lysed in MNT buffer. 80% of the 
cell lysate was affinity purified with Glutathione S-transferase-tagged  
calreticulin (GST-CRT) while 20% of the cell lysate was immunopurified with anti-Myc 
antibody. GST-CRT affinity purifications were then eluted in buffer containing 1% SDS, 
diluted in MNT, and immunopurified using anti-Myc-Tag antibody. Samples were 
resolved by reducing 9% SDS-PAGE. (B) Quantification of reglucosylation in panel A. 
Percent reglucosylation for each ATIII variant is calculated by quantifying the bands 
corresponding to ATIII, multiplying the lysate band by 4, and dividing the amount of 
ATIII in the sequential IP by the amount of ATIII in the non-sequential IP at each time 
point. All reglucosylation values are normalized to WT ATIII. (C) Same as panel A, 
except DNJ was added 15 mins prior to each time point, not throughout the experiment. 
(D) Quantification of reglucosylation in panel C. Percent reglucosylation was calculated 












Figure 2.9 UGGT1 is not required for ATIII C247A/C430A to be retained 
 
(A) ATIII and ATIII C247A/C430A is expressed in both  
WT and UGGT1-/- MEF cells. Cells were radiolabeled with [35S]-Cys/Met for 30 mins 
and chased for the indicated times. At each time point, cells were lysed in  
MNT buffer. At each time point, cell lysate and media were collected. Cells were lysed in 
MNT buffer. ATIII was immunoprecipitated using anti-Myc antibody.  
Samples were resolved by both reducing and non-reducing 9% SDS-PAGE. (B) 
Quantification of ATIII secretion from panel A. The lysate and media were  
quantified and ATIII secretion is presented as a percentage of ATIII in the media to 





















Figure 2.10 ATIII C247A/C430A is poorly degraded  
 
(A) ATIII WT and disulfide mutants were expressed in CHO cells. Cells were 
radiolabeled with [35S]-Cys/Met for 30 min and chased for the indicated times. At each 
time point, cell lysate, media, and Triton X-100 insoluble fractions were collected and 
processed as described in Figure 2.1A. (B) Quantification of A. The percent of each 
protein remaining was calculated by quantifying ATIII present in each fraction of the 
reducing gel and dividing by the amount of ATIII immediately after the chase (0 hr). The 
amount of protein in the indicated fraction at each time point is represented as a fraction 
of the total amount of protein present at that time point. All experiments are 
















Figure 2.11 IRE-1 but not ATF6 or PERK is activated by ATIII overexpression 
 
(A) ATIII variants and A1AT NHK were expressed in CHO cells for 24 hr. Control cells 
were treated with DMSO or tunicamycin (Tm) for 24 hr. Cells were lysed and RNA was 
collected. cDNA was generated and amplified via PCR using XPB-1 specific primers. (B) 
ATIII variants and A1AT NHK were expressed in CHO cells for 24 hr. Control cells 
were treated with either DMSO or Tm for 24 hr. Cells were then lysed with MNT and 
TCA precipitated. 5% whole cell lysate was then resolved on a 9% SDS-PAGE and 
imaged by western blot using anti-Myc antibody (ATIII), anti-Perk antibody, and anti-
A1AT antibody (C) ATIII variants and A1AT NHK were expressed in CHO cells for 24 
hr. Control cells were treated with either DMSO or Tm for 24 hr. Cells were then lysed 
with MNT and TCA precipitated. 5% whole cell lysate was then resolved on a 9% SDS-
PAGE and imaged by western blot using the indicated antibodies. (D) Quantification of 
panel B. Relative BiP expression was calculated by normalizing all BiP levels to DMSO, 









Figure 2.12 ATIII C247A/C430A binds poorly to EDEM1, EDEM2, and EDEM3 
 
(A) Flag-tagged EDEM1 was co-expressed with Myc-tagged ATIII WT,  
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Myc-tagged ATIII C247A/C430A, and A1AT NHK in CHO cells, as indicated. Cells 
were radiolabeled with [35S]-Cys/Met for 30 min and chased for the indicated  
times. Cells were lysed in MNT buffer. Lysates were then split equally and 
immunoprecipitated with either anti-Myc, Flag, or A1AT antibodies, as indicated.  
Samples were resolved by reducing 9% SDS-PAGE and imaged by phosphorimaging. 
EDEM1 is denoted by an asterisk, while ATIII and A1AT NHK are denoted  
by a filled circle. (B) Quantification of EDEM1 co-immunoprecipitation from panel A. 
Percent co-immunoprecipitation was determined by dividing the amount of  
EDEM1 immunoprecipitated by ATIII or NHK to total EDEM1. (C-F) Either Flag-
tagged EDEM2 or HA-tagged EDEM3 were co-expressed with Myc-tagged 
ATIII WT, Myc-tagged ATIII C247A/C430A, and A1AT NHK in CHO cells. Lysates 
were treated the same as previous panels and immunoprecipitated using the  
indicated antibodies. Quantifications were conducted as described in panel B. All 




































Figure 2.13 ATIII quality control model 
 
Substrate features are generally understood to dictate the ER quality control pathways 
substrates engage, as depicted by arrows corresponding to different combinations of 
substrate features traversing quality control pathways. ATIII does not follow expected 


















Figure 2.14 Hydropathy plots of acid phosphatase (AcP 101-118), ATIII and A1AT 




Kyte-Doolittle scores of amino acids C-terminal to the glycan using a window size of 5 
amino acids are depicted. The asparagine residue for each glycan is positioned at 0. 
Positive values represent hydrophobicity. Oscillating hydrophobicity profiles with two 
hydrophobic patches of three or more amino acids are correlated with increased 
reglucosylation by UGGT1. AcP 101-118 is depicted as an example of a well-
reglucosylated substrate possessing a characteristic hydropathy profile (Taylor et al, 
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Abstract 
The protein quality control sensors UDP-glucose: glycoprotein 
glucosyltransferase (UGGT) 1 and 2 are proposed to act as gatekeepers of the early 
secretory pathway. They initiate rebinding to the carbohydrate-dependent chaperones 
calnexin and calreticulin that associate with proteins possessing monoglucosylated 
glycans. The UGGTs control glycoprotein exit from the endoplasmic reticulum (ER) for 
trafficking to the Golgi or ER retention to provide additional folding opportunities. A 
quantitative glycoproteomics strategy was used to identify cellular glycoproteins 
modified by the UGGTs at endogenous levels and delineate the specificities of UGGT1 
and UGGT2. UGGT substrates were comprised of seventy-one mainly large multidomain 
and heavily glycosylated proteins when compared to the general N-glycome. UGGT1 
was the dominant glucosyltransferase with a preference towards large plasma membrane 
proteins whereas UGGT2 favored the modification of smaller, soluble lysosomal 
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proteins. This study provides insight into the cellular secretory load that utilizes multiple 
rounds of carbohydrate-dependent chaperone intervention for proper maturation. 
 
Introduction 
Protein folding in the cell is an error-prone process and protein misfolding is the 
basis for a large number of disease states (Hebert & Molinari, 2007; Hartl, 2017). A 
significant fraction of the proteome in mammalian cells passes through the secretory 
pathway by first being targeted to the endoplasmic reticulum (ER) where folding occurs 
(Uhlén et al., 2015; Itzhak et al., 2016; Adams, Oster, et al., 2019). Molecular chaperones 
of the ER help to guide secretory pathway cargo along a productive folding pathway by 
directing the trajectory of the folding reaction, inhibiting non-productive side reactions 
such as aggregation or by retaining immature or misfolded proteins in the ER until they 
can properly fold or be targeted for degradation. Understanding how chaperone binding 
controls the maturation and flux of proteins through the secretory pathway is of important 
fundamental biological concern and will impact our knowledge of protein folding 
diseases and the development of potential therapeutics including the production of 
biologics that are frequently secretory proteins. 
 Proteins that traverse the secretory pathway are commonly modified with N-
linked glycans as they enter the ER lumen (Zielinska et al., 2010). These carbohydrates 
serve a variety of roles including acting as quality control tags or attachment sites for the 
lectin ER chaperones calnexin and calreticulin (Helenius & Aebi, 2004; Hebert et al., 
2014). N-glycosylation commences co-translationally in mammals and the first round of 
binding to calnexin and calreticulin is initiated shortly thereafter by the rapid trimming of 
85 
 
glucoses by glucosidases I and II to reach their monoglucosylated state (W. Chen et al., 
1995; Cherepanova et al., 2019). Lectin chaperone binding is multifunctional as it has 
been shown to: (1) direct the folding trajectory of a protein by acting as a holdase that 
slows folding in a region-specific manner; (2) act as an adapter or platform to recruit 
folding factors including oxidoreductases (ERp57 and ERp29) and a peptidyl-prolyl cis 
trans isomerase (CypB) to maturing nascent chains; (3) diminish aggregation; (4) retain 
immature, misfolded or unassembled proteins in the ER; and (5) target aberrant proteins 
for degradation (Rajagopalan et al., 1994; Hebert et al., 1996; Daniels et al., 2003; 
Molinari et al., 2003; Oda et al., 2003; N. Wang et al., 2008; Kozlov & Gehring, 2020). 
For glycoproteins, the lectin chaperones appear to be the dominant chaperone system as 
once an N-glycan is added to a region on a protein, it has been shown to be rapidly 
passed from the ER Hsp70 chaperone BiP to the lectin chaperones, further underscoring 
their central role in controlling protein homeostasis in the secretory pathway (Helenius & 
Hammond, 1994). 
 N-glycan trimming to an unglucosylated glycoform by glucosidase II supports 
substrate release from the lectin chaperones. At this stage, if the protein folds properly, it 
is packaged into COPII vesicles for anterograde trafficking (C. Barlowe & Helenius, 
2016). Alternatively, substrates that are evaluated to be non-native are directed for 
rebinding to the lectin chaperones by the protein folding sensor UDP-glucose: 
glycoprotein glucosyltransferase 1 (UGGT1) that reglucosylates immature or misfolded 
proteins (Helenius, 1994; Sousa & Parodi, 1995b). Since UGGT1 directs the actions of 
this versatile lectin chaperone system and thereby controls protein trafficking through the 
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ER, it acts as a key gatekeeper of the early secretory pathway. Therefore, it is vital to 
understand the activity of UGGT1 and the scope of substrates it modifies. 
 Our current knowledge of the activity of UGGT1 relies largely on studies using 
purified components. UGGT1 was found to recognize non-native or near-native 
glycoproteins with exposed hydrophobic regions using in vitro approaches where the 
modification of glycopeptides, engineered or model substrates by purified UGGT1 was 
monitored (Ritter & Helenius, 2000; Taylor et al., 2003; Caramelo et al., 2004). Recent 
crystal structures of fungal UGGT1 have shown that it possesses a central, hydrophobic 
cavity in its protein sensing domain, which may support hydrophobic-based interactions 
for substrate selection (Roversi et al., 2017; Satoh et al., 2017). 
 Cell-based studies of UGGT1 have relied on the overexpression of cellular and 
viral proteins (Soldà et al., 2007; Pearse et al., 2008; Ferris et al., 2013; Tannous et al., 
2015). Uggt1 knockout studies have found that the roles of UGGT1 appear to be 
substrate specific as UGGT1 can promote, decrease or not affect the interaction between 
substrates and calnexin (Soldà et al., 2007). Prosaposin, the only known cellular substrate 
of UGGT1 when expressed at endogenous levels, grossly misfolds in the absence of 
Uggt1 and accumulates in aggresome-like structures (Pearse et al., 2010). Work in 
animals has further emphasized the importance of UGGT1 as the deletion of Uggt1 in 
mice is embryonically lethal (Molinari et al., 2005). 
 UGGT1 has a paralogue, UGGT2, but it has no demonstrated cellular activity 
(Arnold et al., 2000). Domain swapping experiments have demonstrated that UGGT2 
possesses a catalytically active glucosyltransferase domain when appended to the folding 
sensor domain of UGGT1 (Arnold & Kaufman, 2003). In vitro experiments using 
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purified, chemically glycosylated interleukin-8 (IL-8), which is not glycosylated in cells, 
have found that UGGT2 can glucosylate IL-8 (Y. Takeda et al., 2014). This suggests that 
UGGT2 may be an additional reglucosylation enzyme or protein folding sensor of the 
ER.  
 Unlike the classical ATP-dependent chaperones that directly query the 
conformation of their substrates (Balchin et al., 2016), binding to the lectin chaperones is 
dictated by enzymes that covalently modify the substrate (Helenius & Aebi, 2004; Hebert 
et al., 2014). Rebinding to the carbohydrate-dependent chaperones is initiated by the 
UGGTs that interrogate the integrity of the structure of the protein. Therefore, the 
proteome-wide detection of cellular UGGT substrates provides the unprecedented 
opportunity to identify clients that require multiple rounds of chaperone binding and are 
more reliant on lectin chaperone binding for proper maturation and sorting. Therefore, we 
designed a cell-based quantitative glycoproteomics approach to identify high-confidence 
endogenous substrates of UGGT1 and UGGT2 by the affinity purification of 
monoglucosylated substrates in CRISPR/Cas9-edited cells. UGGT1 and UGGT2 
substrates were found to display multiple features of complex proteins including 
extended lengths plus large numbers of Cys residues and N-glycans. Specific substrates 
of either UGGT1 or UGGT2 were also discovered, therefore determining that UGGT2 
possessed glucosyltransferase activity and identifying its first natural substrates. UGGT1 
demonstrated a slight preference for transmembrane proteins, especially those targeted to 
the plasma membrane, while UGGT2 modification favored soluble lysosomal proteins. 
The identification of reglucosylated substrates improves our understanding of their 
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folding and maturation pathways and has implications regarding how folding trajectories 




To identify the substrates that are most dependent upon persistent 
calnexin/calreticulin cycle binding, we isolated and identified endogenous substrates for 
the ER protein folding sensors UGGT1 and UGGT2. As the product of a reglucosylation 
by the UGGTs is a monoglucosylated N-glycan, the presence of the monoglucosylated 
glycoform was used as a readout for substrate reglucosylation. N-glycans are originally 
transferred to nascent glycoproteins containing three glucoses, therefore a 
monoglucosylated glycan can be generated either through trimming of two glucoses from 
the nascent N-linked glycan or through reglucosylation by the UGGTs. In order to isolate 
the reglucosylation step from the trimming process, a gene edited cell line was created 
that transfers abbreviated unglucosylated N-linked glycans to nascent chains. The N-
linked glycosylation pathway in mammalian cells is initiated through the sequential 
addition of monosaccharides, mediated by the ALG (Asn-linked glycosylation) gene 
products, to a cytosolically exposed dolichol-P-phosphate embedded in the ER membrane 
(Aebi, 2013; Cherepanova et al., 2016) (Figure 3.1A). The immature dolichol-P-
phosphate precursor is then flipped into the ER lumen and sequential carbohydrate 
addition is continued by additional ALG proteins. The completed N-glycan 
(Glc3Man9GlcNAc2) is then appended to an acceptor Asn residue in the sequon Asn-Xxx-
Ser/Thr/Cys (where Xxx is not a Pro) by the oligosaccharyl transferase (OST) complex 
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(Cherepanova et al., 2016). Initially, a Chinese Hamster Ovary (CHO) cell line with a 
defect in Alg6 was employed to establish the utility of this approach to follow 
(re)glucosylation (Quellhorst et al., 1999; Cacan et al., 2001; Pearse et al., 2008, 2010; 
Tannous et al., 2015). As the CHO proteome is poorly curated compared to the human 
proteome, CRISPR/Cas9 was used to knock-out the ALG6 gene in HEK293EBNA1-6E 
cells to provide a cellular system that transferred non-glucosylated glycans 
(Man9GlcNAc2) to substrates. In these ALG6-/-cells, a monoglucosylated glycan is solely 
created by the glucosylation by the UGGTs providing a suitable system to follow the 
glucosylation process (Figure 3.1B).  
To aid in substrate identification, an inhibitor of glucosidases I and II, 
deoxynojirimycin (DNJ), was added 1 hr prior to cell lysis to block glucose trimming and 
trap monoglucosylated products. Monoglucosylated substrates were then isolated by 
affinity purification using recombinant glutathione S-transferase-calreticulin (GST-CRT), 
as calreticulin binds monoglucosylated proteins. To account for non-specific binding, a 
lectin-deficient construct (GST-CRT-Y109A) was used as an affinity purification control 
(Kapoor et al., 2004). Affinity purified substrates were reduced, alkylated, and trypsin 
digested. The resulting peptides were labeled with tandem mass tags (TMT) (Rauniyar & 
Yates, 2014), deglycosylated using PNGaseF, and analyzed by mass spectrometry to 
identify substrates of the UGGTs. The use of TMT, as well as the control GST-CRT-
Y109A affinity purification, allows for robust, quantitative identification of substrates of 
the UGGTs. The resulting data was analyzed by calculating the fold change in abundance 
of the TMT associated with proteins identified through affinity purification using wild 
type GST-CRT over affinity purification using GST-CRT-Y109A. To be considered a 
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UGGT substrate, a cutoff of three-fold (wild type GST-CRT/GST-CRT-Y109A) was 
applied. This conservative cutoff was set to give a high level of confidence in the 
identified substrates, as below this cutoff, increasing fractions of non-secretory pathway 
proteins were found. 
 
Substrate identification of the UGGTs 
In order to determine the cellular substrates of the UGGTs, the above 
glycoproteomics protocol was followed using ALG6-/- cells. A restricted pool of thirty-
seven N-linked glycosylated proteins was identified as substrates of the UGGTs (Figure 
3.1C). Prosaposin, the only previously known endogenous substrate of the UGGTs, was 
included in this group, supporting the utility of the approach (Pearse et al., 2010). Integrin 
b-1 showed the most significant fold change (wild type GST-CRT/GST-CRT-Y109A) of 
~26-fold, indicating there is a large dynamic range of reglucosylation levels. 
The cell localizations of UGGT substrates were then determined by using their 
Uniprot classification. Approximately two thirds of the UGGT substrates are destined for 
the plasma membrane or lysosomes (Figure 3.2C and 3.2D). Additional substrates are 
secreted or are resident to the ER or nuclear membrane. Nuclear pore membrane 
glycoprotein 210 (NUP210) was the only nuclear membrane protein found to be 
reglucosylated and it is the sole subunit of the nuclear pore that is N-glycosylated (Beck 
& Hurt, 2016). The nucleus and ER share a contiguous membrane. Proteins targeted to 
the nuclear membrane are first inserted into the ER membrane, then move laterally to the 
nuclear membrane (Katta et al., 2014). Four proteins were designated as ‘multiple 
localizations’ including cation-independent mannose-6-phosphate receptor (CI-M6PR), 
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which traffics between the Golgi, lysosome and plasma membrane (Dell’Angelica & 
Payne, 2001). 
 To distinguish the general pool of substrates that the UGGTs are expected to be 
exposed to, N-glycosylated proteins of the secretory pathway proteome (N-glycome) 
were computationally defined (Supplemental Table 2). The N-glycome is comprised of 
proteins that are targeted to the ER either for residency in the secretory/endocytic 
pathways or for trafficking to the plasma membrane or for secretion. The reviewed 
UniprotKB H. sapiens proteome (20,353 total proteins) was queried to identify all 
proteins annotated as N-glycosylated, resulting in a set of 4,520 proteins. This set was 
then curated to remove proteins predicted to be mitochondrial, contain less than 50 amino 
acids or redundant isoforms. The resulting N-glycome contained 4,361 proteins, 
predicting ~21% of the proteome is N-glycosylated. Comparing UGGT substrates to the 
N-glycome allows for the characterization of feature preferences of substrates for the 
UGGTs. 
The majority of the N-glycome was either localized to the plasma membrane 
(37%) or was secreted (20%) according to their Uniprot designations. Smaller fractions 
of the N-glycome reside in the ER (5%), Golgi (4%) or lysosomes (2%). UGGT 
substrates are therefore significantly enriched for lysosomal proteins compared to the N-
glycome, while all other localizations display a similar distribution to their availability. In 
total, these results demonstrate the ability to identify substrates of the UGGTs 
proteomically and suggest that the UGGTs display substrate preferences. 
 
Determination of UGGT1 and UGGT2 specific substrates 
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There are two ER glucosyltransferase paralogues, UGGT1 and UGGT2, though 
currently there is no evidence that UGGT2 acts as a protein sensor or a 
glucosyltransferase in the cell.  Therefore, we sought to determine if UGGT2 has 
glucosyltransferase activity in the cell, and if so, do these two paralogues have different 
substrate specificities. To address this concern, GST-CRT affinity purification and TMT 
mass spectrometry were used to identify substrates of UGGT1 in ALG6/UGGT2-/- cells 
and potential UGGT2 substrates in ALG6/UGGT1-/- cells.  
With the ALG6/UGGT2-/- cells, 66 N-glycosylated proteins were identified as 
reglucosylation substrates using the three-fold cutoff (GST-CRT/CST-CRT-Y109A) 
(Figure 3.3A). Nearly double the number of UGGT1 substrates were identified through 
this approach compared to using ALG6-/- cells where both UGGT1 and UGGT2 were 
present. This expansion in substrate number is likely due to the ~50% increase in 
expression of UGGT1 in ALG6/UGGT2-/- cells (Figure 3.4A). The substrate 
demonstrating the most significant fold change (23.5-fold) was CD164, creating a similar 
dynamic range for reglucosylation to that observed in ALG6-/- cells.  
To identify possible UGGT2 specific substrates, ALG6/UGGT1-/- cells were used 
to isolate UGGT2 modified substrates. Thirty-four proteins passed the three-fold GST-
CRT/GST-CRT-Y109A cutoff, with 33 of these proteins predicted to be N-glycosylated 
and localized to the secretory pathway (Figure 3.3B). Importantly, this demonstrated for 
the first time that UGGT2 was a functional glycosyltransferase capable of reglucosylating 
a range of cellular substrates. The glycoprotein with the most significant fold change was 
arylsulfatase A (10.4-fold). Notably, 8 of the 9 strongest UGGT2 substrates or, 15 of 33 
substrates overall, are lysosomal proteins (Figure 3.3B and Figure 3.5A). While UGGT1 
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was also observed to engage a significant percentage of lysosomal proteins (27%), 45% 
of UGGT2 substrates are lysosomal. Both of these percentages are significantly enriched 
when compared to the N-glycome for which only 2% is comprised of resident lysosome 
proteins (Figure 3.2B).  
UGGT1 substrates were enriched for plasma membrane localized proteins (35%) 
when compared to UGGT2 substrates (18%), while plasma membrane proteins were 
found to compose a similar percent of the N-glycome (37%) compared to UGGT1 
substrates. Similar percentages of UGGT1 and UGGT2 substrates localize to the ER 
(18%), are secreted (12%), or are found in multiple localizations (6%) (Figure 3.5A). 
Even though 4% of the N-glycome is composed of Golgi proteins (Figure 3.2B), neither 
UGGT1 nor UGGT2 appeared to modify Golgi localized proteins.  
The number of UGGT1 substrates was double that of UGGT2 suggesting that 
UGGT1 carried the main quality control load. Only three out of thirty-three UGGT2 
substrates were specific to UGGT2. These three UGGT2 specific substrates included 
arylsulfatase A, a-N-acetylgalactosaminidase and b-hexosaminidase subunit b (HexB), 
three soluble lysosomal enzymes (Figure 3.5B and C). Thirty substrates overlapped 
between UGGT1 and UGGT2, while thirty-six substrates were found to be specific to 
UGGT1 (Figure 3.5B). The preference for the shared substrates was explored by plotting 
all proteins identified as a substrate of either glucosyltransferase on a log10 scale of the 
associated TMT value in ALG6/UGGT2-/- cells divided by the values in ALG6/UGGT1-/- 
cells (Figure 3.5C). Proteins enriched as UGGT2 substrates therefore possess positive 
values while UGGT1 enriched substrates have negative values.  
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The three substrates found to be specific to UGGT2 clustered away from all other 
proteins (Figure 3.5C at the top left). The remaining UGGT2 enriched substrates, except 
for one ER localized protein, localized to the lysosome. All the UGGT2 favored 
substrates were soluble proteins. In contrast, UGGT1 favored proteins were greater in 
number and displayed a diversity of localizations with a preference for plasma membrane 
proteins. These results indicate that UGGT2 is a functional glucosyltransferase, which 
preferentially engages soluble lysosomal proteins while UGGT1 modifies a wider variety 
of proteins with a preference for plasma membrane and transmembrane domain-
containing proteins in general. 
 
Validation of UGGT substrates 
Having identified numerous novel substrates of the UGGTs, a select number of 
these substrates were tested for reglucosylation to validate the identification approach. 
Substrates were chosen based on a diversity of topologies, lengths, differences in 
propensities as UGGT1 or UGGT2 substrates and reagent availability. Monoglucosylated 
substrates were affinity isolated from ALG6-/-, ALG6/UGGT1-/-, ALG6/UGGT2-/- and 
ALG6/UGGT1/UGGT2-/- cells using GST-CRT compared to CST-CRT-Y109A. 
Substrates were then identified by immunoblotting with the percent reglucosylation 
determined by subtracting the amount of protein bound by GST-CRT-Y109A from that 
of GST-CRT, divided by the total amount of substrate present in the whole cell lysate, 
and multiplying by 100. 
CI-M6PR and insulin-like growth factor type 1 receptor (IGF-1R) are both large 
type I membrane protein that possess multiple N-glycosylation sites (Figure 3.6D and H). 
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Overall 10% of CI-M6PR was reglucosylated in ALG6-/- cells (Figure 3.6B). The 
modification level of CI-M6PR was significantly reduced in ALG6/UGGT1-/-, but not 
ALG6/UGGT2-/- cells. As a control, reglucosylation was not observed in 
ALG6/UGGT1/UGGT2-/- cells. A similar profile was observed for IGF-1R where 
reglucosylation levels reached 12% in ALG6/UGGT2-/- cells (Figure 3.6E-G). Altogether, 
these findings were consistent with the quantitative glycoproteomics isobaric labeling 
results (Figure 3.6C and G), confirming that CI-M6PR and IGF-1R are efficient 
substrates of UGGT1.   
 Next, the reglucosylation of the type II membrane protein, ectonucleotide 
pyrophosphatase/phosphodiesterase family member 1 (ENPP1) was analyzed (Figure 
3.7D). ENPP1 was found to be reglucosylated at similar levels in ALG6-/- (7%) and 
ALG6/UGGT1-/- (7%) cells. In ALG6/UGGT2-/- cells, reglucosylation increased to 12%, 
while in ALG6/UGGT1/UGGT2-/- cells reglucosylation decreased to 1% (Figure 3.7A and 
B). These results suggest that ENPP1 can be reglucosylated by both UGGT1 and 
UGGT2, with a slight preference for UGGT1, supporting the TMT mass spectrometry 
results (Figure 3.7C). 
 The reglucosylation of the smaller soluble lysosomal protein, HexB, was also 
tested (Figure 3.7E-H). HexB is processed into three disulfide-bonded chains in the 
lysosome (Mahuran et al., 1988). Only immature or ER localized proHexB was affinity 
purified by GST-CRT (Figure 3.7E, lanes 2, 5, 8 and 11). HexB was reglucosylated at 
34% in ALG6-/- cells (Figure 3.7F). No significant change in glucosylation levels were 
observed when UGGT1 was also knocked out (35%). However, a reduction to 20% 
reglucosylation of HexB was observed in ALG6/UGGT2-/- cells, and complete loss of 
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reglucosylation was observed in ALG6/UGGT1/UGGT2-/- cells. ALG6/UGGT1-/- cells 
consistently displayed increased levels of expression of HexB (Figure 3.7E, lane 4), 
which was supported by RNAseq data (Figure 3.8B). These results confirm the mass 
spectrometry results, which showed HexB to be a favored substrate of UGGT2 (Fig 
3.7G). It is also notable that HexB, as the first validated substrate of UGGT2, is highly 
reglucosylated. Taken together, these results demonstrate that the mass spectrometry 
screen accurately identified substrates of the UGGTs, as well as differentiated between 
substrates specific to either UGGT1 or UGGT2.  
 
Analysis of UGGT substrates  
To investigate the properties of the substrates modified by the UGGTs and 
identify potential types of proteins UGGT1 and UGGT2 modify, a systematic analysis of 
the substrates of the UGGTs was performed and compared to the general properties of the 
N-glycome. All characteristics were analyzed using UniprotKB annotations. Initially, the 
length of substrates was compared to the N-glycome. The N-glycome ranged widely in 
size, from elabela (54 amino acids) to mucin-16 (14,507 amino acids). The overall amino 
acid distribution of the N-glycome was significantly shifted smaller compared to the size 
of UGGT substrates (Figure 3.9A). The median size of the N-glycome was 443 amino 
acids, compared to 737 for UGGT substrates found in ALG6-/- cells. Substrates of both 
UGGT1 (718 amino acid median) and UGGT2 (585 amino acids) are significantly larger 
when compared to the N-glycome. This increase in length may lead to more complex 




The distribution of the number of N-glycans possessed by the N-glycome (median 
of 2 glycans per glycoprotein) was also shifted significantly smaller than that of UGGT1 
(7 glycans) or UGGT2 (5 glycans) substrates (Figure 3.9B). All the UGGT substrates 
displayed both a larger shifted peak and a prominent extended shoulder compared to the 
N-glycome. Despite the identification of UGGT1 and UGGT2 substrates generally 
containing high numbers of N-glycans, multiple substrates possessed as few as two N-
glycans, suggesting that the experimental approach did not require a high number of 
monoglucosylated glycans for GST-CRT affinity isolation.   
The ER maintains an oxidizing environment that supports the formation of 
disulfide bonds. Complex folding pathways can involve the engagement of 
oxidoreductases, such as the calnexin/calreticulin-associated oxidoreductase ERp57, to 
catalyze disulfide bond formation and isomerization (Margittai & Sitia, 2011; Kozlov & 
Gehring, 2020). The most common number of Cys residues in proteins identified as 
UGGT substrates was 2, which was similar to the N-glycome Cys content (Figure 3.9C). 
However, there are variations in the median number of Cys residues as for the N-glycome 
it is 11, which is smaller than that found in ALG6-/- cells (16 Cys), and for UGGT1 
substrates observed in ALG6/UGGT2-/- cells (13 Cys). In contrast, a median of 9 Cys was 
observed for UGGT2 substrates. Therefore, UGGT1 appears to display a slight 
preference for proteins with high Cys content, when compared to the N-glycome and 
UGGT2 substrates. 
UGGT1 or UGGT2 substrates displayed similar pI distributions with pIs 
predominantly near a pH of 6.0, while a second smaller peak centered around a pH of 8.5. 
Interestingly, a pronounced valley was observed at pH 7.9 under all conditions, 
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presumably due to the instability of proteins with pIs of a similar pH to that of the ER. 
The N-glycome displayed a more bimodal distribution with significant population of both 
acidic and basic pIs (Figure 3.9D). These results suggest that both UGGT1 and UGGT2 
preferentially engage proteins with low pIs.  
  The predicted topologies of the substrates of the UGGTs and the N-glycome 
were also analyzed. Approximately 70% of the N-glycome is comprised of membrane 
proteins, with half of these membrane proteins possessing multiple transmembrane 
domains, followed by single membrane pass proteins with a type I orientation (a third) 
with the remainder being type II membrane proteins (Figure 3.9E). A total of 43% of 
UGGT substrates in ALG6-/- cells contained a transmembrane domain with the vast 
majority of these substrates having their C-terminus localized to the cytosol in a type I 
orientation, while two substrates possessed the reverse type II orientation and a single 
multi-pass membrane substrate (NPC1) was identified. When the UGGTs were 
considered separately, about half of the UGGT1 substrates (ALG6/UGGT2-/- cells) 
possessed at least one transmembrane domain, with 70% of these membrane proteins 
being in the type I orientation, a quarter in a type II orientation and two being multi-pass 
proteins (NPC1 and scavenger receptor class B member 1 (SR-BI)). In contrast to 
UGGT1, the majority of UGGT2 substrates were soluble proteins (72%) with the 
breakdown of remaining transmembrane proteins being similar to that of UGGT1 with 
the majority being type I membrane proteins. The preference of UGGTs for type I 
transmembrane proteins is likely caused by their larger luminal-exposed domains and N-
glycan numbers compared to multi-pass membrane proteins (Figure 3.10A and B). 
Notably, substrates of the UGGTs had significantly larger luminal domains than the 
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membrane proteins of the N-glycome, though especially for the multi-pass membrane 
proteins (Figure 3.10A). Furthermore, while the pIs of type II and polytopic membrane 
proteins were bimodal, they were overall more basic, which appears to be a property 
disfavored by UGGT substrates (Figure 3.10C). Overall, these results show that UGGT1 
efficiently modifies both soluble and membrane associated proteins, while UGGT2 
strongly favors soluble substrates.   
 
Efficient IGF-1R trafficking requires lectin chaperone engagement 
A number of natural substrates of the UGGTs were identified using a 
glycoproteomics approach with gene edited cell lines. As reglucosylation by the UGGTs 
can direct multiple rounds of lectin chaperone binding, the necessity for reglucosylation 
to support the efficient maturation of a reglucosylated substrate was investigated. IGF-1R 
is proteolytically processed in the trans-Golgi by proprotein convertases including furin, 
facilitating the monitoring of IGF-1R trafficking from the ER to the Golgi (Lehmann et 
al., 1998). The requirement for lectin chaperone binding and reglucosylation to aid IGF-
1R trafficking was analyzed.  
 Initially, cells were treated without or with the inhibitor of a-glucosidases I and 
II, DNJ, to accumulate IGF-1R in the triglucosylated state to bypass entry into the 
calnexin/calreticulin binding cycle (Helenius & Hammond, 1994; Hebert et al., 1995). At 
steady state as probed by immunoblotting of cell lysates, IGF-1R accumulated in the ER 
localized pro form relative to the mature form after DNJ treatment (Figure 3.11A) 
resulting in a 19% decrease in the level of the trans-Golgi processed mature protein 
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(Figure 3.11B). This indicated that the lectin chaperone binding cycle helps support 
efficient IGF-1R trafficking.  
 There are two modes for engaging the lectin chaperone cycle: initial binding, 
which can potentially commence co-translationally for glycoproteins such as IGF-1R that 
have N-glycans located at their N-terminus through their trimming of the terminal two 
glucoses by glucosidases I and II; or by rebinding, which is directed by the 
reglucosylation of unglucosylated species by the UGGTs (Parodi & Caramelo, 2015; 
Lamriben et al., 2016). The contribution of each mode of monoglucose generation for the 
proper trafficking of IGF-1R was analyzed.  
IGF-1R maturation was investigated in ALG6-/- cells as in these cells the N-glycan 
transferred to the nascent substrate is non-glucosylated, leading to a lack of initial 
glucosidase trimming mediated lectin chaperone binding. Reglucosylation by the UGGTs 
is required for lectin chaperone binding in ALG6-/- cells. Similar to DNJ treatment in wild 
type cells, ALG6-/- cells demonstrate a 20% decrease in mature IGF-1R relative to the pro 
form at steady state (Figure 3.11C, lanes 1 and 3, and Figure 3.11D). As 
hypoglycosylation can occur in a substrate dependent manner in Alg6-/- cells (Shrimal & 
Gilmore, 2015), the mobility of IGF-1R with and without N-glycans (PNGase F treated) 
was monitored by comparing the mobility of IGF-1R by SDS-PAGE and immunoblotting 
of wild type and ALG6-/- cell lysates. IGF-1R appeared to be fully glycosylated (Figure 
3.11C). To confirm that the pro form of IGF-1R represented ER localized protein rather 
than protein trafficked out of the ER but not processed by proprotein convertases, IGF-1R 
from wild-type and Alg6-/- cells was treated with the endoglycosidase EndoH. As EndoH 
cleaves high-mannose glycans which are preferentially present in the ER or early Golgi, 
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an increase in mobility by SDS-PAGE suggests ER localization. In both wild-type and 
Alg6-/- cells, Pro IGF-1R was found to be EndoH sensitive, while mature IGF-1R was 
found to be largely EndoH resistant (Figure 3.11C, lanes 2 and 5), suggesting the 
accumulation of pro IGF-1R in Alg6-/- cells represents impaired ER trafficking rather than 
impaired processing in the trans-Golgi. Altogether, these steady state results suggest that 
lectin chaperone binding is important for efficient IGF-1R maturation. 
As steady state results can be impacted by changes in protein synthesis and 
turnover, a radioactive pulse-chase approach was used to follow protein synthesized 
during a 1 hr [35S]-Met/Cys pulse interval followed by chasing for up to 2-hr under non-
radioactive conditions. Pulse-chase experiments are generally performed with 
overexpressed tag constructs to accumulate and isolate sufficient protein for monitoring. 
Here, endogenous IGF-1R was isolated by immunoprecipitation with anti-IGF-1R 
antibodies and analyzed by SDS-PAGE and autoradiography to determine the percent of 
IGF-1R that was properly processed to its mature form in the trans-Golgi.  IGF-1R was 
found to traffic efficiently out of the ER and to the Golgi in wild type cells as 59% of the 
total protein after a 2-hr chase was mature IGF-1R (Figure 3.12A, lanes 1-3 and F). When 
lectin chaperone binding was inhibited by treatment with DNJ, mature IGF-1R was 
diminished to 22%, underscoring the importance of lectin chaperone binding (Figure 
3.12A, lanes 4-6 and F).  
To delineate the contributions of early compared to late lectin chaperone binding, 
IGF-1R trafficking was followed in gene edited cells that control the methods for lectin 
chaperone engagement. A single early round of lectin chaperone binding will be 
permitted in the absence of both UGGTs or rebinding would only be directed by the 
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UGGT present with knockouts of a single UGGT. Alternatively, early lectin chaperone 
binding as dictated by glucosidase trimming will be absent in the ALG6-/- cells where 
lectin chaperone binding is directed solely through glucosylation by the UGGTs. 
Monitoring the trafficking of IGF-1R in these cells will allow us to determine the 
contributions of the different steps in the lectin chaperone binding cycle for proper IGF-
1R maturation. 
When both UGGTs were absent in UGGT1/2-/- cells, the percent of mature IGF-
1R after 2 hr of chase decreased to 42%. In agreement with early glycoproteomics and 
affinity isolation results showing IGF-1R was largely a UGGT1 substrate, UGGT2 
knockout alone had little influence on IGF-1R trafficking while the knocking out of 
UGGT1 supported IGF-1R trafficking similar to the double UGGT deletion (Figure 3.12, 
7-15 lanes and F). These results support a role for UGGT1 in optimizing IGR-1R 
trafficking. 
To determine the importance of early chaperone binding directed by the 
glucosidases, IGF-1R trafficking was monitored in ALG6-/- cells that support 
reglucosylation but lack the ability for early binding to the lectin chaperones as directed 
by glucosidase trimming of the triglucosylated species. In ALG6-/- cells, the percent of 
mature IGF-1R was significantly decreased to 21%, indicative of an important 
contribution of the initial round of lectin binding, as was suggested by steady state data 
(Fig 5C). The addition of DNJ to ALG6-/- cells would be expected to trap IGF-1R in a 
monoglucosylated state after glucosylation, allowing the effect of prolonged interaction 
with the lectin chaperones to be observed. Under this condition, IGF-1R was strongly 
retained in the ER with no increase observed in the level of mature IGF-1R observed 
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even after 2 hr of chase (Figure 3.12, lanes 16-21 and F). Altogether these results 
demonstrate that while early (glucosidase-mediated) and late (UGGT-mediated) lectin 
chaperone binding contribute to the efficient trafficking from the ER and subsequent 
Golgi processing of IGF-1R, early lectin chaperone binding appears to be most critical 
for supporting proper IGF-1R maturation.  
 
Discussion 
As lectin chaperone binding is directed by the covalent modification of substrates 
by the UGGTs, the identification of bona fide substrates of the UGGTs is central to 
understand the impact the lectin chaperone network has on cellular homeostasis. Features 
of proteins alone cannot accurately predict which chaperones will be required for 
efficient folding and quality control (Adams, Ke, et al., 2019). Previous studies involving 
the UGGTs have focused mainly on the overexpression of biasedly selected substrates or 
using purified proteins, providing uncertain biological relevance (Ritter & Helenius, 
2000; Taylor et al., 2003; Caramelo et al., 2004; Soldà et al., 2007; Pearse et al., 2008; 
Ferris et al., 2013; Tannous et al., 2015). Here, we used a quantitative glycoproteomics-
based strategy to identify seventy-one natural cellular substrates of the UGGTs. When 
compared to the N-glycome that represents the total population of potential substrates 
(4,361 N-glycoproteins in human cells), the UGGTs favored the modification of more 
complex, multidomain proteins with large numbers of N-glycans. These results are in 
agreement with the common requirement of chaperones for the proper folding of more 
complex proteins (Balchin et al., 2016, 2020). The lectin chaperone system is part of the 
robust chaperone network necessary to promote the efficient folding and quality control 
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of substrates and mitigate harmful misfolding events that are associated with a large 
range of pathologies. 
The discovery of 33 UGGT2 cellular substrates provides the first evidence of 
intact UGGT2 acting as a quality control factor in cells (Figure 3.3B). Previous work 
demonstrated that UGGT2 is enzymatically active against chemically engineered 
glycosylated substrates using purified components or when the catalytic domain of 
UGGT2 was appended to the folding sensor domain of UGGT1 (Arnold & Kaufman, 
2003; Y. Takeda et al., 2014). The lower number of UGGT2 substrates compared to 
UGGT1 (66 substrates) is likely due, at least in part, to UGGT2 being expressed at a 
fraction of the level of UGGT1 (~4% in HeLa cells (Itzhak et al., 2016)). Of special note 
is the preference of UGGT2 for lysosomal substrates as 8 of the 9 preferential UGGT2 
substrates are lysosomal proteins (Figure 3.5C). The preferential UGGT2 substrates are 
all soluble proteins, while half of the preferential UGGT1 substrates contained 
transmembrane domains indicative of a further preference of UGGT2 for soluble proteins 
(Figure 3.5C). Given the preference of UGGT2 for soluble lysosomal proteins, it would 
be of interest in future studies to examine lysosomes in UGGT2-/- cells as a number of the 
UGGT2 substrates are associated with lysosomal storage diseases including 
metachromatic leukodystrophy (arylsulfatase A), Sandhoff disease (b-hexosaminidase 
subunit b) and Schindler disease (a-N-acetylgalactosaminidase) (Mahuran, 1999; Cesani 
et al., 2016; Ferreira & Gahl, 2017). 
UGGT1 serves as the predominant ER glycoprotein quality control sensor. While 
overall the 66 UGGT1 substrates are evenly distributed between soluble and membrane 
proteins, the majority of the most efficiently reglucosylated proteins are membrane 
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proteins (Figure 3.5C). Seventy percent of the membrane proteins modified by UGGT1 
are in the type I orientation possessing luminal N-glycosylated domains of significant 
length. Only two substrates of the UGGTs are multi-pass membrane proteins (NPC1 and 
SR-BI). In contrast to most polytopic membrane proteins that have little exposure to the 
ER lumen (Figure 3.10A), both NPC1 and SR-BI have large heavily glycosylated luminal 
domains. The enrichment of UGGT1 for transmembrane proteins may be influenced 
through a weak association with the ER membrane or a general slower and more complex 
folding process for membrane proteins that provides a longer window for modification.  
An important question to ask is what is the basis for the differing substrate 
specificities of UGGT1 and UGGT2? They display sequence identities that are high 
within the catalytic domains (83% identical) and lower in their folding sensor domains 
(49%) (Arnold & Kaufman, 2003). This sequence disparity within the folding sensor 
domain may drive altered substrate selection. In addition, UGGT1 and UGGT2 may 
reside in separate subdomains within the ER, which could contribute to substrate 
accessibility. The CLN6/CLN8 transmembrane complex appears to recognize lysosomal 
proteins within the ER for COPII packaging in support of a possible mechanism of 
lysosomal substrate selection (Bajaj et al., 2020). An additional possibility addressed was 
that the level of expression of the lysosomal proteins identified as UGGT2 substrates may 
be augmented in ALG6/UGGT1-/-cells. However, only the mRNA expression level of b-
hexosaminidase subunit b was increased relative to ALG6-/- or wild type cells, as 
supported by immunoblot data (Figure 3.7E) with the remaining preferential UGGT2 
lysosomal substrates displaying no significantly change in mRNA expression levels 
(Figure 3.14). The increased expression of b-hexosaminidase subunit b in ALG6/UGGT1-
106 
 
/- cells may be attributed to induction by UPR, as in these cells a slight induction 
primarily through the ATF6 branch of the UPR was observed (Figure 3.15). Further 
studies will be required to understand the varying selectivities of the UGGTs.  
With some 4,350 possible N-glycosylated proteins as potential UGGT substrates, 
why were only 71 proteins identified as substrates of the UGGTs? First, many proteins 
are expected to fold in a chaperone independent manner, especially small, simple 
proteins. Second, our stringent isolation approach prioritized high quality substrates with 
at least a 3-fold induction for GST-CRT/GST-CRT-Y109A binding. Third, the profile of 
reglucosylated substrates is likely cell-type dependent with additional substrates expected 
to be identified in cell types with heavy secretory pathway loads such as pancreatic cells 
or hepatocytes, compared to the kidney line used here. Fourth, ~1,500 proteins of the N-
glycome are multi-pass transmembrane proteins (Figure 3.9E). This class of protein was 
strongly de-enriched as substrates of the UGGTs, likely due to their limited luminal 
exposure and minimal N-glycan content (Figure 3.10A and B). This reduces the pool of 
favored substrates by a third. Fifth, the monoglucosylated protein isolation procedure 
may also be limited by possibly requiring multiple sites of reglucosylation for efficient 
binding to survive the pulldown protocol. However, multiple substrates with two N-
glycans were identified, suggesting heavy glycosylation is not an absolute requirement. 
Additionally, protein expression levels are expected to play some role in substrate 
identification but it does not appear to be a major determining factor as multiple strong 
substrates were expressed at or below an average protein level for the N-glycome and no 
correlation between mRNA expression level and the TMT mass spectrometry fold 
increase for the GST-CRT/GST-CRT-Y109A fraction was observed (Figure 3.8). It 
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would be of interest to determine if proteotoxic stress would increase levels and the range 
of reglucosylated substrates as both the pool of non-native proteins and the amount of the 
UPR-induced substrates of the UGGTs would be expected to increase. It is also possible 
that some proteins identified as substrates of the UGGTs may misfold after missing the 
first round of calnexin/calreticulin binding in ALG6-/- cells and therefore engage the 
UGGTs more efficiently. 
As carbohydrate binding can be dictated initially by glucosidase trimming 
followed by additional later rounds of binding dictated by UGGT reglucosylation, it is of 
importance to understand which stage of the binding cycle contributes most significantly 
to proper protein maturation and cell homeostasis. N-glycans in Sacchromyces cerevisiae 
and other single cell species are transferred post-translationally as they are missing the 
OST isoform subunit that interacts with the Sec61 translocon and supports early co-
translational modification (Ruiz-Canada et al., 2009; Shrimal et al., 2019). A second OST 
isoform appears in multicellular organisms that is translocon-associated. In addition, 
reglucosylation activity was first observed in single cell parasites of Trypanosoma cruzi 
where glycans are transferred as Man9GlcNAc2 moieties thereby bypassing the initial 
glucosidase initiated binding step observed in metazoans (Parodi & Cazzulo, 1982). 
These seminal T. cruzi studies from Parodi and colleagues that first discovered the 
(re)glucosylation activity, later attributed to UGGT1, were the inspiration for the 
development of the experimental ALG6-/- system used in this study to isolate substrates of 
the UGGTs. Conservation analysis of glycosylation and the lectin chaperone pathway 
suggests that reglucosylation supporting the quality control function of the calnexin cycle 
evolved prior to its role in assisting in earlier folding events. 
108 
 
Using CRISPR edited cell lines, the contributions of the various steps for 
chaperone binding engagement for the UGGT1 substrate IGF-1R was experimentally 
explored as its processing in the Golgi provided a robust Golgi trafficking assay. 
Furthermore, IGF-1R is a target in cancer biology as it is important for cell growth (Sell 
et al., 1994; Desbois-Mouthon et al., 2006; Chng et al., 2006; King et al., 2014; Mutgan 
et al., 2018). When binding to the lectin chaperones was blocked in wild type cells by 
glucosidase inhibition with DNJ treatment, supporting the production of triglucosylated 
trapped species, the percent of processed IGF-1R strongly decreased compared to 
untreated cells, demonstrating a requirement of lectin chaperone engagement for the 
efficient maturation, trafficking and processing of IGF-1R. In UGGT1/2-/- cells, IGF-1R 
can enter the first round of glucosidase-mediated binding to the lectin chaperones but 
rebinding directed primarily by UGGT1 mediated reglucosylation cannot occur (Figures 
3.12A, B and Figure 3.13). This led to a reduced efficiency in the accumulation of mature 
IGF-1R. The first round of lectin chaperone binding is bypassed in ALG6-/- cells as the N-
glycans transferred to proteins do not contain glucoses (Figure 3.13). Therefore, only the 
rebinding events mediated by reglucosylation take place. More strikingly in ALG6-/- cells, 
this led to a dramatic reduction in IGF-1R processing at a greater level than in UGGT1/2-
/- cells, indicating the first round of binding to the lectin chaperones was most critical for 
IGF-1R maturation. The addition of DNJ in ALG6-/- cells supported the trapping of 
reglucosylated side chains and severely reduced Golgi processing, suggesting that 
reglucosylation-mediated persistent interaction with the lectin chaperones delays IGF-1R 
exit from the ER.  
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Understanding the proteins that interact with or rely on chaperone systems will 
advance our understanding of protein homeostasis (Houry et al., 1999; Kerner et al., 
2005). Large multi-domain proteins such as IGF-1R and many of the other substrates of 
the UGGTs have apparently evolved to utilize the lectin chaperone system to help direct 
their complex folding trajectories. The co-evolution of chaperones and their substrates 
has led to the expansion of the complexity of the proteome for multicellular organisms 
(Balchin et al., 2016; Rebeaud et al., 2020). The large group of substrates of the UGGTs 
identified here represents glycoproteins that utilize multiple rounds of lectin chaperone 
engagement for proper maturation and are likely more prone to misfold under stress. 
Future studies will determine if this increased vulnerability makes these substrates more 




Antibodies used were: rabbit monoclonal IGF-1 receptor b (D23H3, Cell 
Signaling), rabbit monoclonal IGF-IIR/CI-M6PR (D3V8C, Cell signaling), rabbit 
monoclonal BiP (C50B12, Cell Signaling), rabbit monoclonal b-hexosaminidase subunit 
b (HEXB) (EPR7978, Abcam), rabbit polyclonal ENPP1 (N2C2, Genetex) rabbit 
polyclonal UGGT1 (GTX66459, Genetex), mouse monoclonal Glyceraldehyde 3-
Phosphate (MAB374, Millipore Sigma), IRDye x anti-rabbit secondary (LiCor). All 





HEK293-EBNA1-6E cells were employed and used as the parental line to create 
all CRISPR/Cas9 edited lines (Tom et al., 2008). Cells were cultured in DMEM (Sigma) 
supplemented with certified 10% fetal bovine serum (Gibco) at 37 °C at 5% CO2. Cells 
were tested for the presence of mycoplasma using a universal mycoplasma detection kit 
(ATCC, Cat # 30-012K). 
 
CRISPR/Cas9-mediated knock outs 
HEK293EBNA1-6E ALG6-/-, ALG6/UGGT1-/-, ALG6/UGGT2-/-, 
ALG6/UGGT1/UGGT2-/-, UGGT1-/-, UGGT2-/-, and UGGT1/2-/- cells were generated via 
CRISPR/Cas9 using gRNA plasmids gh260, gh172, and gh173, and Cas9-GFP plasmid 
CAS9PBKS (Lonowski et al., 2017; Narimatsu et al., 2018). Plasmids gh260 (106851), 
gh172 (106833), gh173 (106834), and CAS9PBKS (68371) were from Addgene. Knock-
out cell lines were generated by co-transfecting HEK293-EBNA1-6E cells at 70% 
confluency in a 10-cm plate with 7 µg of both the associated gRNA and Cas9-GFP 
plasmid, using a 2.5 µg of PEI per 1 µg of plasmid. Cells were allowed to grow for 48 hr 
prior to trypsinization and collection. After trypsinization, cells were collected and 
washed twice with sorting buffer (1% FBS, 1mM EDTA, PBS). Cells were then 
resuspended in sorting buffer at approximately 1 million cells per ml. Cells were then 
bulk separated using flow assisted cell sorting based on the top 10% of Cas9-GFP 
expressing cells (FACS Aria II SORP, Becton Dickinson and Company). Cells were then 
plated at 5, 10, 20 thousand cells per 10 cm plate in pre-conditioned DMEM media with 
20% FBS. Colonies derived from a single cell were isolated using cell cloning cylinders 
(Bellco Glass), trypsinized from the plate, and further passaged. Knock-outs were 
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confirmed by immunoblotting and staining for UGGT1 or, where antibodies were not 
available, isolating genomic DNA using a genomic DNA isolation kit (PureLink genomic 
DNA mini kit, Thermo Fisher), PCR amplification of the genomic DNA region of 
interest, and insertion of genomic DNA into pcDNA3.1-. Plasmids were then sequenced 
for conformation (Genewiz). 
 
GST-CRT purification 
The plasmid for pGEX-3X GST-CRT was from Prof. M. Michalak (University of 
Alberta). pGEX-3X GST-calreticulin-Y109A was generated by site-directed 
mutagenesis. GST-CRT was expressed in BL21 E. Coli cells in LB medium containing 
ampicillin at 100 µg/ml. Cultures were grown at 37 °C with shaking until an O.D. of 
A600=0.6. Protein expression was then induced by treating cultures with 8.32 mg/L IPTG 
for 2 hr. Cultures were centrifuged at 1,000 g for 10 min. Cell pellets were lysed with 
cold lysis buffer (1 mM phenylmethylsulfonyl fluoride, 2% Triton X-100, PBS pH 7.4) 
and resuspended. Resuspended cells were lysed in a microfluidizer (110L, Microfluidics) 
at 18,000 psi for two passes. The cell lysate was centrifuged for 40 min at 8,000 g at 4 
°C. Lysate was filtered through a 0.45 µm filter. Two ml bed volume glutathione 
sepharose beads (GE Lifesciences, Cat# GE17-0756-01) per liter of lysate was 
equilibrated in wash buffer (1% Triton X-100, 1 mM PMSF, PBS pH 7.4), added to 
cleared lysate, and rotated at 4 °C for 3 hr. Beads were precipitated through 
centrifugation at 1,000 g for 5 min at 4 °C. The supernatant was aspirated and beads were 
washed twice in wash buffer with gentle resuspension between washes. One ml of elution 
buffer (10 mM reduced glutathione, 1 mM PMSF, 50 mM Tris pH 8.5) was added to 
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beads and beads were gently resuspended and allowed to incubate for 5 min at 4 °C. 
Beads were precipitated by centrifugation at 1,000 g for 5 min 4 °C. The eluate was 
collected and a total of 6-elutions were collected. Resulting eluate was tested for purity 
and protein amount on a reducing SDS-PAGE and stained with Imperial protein stain 
(Thermo Fisher, Cat# 24617). Elutions were then combined and protein concentration 
was quantified by a Bradford assay (Bio-Rad). Purified protein was then stored at -80 °C 
in a 20% glycerol PBS buffer at 1 mg/ml. 
  
GST-CRT isolation and TMT mass spectrometry sample preparation 
Five 10 cm plates were seeded with 3.5 million cells and allowed to grow for 48 
hr. Cells were treated with N-butyldeoxynojirimycin hydrochloride (DNJ) (Cat # 21065, 
Cayman Chemicals) at 500 µM for 1 hr. Prior to lysis, the media was aspirated and cells 
were washed once with filter sterilized PBS. Cells were lysed in 1 ml of lysis buffer (20 
mM MES, 100 mM NaCl, 30 mM Tris-HCl pH 7.5, 0.5% Triton X-100) per plate. 
Samples were shaken at 4 °C for 5 min and centrifuged at 20,800 g at 4 °C for 5 min. 
Lysate was pre-cleared with 25 µl bed volume of buffer-equilibrated glutathione beads 
per 1 ml of lysate under rotation for 1 hr at 25 µl bed volume. Beads were precipitated by 
centrifugation at 950 g at 4 °C for 5 min. Glutathione beads were pre-incubated with 
either GST-CRT or GST-CRT-Y109A by equilibrating 25 µl bed volume/pull-down 
glutathione beads with lysis buffer. Beads were incubated with 100 µg of purified GST-
CRT/pull-down under gentle rotation at 4 °C for 3 hr. Beads were centrifuged at 950 g at 
4 °C for 5 min and washed twice with lysis buffer. Supernatant was collected and split in 
half, with one half incubated for 14 hr at 4 °C under gentle rotation with glutathione 
113 
 
beads pre-incubated with GST-CRT and the other half under the same conditions with 
GST-CRT-Y109A. 
            After incubation with GST-CRT beads, samples were washed once in lysis buffer 
without protease inhibitors and twice in 100 mM triethylammonium bicarbonate (Thermo 
Fisher Cat# 90114). After the final wash, samples were incubated with 10 µl of 50 mM 
DTT (Pierce, Cat# A39255) for 1 hr at room temperature under gentle agitation. Samples 
were treated with 2 µl of 125 mM iodoacetamide (Pierce, Cat# A39271) and incubated 
for 20 min under gentle agitation, protected from light. Samples were digested with 5 µg 
of trypsin (Promega, Cat# V5280) at 37 °C overnight under agitation. Peptide 
concentration was quantified using a BCA protein quantification kit (Pierce, Cat# 23227). 
0.8 mg 10plex tandem mass tags (TMT) (Themo Fisher) were resuspended in mass 
spectrometry grade acetonitrile and was added to digested peptide and incubated for 1-hr 
at room temp, per manufacturer’s instructions. Labeling was quenched by adding 
hydroxylamine to 0.25% and incubating for 15 min at room temp. Labeled samples were 
pooled, treated with 1,000 units of glycerol-free PNGaseF (NEB, Cat# P0705S), and 
incubated for 2-hr at 37 °C. Samples were cleaned using C18 tips (Pierce, Cat# 87784), 
and eluted in 75% mass spectrometry grade acetonitrile, 0.1% formic acid (TCI 
Chemicals). Sample peptide concentration was then quantified using a colorimetric assay 
(Pierce, Cat# 23275). 
 
Mass spectrometry data acquisition 
An aliquot of each sample equivalent to 3 µg was loaded onto a trap column 
(Acclaim PepMap 100 pre-column, 75 µm × 2 cm, C18, 3 µm, 100 Å, Thermo Scientific) 
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connected to an analytical column (Acclaim PepMap RSLC column C18 2 µm, 100 Å, 50 
cm × 75 µm ID, Thermo Scientific) using the autosampler of an Easy nLC 1000 (Thermo 
Scientific) with solvent A consisting of 0.1% formic acid in water and solvent B, 0.1% 
formic acid in acetonitrile. The peptide mixture was gradient eluted into an Orbitrap 
Fusion mass spectrometer (Thermo Scientific) using a 180 min gradient from 5%-
40%B (A: 0.1% formic acid in water, B:0.1% formic acid in acetonitrile) followed by a 
20 min column wash with 100% solvent B. The full scan MS was acquired over range 
400-1400 m/z with a resolution of 120,000 (@ m/z 200), AGC target of 5e5 charges and 
a maximum ion time of 100 ms and 2 s cycle time. Data dependent MS/MS scans were 
acquired in the linear ion trap using CID with a normalized collision energy 35%.  For 
quantitation of scans, synchronous precursor selection was used to select 10 most 
abundant product ions for subsequent MS^3 using AGC target 5e4 and 
fragmentation using HCD with NCE 55% and resolution in the Orbitrap 60,000. Dynamic 
exclusion of each precursor ion for 30 s was employed. Data were analyzed using 
Proteome Discoverer 2.4.1 (Thermo Scientific). 
 
Computational determination of the human N-glycome and substrates analyses 
The human N-glycome was defined by the total predicted N-glycosylated proteins 
from the reviewed human proteome from the UniprotKB (accessed 8/10/2020). Both 
manual and automated curation of the data set was preformed to remove mitochondrial 
proteins as well as proteins smaller than 50 amino acids from the dataset. All annotations 
were derived directly from the UniprotKB information and annotations available for 
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these proteins were analyzed in R. Determination of the pI values were performed by the 
pI/MW tool on the Expasy database. 
 
Reglucosylation validation assay 
Five 10 cm plates were seeded with 3.5 million cells each and allowed to grow for 
48 hr. Cells were treated with DNJ at 500 µM for 14 hr. Prior to lysis, the media was 
aspirated and cells were washed once with filter sterilized PBS. Cells were lysed in 1 ml 
of MNT (20 mM MES, 100 mM NaCl, 30 mM Tris pH 7.5, 0.5% Triton X-100) with 
protease inhibitors (50 µM Calpain inhibitor I, 1 µM pepstatin, 10 µg/ml aprotinin, 10 
µg/ml leupeptin, 400 µM PMSF) and 20 mM N-ethyl maleimide, shaken vigorously for 5 
min at 4 °C, and centrifuged for 5 min at 17,000 g at 4 °C. 50 µl bed volume of 
glutathione beads was added to each pull-down and incubated for 1 hr at 4 °C under 
gentle rotation. Beads were then precipitated by centrifugation at 1,000 g for 5 min at 4 
°C. Supernatant was collected with 10% used for WCL and the remainder split evenly 
between GST-CRT and GST-CRT-Y109A conjugated glutathione beads, which were 
generated as previously described, and incubated for 16 hr at 4 °C under gentle rotation. 
Beads were precipitated at 1,000 g for 5 min at 4 °C. Supernatant was aspirated and beads 
were washed twice with lysis buffer without protease inhibitors. Beads were treated with 
reducing sample buffer (30 mM Tris-HCl pH 6.8, 9% SDS, 15% glycerol, 0.05% 
bromophenol blue). WCLs were trichloroacetic acid (TCA) precipitated by adding TCA 
to cell lysate to a final concentration of 10%. Cell lysate was then briefly rotated and 
allowed to incubate on ice for 15 min before centrifugation at 17,000 g for 10 min at 4 
°C. Supernatants were aspirated and washed twice with cold acetone and centrifuged at 
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17,000 g for 10 min at 4 °C. Supernatants were aspirated and the remaining precipitant 
was allowed to dry for 5 min at room temperature and briefly at 65 °C. Precipitated 
protein was resuspended in sample buffer. Samples were resolved on a 9% reducing 
SDS-PAGE and imaged by immunoblotting.   
 
Metabolic labeling and IGF-1R immunoprecipitation 
Two million cells were plated in 6 cm plates and allowed to grow for 40 hr. Cells 
were pulse labeled for 1 hr with 120 µCi of EasyTag Express35S Protein Labeling Mix 
[35S]-Cys/Met (PerkinElmer; Waltham, MA). Immediately after the radioactive pulse, 
cells were washed with PBS and either lysed in MNT with a protease inhibitor cocktail 
(Halt protease and phosphatase inhibitor single-use cocktail, Thermo Fisher) and 20 mM 
NEM, or chased for indicated time using regular growth media. Where indicated, cells 
were treated with 500 µM DNJ for 30 min prior to [35S]-Cys/Met labeling and through 
the chase. Cell lysates were shaken for 5 min at 4 °C, centrifuged at 17,000 g for 5 min at 
4 °C, and the supernatants were collected. Samples were pre-cleared with a 20 µl bed 
volume of protein-A sepharose beads (GE Healthcare) by end-over-end rotation for 1 hr 
at 4 °C. The supernatants were collected and incubated with a 30 µl bed volume of 
protein-A-sepharose beads and 1.5 µl of a-IGF-1 receptor b (D23H3) XP (Cell 
Signaling) per sample. Samples were washed with MNT without protease inhibitors or 
NEM and eluted in sample buffer. Samples were then resolved on a 9% reducing SDS-
PAGE, imaged using a GE Typhoon FLA 9500 phosphorimager (GE Healthcare), and 





Three million cells for each indicated cell line were plated in a 10-cm plate and 
allowed to grow for 48 hr. Cells were lysed in 300 µl RIPA buffer (1% SDS, 1% NP-40, 
0.5% sodium deoxycholate, 150 mM NaCl, 50 mM Tris-HCl pH 8.0) with protease 
inhibitor cocktail and 20 mM NEM. Samples were then sonicated for 20-sec at 40% 
amplitude (Sonics vibra cell VC130PB), shaken vigorously for 5 min, and centrifuged for 
5 min at 17,000 g. 20 µl of the resulting lysate was heated at 95 °C for 5 min, and treated 
with either 10 µl of PNGaseF or EndoH for 1 hr at 37 °C, according to the 
manufacturer’s instructions (NEB). Samples were diluted 1:1 into  sample buffer and 
imaged by immunoblotting. 
 
RNAseq library preparation and Sequencing 
Three million cells for each indicated cell line were plated in 10 cm plates and 
allowed to grow for 48 hr. Cells were then lysed in TRIzol buffer and RNA was isolated 
using RNA Clean Concentrate Kit with in-column DNase-I treatment (Zymo Research 
Corp), following manufacturer instructions. The quantity of RNA was assayed on Qubit 
using RNA BR assay (Life Technologies Corp), and quality was assessed on Agilent 
2100 Bioanalyzer using RNA 6000 Nano Assay (Agilent Technologies Inc). Total RNA 
was used to isolate poly(A) mRNA using NEBNext Poly(A) mRNA Magnetic Isolation 
Module, and libraries were prepared using NEBNext UltraII Directional RNA Library 
Prep Kit for Illumina (New England Biolabs) following manufacturer instructions. The 
quantity of library was assayed using Qubit DNA HS assay (Life Technologies Corp), 
and quality was analyzed on Bioanalyzer (Agilent Technologies Inc). Libraries were 
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sequenced on Illumina NextSeq 500 platform using NextSeq 500/550 High Output v2 kit 
(150 cycles) with 76 bp paired-end sequencing chemistry.  
  Sequence quality was assessed using FastQC (Andrews, n.d.) and MultiQC 
(Ewels et al., 2016). Reads were aligned to the hg38 human reference genome using 
STAR (Dobin et al., 2013). Transcript abundance was quantified using RSEM (B. Li & 
Dewey, 2011) and normalized to counts per million (CPM) in R using the edgeR 
software package (Robinson et al., 2010). Analyses to compare gene expression between 
cell types was conducted in Excel by finding the average CPM in the pool of genes of 
interest for the associated cell type and determining the standard deviation away from the 












Figure 3.1 Reglucosylation substrate identification experimental design 
 
(A) The pathway of N-glycosylation in eukaryotic cells is depicted. N-glycan synthesis is 
initiated in the outer ER membrane leaflet on a dolichol-P-phosphate facing the 
cytoplasm. Flipping of the precursor N-glycan to the ER luminal leaflet and further 
synthesis steps mediated by ALG proteins leads to eventual transfer of a 
Glc3Man9GlcNAc2 N-glycan to a substrate by the OST complex. ALG6 (red lettering) 
catalyzes the transfer of the initial glucose onto the Man9 precursor N-glycan. (B) In wild 
type (WT) cells, a Glc3Man9GlcNAc2 N-glycan is transferred to substrates. 
Monoglucosylated substrates may therefore occur via trimming by glucosidases I/II 
(GlsI/II) or reglucosylation by UGGT1/2. In ALG6-/- cells, a Man9GlcNAc2 N-glycan is 
transferred to substrates. Therefore, monoglucosylated substrates may only occur through 
reglucosylation by UGGT1/2. DNJ (500 µM) was added to block the trimming of 
monoglucosylated substrates by GlsII. ALG6-/- cells were then lysed and split equally 
between affinity purifications with either GST-CRT or GST-CRT-Y109A bound to 
glutathione beads. Affinity-purified samples were then reduced, alkylated, trypsinzed, 
and labeled with TMT labels. Samples were then deglycosylated with PNGaseF, pooled, 





Figure 3.2 Identification of the substrates of the UGGTs 
 
(A) Substrates were identified by dividing the quantification of the TMT label in the 
GST-CRT condition for each protein by that of the associated GST-CRT-Y109A 
condition, yielding the fold increase. Localization as predicted by Uniprot annotation is 
depicted. A cutoff of three-fold increase was applied. Data is representative of two 
independent experiments. Error bars represent standard error of the mean (SEM). (B) The 
N-glycome was computationally determined by collecting all proteins annotated to 
contain an N-glycome by Uniprot. Annotated localization information was then used to 
computationally determine the localization distribution of the N-glycome as well as the 






Figure 3.3. Identification of UGGT1 and UGGT2 specific substrates 
 
(A) Reglucosylation substrates in ALG6/UGGT2-/- cells were identified and quantified as 
previously described in Figure 3.1. Localizations as annotated by Uniprot are depicted. 
Data are representative of two independent experiments. Error bars represent SEM. (B) 
Reglucosylation substrates in ALG6/UGGT1-/- cells were identified and quantified as 













Figure 3.4 UGGT1 and UGGT2 expression 
 
(A) The indicated cells were lysed and whole cell lysates were resolved by SDS-PAGE 
and imaged by immunoblotting against UGGT1 and GAPDH. Asterisk denotes 
background band. Data are representative of three independent experiments with 
quantification shown in B. UGGT1 expression was normalized to that of ALG6-/- cells. 
Error bars represent standard deviation. Asterisk denotes a p-value of less than 0.05. (C) 
Counts per million of UGGT2 mRNA generated by RNAseq from Supplemental Table 4 
was analyzed for the level of UGGT2 mRNA expression in the indicated cell lines. 
Counts per million of all genes were averaged and the standard deviation from the 
average for UGGT2 mRNA was determined. Error bars represent the standard deviation. 






Figure 3.5 UGGT1 and UGGT2 substrates comparison 
 
(A) The distribution of localizations as annotated by Uniprot for reglucosylation 
substrates identified in both ALG6/UGGT2-/- and ALG6/UGGT1-/- cells is depicted. (B) 
The overlap of reglucosylation substrates identified in both ALG6/UGGT2-/- cells (purple) 
and ALG6/UGGT1-/- cells (grey) is visualized by a Venn diagram. (C) Reglucosylation 
substrate enrichment in either ALG6/UGGT1-/- or ALG6/UGGT2-/- cells is depicted by 
dividing the TMT quantification for each protein in ALG6/UGGT2-/- cells by the 
associated value in ALG6/UGGT1-/- cells on a log10 scale. Positive and negative values 
represent enrichment in ALG6/UGGT1-/- and ALG6/UGGT2-/- cells, respectively. 
Localization based on Uniprot annotation is depicted. Proteins are depicted as either 






Figure 3.6 Validation of CI Man-6-Phosphate receptor and IGF-1R reglucosylation 
 
(A) The designated cell lines were lysed and split into whole cell lysate (WCL, 10%) or 
affinity purification by GST-CRT-WT or GST-CRT-Y109A and imaged by 
immunoblotting against the CI Man-6-Phosphate receptor. Data is representative of three 
independent experiments with quantification shown in panel B. Quantifications were 
calculated by subtracting the value of protein in the Y109A lane from the value of protein 
in the associated WT lane, divided by the value of protein in the associated WCL lane. 
Error bars represent the standard deviation. Asterisks denote a p-value of less than 0.05 
(C) TMT mass spectrometry quantification of CI Man-6-Phosphate receptor 
reglucosylation from ALG6/UGGT1-/- cells (Figure 3.3B) and ALG6/UGGT2-/- cells 
(Figure 3.3A). (D) Cartoon representation of CI Man-6-Phosphate receptor with N-
glycans (branched structures), the signal sequence (grey), luminal/extracellular domain 
(blue), transmembrane domain (black) and intracellular domain (green) depicted. Number 
of amino acids and Cys residues are indicated. (E) Reglucosylation of IGF-1R, conducted 
as previously described above. Pro IGF-1R and mature IGF-1R are both observed due to 
proteolytic processing. Data are representative of three independent experiments with 
quantification displayed in F. (G) TMT mass spectrometry quantification of IGF-1R from 













Figure 3.7 Validation of ENPP1 and b-hexosaminidase subunit b reglucosylation 
 
(A) The reglucosylation of ENPP1 shown with quantification displayed in B, as 
described in Figure 3.6 (C) TMT mass spectrometry quantification of ENPP1 from 
Figure 3.3A and B with cartoon depiction of ENPP1 in D as described in Figure 3.6 (E) 
Reglucosylation of b-hexosaminidase subunit b with quantification displayed in F and 
TMT mass spectrometry quantification of b-hexosaminidase subunit b from Figure 3.3A 
















Figure 3.8 mRNA expression analysis of UGGT1 and UGGT2 substrates 
 
(A) Reglucosylated substrates identified in ALG6-/- (A), ALG6/UGGT1-/- (B) and 
ALG6/UGGT2-/- (C) cells were compared to the average expression for the N-glycome in 
counts per million. The standard deviation from the average is plotted, with the error bars 
representing the standard deviation. Blue dots above each gene represent the level of fold 
increase (GST-CRT/GST-CRT-Y109A) found by TMT mass spectrometry (Figure 3.2 
and 3.3). The Pearson’s correlation coefficient (R) between the mRNA expression and 









Figure 3.9 Analysis of substrates of the UGGTs and the N-glycome 
 
(A) Amino acid lengths of each protein in the indicated datasets was visualized by 
density plot, with the total area under the curve integrated to 1. Amino acid number was 
obtained via Uniprot annotation. All density plots were generated using R and the ggplot 
package. (B) The number of N-glycans (B) or Cys residues (C) for each protein in the 
indicated datasets was visualized by density plot with the numbers determined using their 
Uniprot annotation. (D) The isoelectric point (pI) values for each protein in the indicated 
datasets was visualized by density plot. The pI values were obtained via ExPASy 
theoretical pI prediction. (E) The computationally predicted N-glycome and the indicated 
reglucosylation substrates were determined as either soluble or transmembrane using 
Uniprot annotations. The transmembrane portion of each dataset was then analyzed for 
type I, type II, or multi-pass topology using the associated Uniprot annotation. Proteins 
which were annotated by Uniprot as transmembrane but lacked topology information 













Figure 3.10 Analysis of N-glycome transmembrane proteins 
 
(A) The computationally determined N-glycome was separated into soluble, type I, type 
II, and multi-pass transmembrane proteins using Uniprot annotations. Luminally exposed 
amino acids were computationally determined using Uniprot annotations for each subset 
of the N-glycome and each indicated reglucosylation substrate dataset. The resulting data 
was visualized by density plot. (B) The indicated N-glycome subsets were analyzed for 
N-glycan content using Uniprot annotation and visualized by density plot, as described. 
(C) The indicated N-glycome subsets were analyzed for predicted pI using ExPASy 






Figure 3.11 Calnexin/calreticulin cycle role for IGF-1R trafficking at steady state 
 
(A) WT HEK293-EBNA1-6E cells treated without or with DNJ (500 µM) for 12-hr were 
lysed and WCL samples were resolved by reducing 9% SDS-PAGE and imaged by 
immunoblotting against IGF-1R. Data are representative of three independent 
experiments with quantification shown in B. Percent of IGF-1R mature was calculated by 
dividing the amount of mature protein by the total protein in each lane. Errors bars 
represent standard deviation. Asterisk denotes a p-value of less than 0.05 (C) The 
indicated cell lines were lysed in RIPA buffer. Samples were split evenly between non-
treated and PNGaseF or EndoH treated. Samples were visualized by immunoblotting 
against IGF-1R and data are representative of three independent experiments with 









Figure 3.12 Mechanistic calnexin/calreticulin cycle role for IGF-1R trafficking 
 
(A) Indicated cells were treated without or with DNJ, pulsed with [35S]-Met/Cys for 1-hr 
and chased for the indicated times. Cells were lysed and samples were 
immunoprecipitated using anti-b IGF-1R antibody and resolved by reducing SDS-PAGE 
and imaged by autoradiography. Data are representative of three independent 


















Figure 3.13 Model for IGF-1R engagement by the lectin chaperone cycle 
 
In WT cells, N-glycans with three terminal glucoses are appended to IGF-1R. Trimming 
of two terminal glucoses by glucosidases I/II generates a monoglucosylated protein 
which supports an initial round of interaction with calreticulin (calnexin not shown, 
denoted by a 1). Trimming of the final glucose by glucosidase II yields a non-
glucosylated N-glycan. If recognized as non-native primarily by UGGT1, and to a lesser 
extent UGGT2, IGF-1R may then be reglucosylated, supporting a second round of 
interaction with calreticulin (denoted by a 2+). Multiple rounds of trimming, 
reglucosylation and binding to calnexin or calreticulin can occur until proper folding and 
trafficking. Under this system, IGF-1R is efficiently trafficked from the ER and mature 
132 
 
IGF-1R accumulates. When glucosidase I/II activity is inhibited by treatment with DNJ 
in WT cells, all rounds of binding to the lectin chaperones are ablated and IGF-1R is 
retained in the ER, yielding primarily pro IGF-1R. In UGGT1/2-/- cells, initial binding to 
calnexin or calreticulin directed by glucosidases I/II trimming is maintained but rebinding 
via reglucosylation does not occur. Under this system, IGF-1R is inefficiently trafficked 
from the ER. In ALG6-/- cells, N-glycans are transferred without glucoses, eliminating the 
initial round of binding to calnexin or calreticulin by glucosidases trimming. Only the 
second round of binding is supported by UGGT1, and to a lesser extend UGGT2, 
mediated reglucosylation. Upon treatment with DNJ, reglucosylated IGF-1R may 











































As the ER is the site of folding and maturation for a large percentage of the 
proteome, it is critical to understand the quality control processes these proteins are 
subjected to. Errors in ER quality control are implicated in numerous diseases (Hartl, 
2017; Hebert & Molinari, 2007), and targeted approaches to improve these and other 
disease states with connections to ER quality control are of great interest. As 
demonstrated by work presented here (Adams, Ke, et al., 2019), it is highly difficult to 
predict what branch of ER quality control a given protein will engage, and as such must 
be experimentally determined. An understanding of what quality control branch a protein 
of interest is engaged by allows for the identification of potential sites of intervention 
regarding the maturation and trafficking pathway associated. 
A large percentage of proteins targeted to the ER are N-glycosylated (Quellhorst 
et al., 1999; Zielinska et al., 2010) and therefore are potentially engaged by the N-glycan 
dependent calnexin/calreticulin cycle. This cycle is a major branch of ER quality control 
known to be involved in the folding and maturation pathway of multiple glycosylated 
substrates (Hebert et al., 1996; Molinari et al., 2005; Ferris et al., 2013; Adams, Oster, et 
al., 2019). UGGT1, and the lesser studied UGGT2, are key drivers of the 
calnexin/calreticulin cycle and essential for cellular proteostasis (Hebert et al., 1995; 
Molinari et al., 2005; Pearse et al., 2010; Tannous et al., 2015), but are poorly studied 
with regards to their endogenous roles as most work uses overexpressed proteins or in 
vitro approaches. The general goal of this work was therefore to experimentally identify 
and investigate the substrates which are engaged by UGGT1 and UGGT2 and are 
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therefore most dependent on the calnexin/calreticulin cycle. To this end, this work laid 
out an experimental workflow which identified a combined total of 71 substrates of 
UGGT1 and UGGT2, as well as a number of exciting discoveries regarding the substrate 
specificity of each glucosyltransferase and the role of the calnexin/calreticulin cycle for 
one UGGT1 substrate, IGF-1R (Chapter 3). This work has helped to open a number of 
possibilities for future research which will be described here. 
 
Cell type and condition specific reglucosylation substrates 
  
 The work presented in Chapter 3 was conducted in HEK293-EBNA1-6E cells. 
The profile of substrates for UGGT1 and UGGT2 are likely, to an extent, specific to this 
cell line as each cell line exhibits unique protein expression profiles which are therefore 
available to be queried by ER quality control (Wilhelm et al., 2014; Ding et al., 2016). It 
would be of great interest to conduct the previously described workflow of UGGT1 and 
UGGT2 substrate identification in other cells lines including cell types with a high 
secretory load, such as liver or pancreatic cells. These cells express secretory pathway 
proteins at a high level and may therefore require increased chaperone engagement to 
maintain proteostasis in the crowded environment. Also, identifying UGGT1 and UGGT2 
substrates in neuronal-derived cell lines would be of interest as congenital disorders of 
glycosylation involving ALG6, an early component of the calnexin/calreticulin cycle, 
often manifest as neurological issues (Morava et al., 2016). It is therefore possible that in 
some neuronal cells, specific proteins require high levels of engagement by UGGT1 or 
UGGT2 and the calnexin/calreticulin cycle, and therefore ablation of this cycle through 
an ALG6 mutation could lead to disease onset due to misfolding of these proteins, similar 
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to the severe loss of trafficking of IGF-1R observed under ALG6-/- (Figure 3.12). 
Identifying these potential substrates may allow for improved explanation of disease 
phenotype and potential therapeutic approaches. The identification of substrates highly 
engaged by UGGT1 and UGGT2 in different cell types may therefore highlight 
glycoproteins which are most sensitive to off-pathway folding and therefore require high 
chaperone engagement for each cell type. This information may be valuable for 
understanding tissue-specific phenotypes of protein misfolding diseases and highlighting 
the potential benefit of targeting the calnexin/calreticulin cycle for treatment. 
 As UGGT1 and UGGT2 engage non-native proteins and promote chaperone 
interaction, their role may be especially important under conditions of proteostatic stress. 
Under such stress conditions, ER proteins may misfold at a high rate and therefore 
UGGT1 and UGGT2 would engage these substrates at an increased level. This would 
function to promote increased chaperone engagement, therefore retaining non-native 
proteins while decreasing potential aggregation and secretion of non-functional proteins. 
Numerous stress treatments, including oxidative stress, heat stress, and nutrient starvation 
could be investigated in order to observe both levels of reglucosylation of substrates as 
well as identify proteins which were not found to be substrates under homeostatic 
conditions but become substrates upon stress-induced misfolding. Oxidative stress may 
be of special interest as UGGT1 and UGGT2 tightly bind Sep15, a selenocysteine-
containing protein which has a high redox potential but no well-defined role (Kasaikina 
et al., 2011; Y. Takeda et al., 2014). The entire pool of Sep15 is engaged by either 
UGGT1 or UGGT2 and may be involved in binding unpaired or mispaired Cys residues 
on UGGT1 and UGGT2 substrates, thereby directing substrate recognition. In addition to 
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oxidative stress, reglucosylation substrate identification could be conducted under Sep15 
knockout, which may also help identify substrates directly engaged by this intriguing 
oxidoreductase. 
 The profile of engaged substrates may also be altered by the overexpression of a 
known substrate of UGGT1 or UGGT2, such as those identified in Chapter 3, or a known 
misfolding mutant of a substrate. This would mimic the environment of the ER in a 
disease state dominated by a misfolded protein which is heavily engaged by ER quality 
control. Under this condition, UGGT1 or UGGT2 may be titrated away from other 
substrates, resulting in decreased chaperone engagement and potentially leading to 
secondary effects. Potential substrates include b-hexosaminidase subunit b, arylsulfatase 
A, or a-N-acetylgalactosaminidase, all of which are UGGT2 substrates with mutations 
leading to lysosomal storage diseases (Mahuran, 1999; Cesani et al., 2016; Ferreira & 
Gahl, 2017), or collagen a-1(VI) chain, for which multiple known mutations exist which 
lead to decreased secretion and disease onset (Giusti et al., 2005; Lucioli et al., 2005). 
Observation of such an effect would demonstrate that the levels of UGGT1 or UGGT2 
can become exhausted, and therefore under disease states due to a misfolded mutant, 




 While the work presented here identified proteins which are substrates of UGGT1 
and UGGT2 (Chapter 3), this work did not identify which specific glycan or glycans on 
the protein was reglucosylated as the entire protein was affinity purified by GST-CRT 
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prior to mass spectrometry preparation. As such, details regarding the sites of interaction 
for UGGT1 or UGGT2 and calnexin/calreticulin could not be elucidated. The 
identification of the specific glycans which are reglucosylated would be of great value for 
multiple reasons. As previous work has demonstrated, an understanding of the glycans 
which are engaged by calnexin/calreticulin can allow for an understanding of the folding 
trajectory and chaperone engagement pathway for a given substrate (Daniels et al., 2003). 
Such a detailed picture could be gained for numerous substrates by the identification of 
glycan-specific reglucosylation. This would allow for the identification of potential sites 
of alteration in order to modify the maturation pathway of a given substrate of interest, 
potentially to increase or decrease the level of ER quality control engagement. Glycan-
specific information may also allow for an understanding of preferred binding sites for 
UGGT1 and UGGT2. Those sites could then be analyzed for sequence similarity and 
biophysical characteristics such as hydrophobicity, a-helix or b-sheet propensity, or the 
presence of unique amino acids such as Cys and Pro. This information would allow for a 
greatly improved ability to predict the substrates UGGT1 or UGGT2 engages as well as 
specific sites of engagement. Such prediction would be valuable as the chaperone 
engagement pathway of a substrate may be of interest though empirical data has not 
determined if UGGT1 or UGGT2 engage that substrate, due to potential experimental 
issues such as expression level in a given cell line or a disease relevant mutation.  
 In order to gain glycan-specific information, the existing protocol laid out in this 
work must be adapted (Figure 4.1). First, the steps of calreticulin affinity purification and 
trypsin-mediated peptide generation could be altered. The initial GST-CRT affinity 
purification post-lysis could be kept in order to enrich the pool of monoglucosylated 
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substrates. These proteins would then need to be eluted from GST-CRT using heat and a 
buffer which forms very small micelles, such as sodium deoxycholate, before alkylation 
and trypsinization. The sample would then be heated to denature trypsin and digested 
peptides would then be transferred to a filter-based approach as has been used for other 
applications regarding glycoprotein purifications (Zielinska et al., 2010). Peptides would 
then be placed into a second round of GST-CRT affinity purification, without beads, 
before being transferred to a 30 kDa filter. On this filter, GST-CRT bound peptides 
would be retained while non-bound peptides would flow through. The addition of the 
endoglycosidase PNGaseF would deglycosylated peptides, leading to a loss of interaction 
with GST-CRT and allowing those peptides to flow through the filter and be collected. 
As PNGaseF deglycosylates peptides via deamidation of the N-glycosylated Asn residue, 
sites of deamidated Asn could be identified by mass spectrometry, allowing for specific 
identification of N-glycosylated peptides. This would increase the confidence in 
identified peptides, as non-deamidated peptides, as well as peptides without an N-
glycosylation motif, would have been non-specifically purified. The resulting peptides 
could be TMT-labeled, allowing for quantitative mass-spectrometry peptide 
identification. Conducting this work using the described ALG6/UGGT1-/- or 
ALG6/UGGT2-/- cell lines would allow for identification of UGGT1 or UGGT2 glycan-
specific substrates. The described approach has been undertaken in the lab by Kevin 
Guay with promising initial results. 
 
Live-cell reglucosylation imaging 
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 While the work presented in Chapter 3, as well as the potential addition of glycan-
specific reglucosylation data, lends great insight into lectin chaperone-mediated protein 
folding in the ER, there is still much spatio-temporal detail which remains unknown. 
Many questions could be addressed by gaining real-time and spatial data regarding 
reglucosylation. While the ER is composed of a singular lumen, much recent work has 
demonstrated that the ER is organized into subdomains through concentration of proteins 
with similar functions (Graham et al., 2019; Saito & Maeda, 2019; Nishimura & Stefan, 
2020), as well as morphologically distinct regions (Borgese et al., 2006; Westrate et al., 
2015). Therefore, a primary question is does reglucosylation in general occur within 
distinct subdomains of the ER, and do UGGT1 and UGGT2 specifically function in 
different subdomains of the ER. Data presented in Chapter 3 indicates UGGT2 more 
heavily engages lysosomal proteins than does UGGT1, suggesting the possibility that 
UGGT1 and UGGT2 function in distinct regions of the ER which are accumulated for 
different sets of substrates. Another unanswered question is does UGGT1 or UGGT2 
function with temporal specificity, such as high activity at distinct phases during the cell 
cycle or peaks of activity under proteotoxic stress. In order to answer these questions, it is 
necessary to develop a live-cell reporter of reglucosylation. A FRET-based reporter has 
been used for live-cell imaging of O-glycosylation (Carrillo et al., 2011), suggesting this 
approach may be functional for imaging reglucosylation.  
 To this end, we have been working to generate a fluorescence lifetime imaging 
microscopy (FLIM)-FRET-based reporter for reglucosylation. The FLIM-FRET approach 
allows for improved quantification and noise reduction as compared to standard FRET 
(Becker, 2012). From N- to C-termini, the reporter will contain a signal sequence for ER 
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targeting, the fluorescent protein mTFP1 (the donor in the FLIM-FRET pair), a flexible 
linker of Gly and Ser residues, the lectin region of calreticulin, a second flexible linker, a 
glycosylated sequence which is recognized by either UGGT1 or UGGT2, the dark 
fluorescent protein ShadowG (the acceptor in the FLIM-FRET pair) (Murakoshi et al., 
2015), and a KDEL sequence for ER-retention. Flexible linkers may be added or 
modified in order to achieve a function reporter. The reporter would function through 
reglucosylation of the glycosylated substrate, leading to the lectin domain of calreticulin 
binding to the monoglucosylated glycan. This would lead to a conformation shift of the 
reporter and bring the FLIM-FRET pairs into close contact. Under excitation, the 
fluorescence lifetime of mTFP1 would be measured. Increased reglucosylation of the 
reporter would lead to increased FLIM-FRET, yielding a decreased fluorescence lifetime 
of mTFP1 (Figure 4.2). 
 The described construct has been generated except for the glycosylated substrate 
region. The ideal substrate for either UGGT1 or UGGT2 may be identified through data 
generated by glycan-specific reglucosylation substrates, but may also be found through 
substrates presented in Chapter 3. For example, the UGGT2 substrate b-hexosaminidase 
subunit b contains four glycans (Figure 3.7). Using overexpression assays, these glycans 
could be individually mutated to determine the specific glycan, or glycans, that are 
reglucosylated by UGGT2. The region surrounding the glycan of interest could then be 
used as the substrate.  
In addition to the described uses of this reporter in addressing spatio-temporal 
questions regarding reglucosylation, this reporter could also be useful as a high-
throughput assay for the development of inhibitors or activators of UGGT1 or UGGT2. A 
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library of compounds could be investigated for the ability to decrease FLIM-FRET in a 
multi-well plate format before further investigation of compounds of interest using more 
direct techniques such as those used in Figure 3.6 and 3.7. These compounds could then 
be used both for targeted cell biology studies regarding the function of UGGT1 and 
UGGT2 as well as investigating potential therapeutic function for diseases relating to ER 
quality control, such as cystic fibrosis or lysosomal storage diseases (Younger et al., 
2006; Dersh et al., 2016). As described in Chapter 3, IGF-1R is overexpressed in many 
cancers and, under UGGT1 and UGGT2 knockout, is trafficked to the plasma membrane 
at a decreased rate (Figure 3.12). Therefore, a potential inhibitor of UGGT1 and UGGT2 
may function as a treatment against cancer. As many substrates are engaged by UGGT1 
and UGGT2, such therapeutic intervention would be of interest in a number of related 
diseases. Additionally, an inhibitor of either UGGT1 or UGGT2 would be very useful for 
basic cell biology questions related to the calnexin/calreticulin process, as the function of 
UGGT1 or UGGT2 could be specifically inhibited without the requirement of generating 
a knockout in each cell line of interest. 
 
Role of UGGT2 in lysosomal function 
A significant result presented in Chapter 3 is that UGGT2 has reglucosylation 
activity and is preferential towards lysosomal proteins (Figure 3.5). The majority of the 
proteins are enzymes which function in the degradation process of carbohydrates or lipids 
and, as previously discussed, can lead to lysosomal storage diseases when mutated. 
Therefore, it would be of great interest to understand the effect of UGGT2 on lysosomal 
function and the potential role it could play in the suppression of disease states through 
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promotion of ER to lysosome trafficking. As some mutations in such enzymes which 
manifest as lysosomal storage diseases do in fact possess partial activity (Leinekugel et 
al., 1992; Wens et al., 2012), it may be therapeutic to promote increased trafficking of 
these mutants to the lysosome. Additionally, impaired UGGT2 activity may lead to a 
substrate specific effect on trafficking to the lysosome. As presented in Figure 4.3, 
ablation of the ability of b-hexosaminidase subunit b to enter the calnexin/calreticulin 
pathway through treatment with the glucosidase inhibitor DNJ lead to a decrease in 
mature b-hexosaminidase subunit b, suggesting UGGT2 is necessary for efficient 
trafficking to the lysosome. Therefore, UGGT2 may play a role in lysosome function 
through promotion of productive folding and trafficking of lysosomal proteins. However, 
much work is needed to clarify the function of UGGT2 for the many functions the 
lysosome possesses, especially with regards to the substrates highlighted in Chapter 3. 
One approach to elucidate the role of UGGT2 in lysosome function would be to 
study the metabolomic profile of the lysosome under UGGT2-/-. If a lysosomal enzyme 
does not fold properly due to a loss of UGGT2 mediated reglucosylation, poor trafficking 
to the lysosome may result. As such, the metabolic pathway catalyzed by the enzyme of 
interest would be altered and metabolites may accumulate. The identification of altered 
levels of metabolites would highlight pathways which are impaired and therefore require 
UGGT2 function. This approach would require the purification of lysosomes from cells 
before lysis and sample preparation. Previous work has demonstrated the ability to purify 
lysosomes using an overexpressed triple HA-tagged TMEM192 construct (Abu-Remaileh 
et al., 2017). TMEM192 is a multi-pass lysosomal membrane protein, and the 
overexpression of this protein with a cytosolically exposed triple HA-tag allows for the 
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purification of lysosomes from cell lysate. Samples can then be sent to mass spectrometry 
facilities with capabilities to conduct metabolomics. Amount of total lysosomal enzymes 
present in both the lysosomal enriched and de-enriched fractions could be analyzed by 
quantitative mass spectrometry or targeted western blots to control for total number of 
cells and expression of lysosomal enzymes.  
However, many lysosomal enzymes at significantly reduced concentrations 
compared to WT levels can still generate similar concentrations of metabolites. As such, 
metabolomics may not effectively identify alterations in enzyme concentrations due to 
trafficking defects in UGGT2-/- cells, though the depletion of multiple enzymes may lead 
to additive effects which could improve the utility of a metabolomics approach. If a 
metabolomics approach is not successful, a more targeted approach using activity assays 
designed against single proteins may be used, as are available for proteins such as b-
hexosaminidase subunit b and arylsulfatase A (Matzner et al., 2007; Thelen et al., 2017). 
In this case, purified lysosomes would also be necessary in order to concentrate the 
sample for the enzymes of interest. While the described Tmem192-HA approach may be 
used, an alternative approach would be to isolate lysosomes using a magnetic purification 
approach which exposes cells for 24 hr to dextran-coated 10-nm iron oxide particles. 
These particles are then endocytosed and delivered to the lysosome, where they 
accumulate and, post cell lysis, allow lysosomes to be purified magnetically (Thelen et 
al., 2017). 
The role of UGGT2 regarding lysosome function may also be investigated 
through microscopy, as a decrease in enzyme localization at the lysosome may lead to 
accumulation of substrates and lead to lysosomal swelling. Lysosome size can then be 
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analyzed via a lysosome targeted fluorescent antibody. Such an approach has been used 
to investigate the effect of chaperone overexpression in primary fibroblasts from patients 
with multiple types of lysosomal storage diseases (Kirkegaard et al., 2016). These 
approaches may also be combined to investigate possible therapeutic treatments 
involving UGGT2 for cell lines expressing mutant lysosomal enzymes.  
 
Role of the calnexin/calreticulin cycle in proteome trafficking 
Pulse-chase data presented in Figure 3.12 demonstrated that endogenous IGF-1R 
exhibits decreased trafficking under multiple conditions which alter the 
calnexin/calreticulin cycle. These data gave a detailed picture of the role of the 
calnexin/calreticulin cycle for IGF-1R, but a proteomic level of detail would be a great 
improvement over attempting numerous targeted pulse-chases for single proteins, 
especially as many proteins will not have antibodies which function for 
immunoprecipitations. While a steady-state approach would allow for more functional 
antibodies as immunoprecipitations would not be necessary, a pulse-chase type approach 
would give much more information regarding trafficking kinetics than a steady-state 
approach. The level of detail between the two general approaches was demonstrated in 
Chapter 3, where IGF-1R was found to display a 19% decrease in trafficking from the ER 
under DNJ treatment at steady-state (Figure 3.11), while a 63% reduction after 2 hr was 
observed under pulse-chase (Figure 3.12). As such, we have begun developing an L-
Azidohomoalanine (AHA) based approach to investigate the role of the 
calnexin/calreticulin cycle for the trafficking of clients of the secretory pathway.  
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AHA is a methionine analog that is metabolically incorporated in the place of 
methionine and possesses an azido moiety. This azido moiety can then be used in copper-
catalyzed alkyne click chemistry reactions to specifically label AHA with desired groups 
such as biotin which can be used to purify labeled proteins. AHA labelling can occur for 
different amounts of time, commonly 1-2 hours, then chased with complete media in 
order to generate a pulse-chase under which the trafficking of the labeled population can 
be tracked. Cell membrane impermeable click-reactive biotin may be used in order to 
label only proteins the region of interest, such as secreted, plasma membrane, ER, or 
lysosome. Purified proteins from a given region can then be prepared for quantitative 
mass spectrometry. By comparing the amount of proteins in the different localizations, 
the effect of a given knock-out or inhibitor on proteomic-scale trafficking can be 
examined. Such conditions may include ALG6-/-, UGGT1-/-, UGGT2-/-, CANX-/-, CALR-/-, 
and combinations, as well as DNJ or potential UGGT1 or UGGT2 inhibitors. The ability 
to understand the role of the calnexin/calreticulin cycle in the trafficking of proteins at a 
proteomic level would allow for an unprecedented amount of information regarding the 
role of this cycle and how it can be modified to alter the folding and trafficking pathway 
of any identified protein of interest. 
 
Summary 
 While ER quality control, and specifically the calnexin/calreticulin cycle, has 
been studied for many years which has greatly expanded the understanding of the quality 
control and chaperone systems which engage nascent secretory pathway proteins, this 
field has not been well examined using proteomic and computational approaches as 
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presented here. By applying a proteomics-based approach, many new avenues of research 
are opening which may allow for a much improved understanding of the role and 
importance of this process at a systematic level. Some of these avenues, including 
identifying reglucosylation substrates in various cell lines and stress conditions as well as 
glycan-specific reglucosylation, are likely to be productive in a short timeline and will be 
very exciting expansions of the current field. With sufficient study, the ER quality control 
processes being discovered may be of great use for both basic cell biology and the 



















Figure 4.1 Glycan-specific reglucosylation substrate identification workflow 
Reglucosylated proteins from cell lysates would first be enriched using the previously 
described on-bead GST-CRT affinity purification approach (Figure 3.1B). Protein would 
then be eluted from GST-CRT using heat and deoxycholate. The sample would then be 
reduced with DTT, alkylated using iodoacetamide, and trypsinized. Trypsin would then 
be heat inactivated and peptides incubated with GST-CRT in solution to bind 
monoglucosylated peptides. The sample would then be placed in a 30 kDa spin filter and 
unbound peptides would flow through the filter while GST-CRT bound peptides would 
be retained. GST-CRT bound peptides would then be eluted through deglycosylation 
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using PNGaseF. Asn residues modified with N-glycans would be deamidated (denoted by 
OH group) after PNGaseF mediated deglycosylation. Samples would then be labeled with 



































Figure 4.2 Live-cell reglucosylation FLIM-FRET reporter 
The current reporter design and proposed method of action is depicted. The reporter 
would be targeted to the ER via a signal sequence (grey), which would be cleaved after 
translocation. The FLIM-FRET pairs mTFP1 (blue) and ShadowG (dark green) are 
placed on the N- and C-termini, respectively. The lectin domain of calreticulin (CRT) 
(red) immediately C-terminal to mTFP1 followed by the glycosylated UGGT1/2 substrate 
(orange). Flexible linker regions are shown by black lines between domains. Upon 
reglucosylation of the glycosylated substrate by UGGT1/2, the lectin domain of CRT 
would bind to the monoglucosylated glycan, bringing mTFP1 and ShadowG in 
sufficiently close proximity to undergo FRET upon donor excitation. FRET between 
mTFP1 and ShadowG would be measured by the fluorescence lifetime microscopy 





















Figure 4.3 Role of the calnexin/calreticulin pathway for b-hexosaminidase subunit b 
trafficking  
WT HEK293-EBNA1-6E cells treated without or with DNJ (500 µM) for 12-hr were 
lysed and WCL samples were resolved by reducing 9% SDS-PAGE and imaged by 
immunoblotting against IGF-1R. Data are representative of three independent 
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